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CHO = Chinese hamster ovary PTB = phosphotyrosine-binding domain
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cPKC = conventional Protein kinase C RGS = regulator of G-protein signaling
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mTOR = mammalian target of rapamycin
mTORC = mTOR-complex
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Introduction
Principles of signal transduction
Communication and interaction between cells is probably older than any multicellular 
organism, since already yeast as a single cell organism have been shown to inﬂuence 
another cell by secreting a signaling molecule. Mating yeast secret a ‘mating factor’ that 
causes other yeast to stop proliferating and instead to prepare for mating (Marsh, Neiman, 
& Herskowitz, 1991), showing that communication between cells is crucial to control critical 
cellular responses. In multi-cellular organisms, cells developed many different 
mechanisms to speciﬁcally interact and/or manipulate each other. The more complex an 
organism the more crucial it becomes to restrict and specify signals to prevent unwanted 
crosstalk between cells. The easiest and simplest way of communication is through direct 
interaction of two or more cells. In case of contact dependent signaling, the molecule, also 
called ligand, is presented on the cell membrane by the neighboring cell. The receiving cell 
presents a receptor on the membrane that speciﬁcally  recognizes and binds one or more 
signaling molecule. Contact-dependent ligand-receptor binding is the main form of 
communication between cells during development and in immune response and 
represents an extremely speciﬁc and local event that requires physical contact between 
the effector and the receiving cell. In higher organisms signals often have to be sent over 
long distances. Cells therefore started to secret soluble signaling molecule instead of 
presenting the signaling molecules on the membrane. The advantage of this system is that 
numerous distant cells can be reached by the secreted molecules but the effect can also 
be a local event and can be limited to a single organ or to events such as infection or 
injury. The secretion of a signaling molecule by a single cell or a group of cells to activate, 
modulate or recruit the same cell is called autocrine signaling, whereas secretion of a 
molecule by a single cell to regulate different adjacent cells is called paracrine signaling. 
During autocrine signaling the hormone produced by one cell binds to receptors on the 
same cell and modulates its cell response. During paracrine signaling the signaling 
molecule is secreted by one cell and affects a different cell nearby. To regulate cell 
responses further away higher organisms have developed endocrine signaling which is 
mediated by hormones that are released into the blood stream and can affect the whole 
body or control certain tissues and organs. The endocrine system ensures that an 
organism can react to an event with a systemic response, such as hormone release into 
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the blood, which in turn can have different local effects. A signaling molecule involved in 
paracrine and endocrine signaling is for example vasopressin. Vasopressin, also known as 
ADH, is mainly synthesized in a region of the brain called hypothalamus where it acts as a 
neurotransmitter and seems to play an important role in memory and diseases such as 
Schizophrenia and Autism (Frank & Landgraf, 2008). Moreover, when secreted into the 
blood, e.g. after osmotic stress, it acts as a peptide hormone and mediates diverse 
biological effects depending on the interacting receptor. The vasopressin receptors V1a, b 
(V1R) and V2 (V2R) are found on the surface a variety of tissue including vascular smooth 
muscle, kidney, liver and spleen. In the kidney vasopressin acts by the V2R and regulates 
the water balance of the organism (Zingg, 1996). The V2R is exclusively  expressed in the 
collecting ducts of the organ (Mutig et al., 2007) and this signaling cascade is a good 
example illustrating how a systemic signal can control local biological processes. In 
summary, all types of communication are based on the same principle: a speciﬁc ligand-
receptor interaction. Most receptors are membrane bound and highly  speciﬁc for one 
group of ligand or even for one kind of signaling molecule. Whether a cell is affected by a 
certain hormone or molecule is therefore dependent on the cell-surface receptors 
presented on the membrane.
Three large classes of the cell surface receptors
As mentioned above, all signaling molecules bind to speciﬁc receptors presented on the 
surface of the target cell. The binding of the ligand to its corresponding receptor induces a 
process that is called signal transduction. Signal transduction describes the translation of 
an extracellular event into an intracellular signal or signaling cascade, which further 
inﬂuences cellular processes such as proliferation, migration and apoptosis. Nearly  all cell-
surface receptors belong to one of the main three classes, which are classiﬁed by their 
mode of signal transduction after activation of the receptor and explained in more detail 
below.
Ligand-gated ion channels 
The ligand-gated ion channel superfamily contains numerous homologous receptor 
proteins that consist of an extracellular binding domain and transmembrane domains. 
Each receptor exists as a multi-subunit structure such as trimeric complexes (P2X 
receptors), tetrameric complexes (NMDA, AMPA receptors) and pentameric complexes 
(nicotinic acetylcholine receptor (nAChR)). The nAChR is a particularly well studied 
example. nAChR belongs to the group of pentameric receptors and is most abundant on 
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the surface of neural cells. Upon binding of nicotine the internal receptor conformation 
changes from closed to open. Each subunit binds two nicotine molecules to fully  open the 
pore, which subsequently allows Na+ ions to travel along their electrochemical gradient. 
As a consequence, the cell membrane depolarizes and an action potential is initiated 
(Brejc et al., 2001). Besides the family  of nACh receptors there are several others, such as 
glutamate receptors, ATP-gated channels and cAMP-gated channels. All ligand gated ion 
channels share the same mechanism. Binding of the ligand induces a conformational 
switch from either ‘open to close’ or ‘close to open’ and changes the permeability of the 
membrane to the corresponding molecule or ion triggering intracellular process (reviewed 
in Collingridge, Olsen, Peters, & Spedding, 2009).
Enzyme coupled-receptors
The second main group  of cell-surface receptors is the superfamily  of enzyme-coupled 
receptors, also referred to as catalytic receptors. These receptors are transmembrane 
proteins that consist of an extracellular domain that recognizes and binds the signaling 
molecule, an intracellular domain that activates downstream signaling and  a 
transmembrane helix that anchors the receptor in the membrane. Three groups of 
enzymatic coupled-receptors are known:
 
i) Receptor serine-threonine kinases, 
ii)Receptor tyrosine kinases (RTK), and 
iii)Tyrosine-kinase associated receptors (cytokine receptors) 
RTK exist as heterodimers when bound with a signaling molecule and perform tyrosine 
phosphorylation on themselves (autophosphorylation) and each other (cross-
phosphorylation). Every  subfamily of enzyme-coupled receptors contains several isoforms 
that form a homo- and heterodimer with speciﬁc ligand-binding properties. For example, 
the family  of EGFR/ErbB receptors consists of four protein isoforms: EGFR (ErbB1, Her1), 
ErbB2 (Her2, Neu), ErbB3 (Her3) and ErbB4 (Her4). It has been shown that all isoforms 
can form homo- or heterodimers with each other and that each combination has a speciﬁc 
ligand afﬁnity with multiple possible ligands (reviewed in Harris, Chung, & Coffey, 2003). 
Dimerization of the receptor occurs in the endoplasmic reticulum (ER) and not as earlier 
expected on the cell membrane (Tao & Maruyama, 2008). Depending on the cell type the 
heterodimer composition is different and not necessarily inﬂuenced by extrinsic factors 
(Zaczek, Brandt, & Bielawski, 2005). Depending on the heterodimer composition the 
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receptors are able to bind several ligands including EGF, TGFɑ, AR, HB-EGF, BTC, EPR 
and EPIGEN. Upon ligand binding tyrosine residues in the C-terminal tail become 
phosphorylated. These so-called Src-Homology 2 (SH2) domains and Phosphotyrosine-
binding domains (PTBs), act as docking sites for other signaling proteins. Receptor 
activation ultimately leads to activation of downstream signaling pathways including 
mitogen activated protein kinase (MAPK), phospholipase Cɣ (PLCɣ) and 
phosphatidylinositol-3 kinase (PI3K), which then further modulates cellular functions. Once 
a receptor is activated and active the cell has to deal with the problem of restricting and 
regulating the receptor and its effects. Enzyme-coupled receptor activity is regulated by 
internalization and subsequently undergoes degradation and/or recycling, depending on 
the ligand. For example, the binding of EGF to the corresponding receptor is very strong 
and remains even in the endosome. Even after internalization of the receptor ligand 
complex the persisting binding of EGF causes continuous ubiquitination of the EGFR in 
the endosome and the ubiquinated protein is then further transported to the lysosomes 
where it undergoes degradation (Madshus & Stang,2009). In contrast, binding of TGFɑ to 
the receptor is much weaker and pH dependent. The changed pH in the endosome causes 
disassociation of the ligand from the receptor and prevents prolonged ubiquitination of the 
EGFR which in turn is recycled and not degraded. The speciﬁc effects of the several 
different ligands on the regulation of EGFR have been investigated in detailed by 
Roepstorff and colleagues (Roepstorff et al., 2009).
G-protein receptors
G-protein coupled receptors (GPCRs) represent the largest family of membrane proteins in 
the human genome. As indicated by the name, these receptors interact with or are coupled 
to trimeric G-proteins on the cytoplasmic side of the membrane. Despite their classiﬁcation 
it has recently been shown in plants that these receptor types can signal through G-protein 
independent pathways (J. G. Chen, 2004). All GPCRs share a common structure of seven 
transmembrane (TM) segments with an extracellular amino terminus and an intracellular 
carboxyl terminus. The greatest homology among the family members is found in the TM 
segments, while the greatest diversity is found in the amino terminus and varies depending 
on the corresponding interacting signaling molecule. In spite of the diversity of ligands 
there seems to be a general mechanism of activation. All GPCR family  members 
transduce external signaling information into an intracellular event by  interacting and 
activating members of the family of heterotrimeric G-proteins. 
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Heterotrimeric G-proteins are crucial for regulation of signaling events within the cell. 
These proteins turn on intracellular signaling cascades in response to extracellular stimuli 
and are key components in the regulation of several cellular responses including cell 
proliferation, migration and survival. Heterotrimeric G-proteins are composed of three 
different subunits ɑ, β and ɣ. Due to their ability to switch between a GTP-bound 
conformation and a GDP-bound conformation they are often called ‘molecular switches’. In 
the GDP-bound conformation G-proteins are primed to bind the receptor while the GTP-
bound conformation modulates downstream effectors. In humans, 21 Gɑ subunits 
(encoded by 16 genes), 6 Gβ subunits (encoded by 5 genes) and 12 Gɣ subunits have 
been identiﬁed so far. The heterotrimers are classiﬁed into four main groups based on their 
sequence homology of the Gɑ subunits: Gɑs, Gɑi, Gɑq and Gɑ12. The interaction between 
G-proteins and GPCRs involves several regions that contribute to the interaction surface 
of the complex. Even though GPCRs are able to activate several G-proteins they  do not 
interact with all G-proteins. Furthermore, each member of the G-protein family interacts 
with many different receptors. The exact mechanism of how speciﬁcity of those 
interactions is achieved remains unknown.
Upon activation of the heterotrimeric G-proteins by a stimulated receptor, the ɑ-subunit 
releases the bound GDP and exchanges it for the energetically higher GTP. Subsequent 
conformational changes of the ɑ-subunit lead to disassociation of the βɣ-complex, 
resulting in two active signaling components. The separation of the complex activates 
downstream effectors, such as adenylyl cyclase, guanylyl cyclase, phospholipase C and 
others. The activity and target speciﬁcity are usually  regulated by special proteins, also 
known as regulator of G-protein signaling (RGSs). The RGS-protein family  consists of at 
least 25 members in humans of which all contain the RGS-domain that binds to the ɑ-
subunit. There are three main mechanisms by which RGS-proteins regulate the activity  of 
the ɑ-subunit:
1. RGS-proteins act as a GTPase activating protein (GAP) accelerating the hydrolysis of 
GTP to GDP and therefore the reassembling of the trimeric complex.
2. RGS-proteins act as effector-antagonists that prevent binding of the G-protein to its 
actual effector.
3. RGS-proteins accelerate the reformation of the trimeric complex by  increasing the 
afﬁnity of the ɑ-subunit to the βɣ-complex.
The spatial and temporal regulation of G-proteins is crucial for a coordinated signaling 
cascade. While the temporal regulation is mainly mediated by  RGS-proteins, spatial 
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regulation is achieved by  covalently attached lipid molecules that bind and thereby restrict 
the protein to the plasma membrane. Activation of G proteins then lead to activation and 
release of second messengers and activation of protein kinases. Protein kinases often 
work as signaling hubs getting input from different sources and regulating important 
cellular processes through a complex network.
Protein kinases in signal transduction
The human kinome includes a total of 518 kinases organized in eight superfamilies. Six 
superfamilies belong to the class of serine/threonine kinases, including STE-, CKI-, AGC-, 
CAMK-, CMGC- and RGC protein family. There are two classes of tyrosine kinases 
including a total of 133 proteins (Manning, Whyte, Martinez, Hunter, & Sudarsanam, 2002). 
Receptor tyrosine kinases (RTKs) are transmembrane proteins with an extracellular 
substrate binding domain and an intracellular kinase domain that phosphorylates the 
target protein. Receptor tyrosine kinases do not act as second messenger and possess 
enzymatic activity that is induced upon ligand binding. The second group is the class of 
non-receptor tyrosine kinases (NRTKs). These proteins are cytoplasmic molecules that are 
not directly  activated by extracellular signals. Instead, activation of NRTKs is mediated by 
RTKs or other cell surface receptors such as G protein-coupled receptors. The family of 
NRTKs is divided in subfamilies based on sequence homology and includes Src-, Abl- and 
Jak kinases. The largest subfamily of NRTKs, with nine members, is the Src kinase family. 
Src proteins are involved in signaling processes including mitogenesis, T- and B-cell 
activation and cell structure. Src kinase has originally  been isolated from cancer cells and 
has been implicated in several human carcinomas, including breast, lung and colon cancer 
(Biscardi, Tice, & Parsons, 1999).The remainder of human kinases is speciﬁc for the 
phosphorylation of serine/threonine residues and consists of at least 385 proteins 
organized in six major groups, 82 families and 135 subfamilies (Manning et al., 2002). 
Serine/threonine kinases are involved in the regulation of every aspect of cellular life and 
proteins and are often essential for survival of the organism. In the following the focus lies 
on the family of protein kinase C (PKCs). PKCs are a group of diverse kinases activated 
by the second messengers DAG and Ca2+. In general, DAG is thought to be responsible 
for membrane recruitment of the protein kinase, where it binds to Ca2+ and 
phosphatidylserine. Activated PKCs interact with numerous targets and are involved in 
many cellular processes. 
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The family of Protein Kinases C
The Protein kinase C (PKC) multigene family  consists of 11 serine/threonine kinases that 
play a crucial role in growth factor signal transduction and are involved in various cellular 
events including cell proliferation, differentiation and cell death. As members of the so 
called AGC family ( named after PKA, PKG and PKC  families) they share common 
features. All PKCs contain a catalytic domain that is highly  conserved among serine/
threonine kinases and a variable N-terminal regulatory domain that maintains the enzyme 
in an inactive conformation and regulates protein-protein interactions. The PKC family is 
further divided into three subfamilies depending on their modus of activation, which in part 
is a consequence of the domain composition of the regulatory  domain. The conventional 
PKCs (ɑ, γ, and the alternatively  spliced βΙ and βII) require diacylglycerol (DAG), 
phosphatidylserine (PS), and calcium for activation. Novel PKCs (δ, ε, η/λ, θ) are 
activated by DAG and PS but are insensitive to calcium. The atypical protein kinase C 
(aPKC) subfamily is composed of two members (ζ and ι/λ) with PKCɩ being the human 
homolog of mouse PKCƛ. The two atypical isoforms are highly related with an amino acid 
sequence homology of 72%. The two isoforms share an almost identical kinase domain 
with all members of the PKC family. In contrast, the regulatory  domain lacks some features 
compared to the other subfamilies and contains only one cysteine rich C1 domain, a 
pseudo-substrate motif and a PB1 domain. Thus, aPKCs only require PS but neither DAG 
nor calcium to acquire full activity. PKC  activation is mediated by G-protein coupled 
receptors and therefore connected to a variety of signaling molecules. The lipid-sensitive 
enzymes are activated through growth factor induced activation of phospholipase C  (PLC). 
Activated PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to generate 
diacylglycerol (DAG) and inositol triphosphate (IP3), which induces an increase of 
intracellular calcium (CA2+). DAG and increased calcium levels then activate most PKC 
isoforms. In the inactive conformation the pseudosubstrate (PS) occupies the ATP-binding 
site and prevents substrate-binding of the enzyme. Interaction and binding of cofactors 
change the conformation and release the PS from the ATP-binding site, making it available 
for catalysis. Even though PKCs are ubiquitously expressed, the expression pattern of the 
different PKC  isoforms is tissue speciﬁc, e.g.  PKCθ is expressed primarily  in skeletal 
muscle, lymphoid organs and hematopoietic cells, while PKC gamma is expressed in 
neurons. Generally, multiple members of the PKC family are found in the same cell.
13
13
Domains and their roles in PKC 
The domain composition of the N-terminus is very heterogenous among different members 
of the PKC family. When ﬁrst discovered by coworkers of Nishizuka at the Kobe University 
in 1977 it was thought to be a new type of an unregulated kinase. It turned out that they 
isolated only  the catalytic domain, since the isolation procedure fragmented the protein 
(Inoue, Kishimoto, Takai, & Nishizuka, 1977; Takai, Kishimoto, Inoue, & Nishizuka, 1977). 
It was obvious from the time of its discovery, that any kind of regulation and speciﬁcity  is 
modulated by the N-terminal regulatory domain. To understand the mechanism behind the 
regulation of PKC it is important to know the function of the components of the system, or 
in this particular case, the individual domains. Each domain has an intrinsic function that is 
under certain circumstances executed or inhibited. The sheer existence of the same 
domain in two different proteins does not necessarily mean that they have exactly the 
same function.
The C1 and C2 domains
The C1 domains are cysteine-rich, 50-51 amino acids long  motifs. They were originally 
identiﬁed as binding sites for DAG and phorbol esters in PKC, but have been found in 
multiple signaling families, including PKDs, chimaerins, RasGRPs, diacylglycerol kinases 
(DGKs) and others. All domains contain a conserved motif: H-x12-C-x2-C-x13/14- C-X2-C-X4-
H-x2- C-x7-C (H-histidine; C=cystidine; x=any AA). In cPKCs and nPKCs the C1 domain 
exists as a tandem motif, C1A and C1B. This motif is responsible for DAG binding through 
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2zinc ions controlled by the C1 domain. Due to the ability to bind DAG as an important 
second messenger or its analog phorbol esters it is also known as phorbol esters/DAG 
binding domain. In aPKCs only one C1 domain is present and PKCɩ/ƛ and ζ are DAG and 
phorbol ester insensitive. Whether this insensitivity is due to the lack of one motif or 
caused by intrinsic differences is still debated. Although all DAG/phorbol esters responsive 
PKC contain a twin cysteine-rich motif it has been show that single C1 domains possess 
all the requirements for binding of phorbol esters (Quest & Bell, 1994). Interestingly, 
despite their different afﬁnities to DAG under normal conditions c/nPKCs display the same 
afﬁnity  for the ligand when forced into a 2D structure (Kazanietz et al., 1993). This 
indicates that the C1 domains have either unique intrinsic structural characteristics or are 
regulated by the overall conformation of the PKCs. However, it is clear that aPKCs are 
DAG and phorbol ester insensitive no matter whether this is due to the ‘atypical 
C1’ (Colón-González & Kazanietz, 2006) domain or not.
The C2 domain consists of 130 amino acid residues and was ﬁrst identiﬁed in activated 
PKCs. The fact that cPKCs, in contrast to nPKCs, are regulated by calcium suggests that 
the C2 domain acts as a calcium-binding motif (Kikkawa, Kishimoto, & Nishizuka, 1989). 
Further studies conﬁrmed that the C2 domain binds anionic phospholipids in a calcium 
dependent manner. The binding of calcium is thought to be the initiating step in cPKC 
activation. Upon calcium binding PKCs transiently  translocate to the membrane. DAG, the 
membrane bound co-activator of PKCs is then able to interact with the C1 domain. 
Subsequent binding of PIP2 and PS facilitates the release of the autoinhibitory 
pseudosubstrate sequence allowing substrate phosphorylation (Evans, Murray, Leslie, & 
Falke, 2006; Sánchez-Bautista, Marín-Vicente, Gómez-Fernández, & Corbalán-García, 
2006). Novel PKCs also contain a C2 domain, although the order of those two is switched 
relative to the cPKCs. Novel PKCs were originally thought to lack the C2 domain, but 
phylogenetic studies identiﬁed a conserved C2 domain (Sossin & Schwartz, 1993). 
Deﬁning nPKC, the C2 domain lacks the ability to bind calcium, resulting in a DAG 
dependent, but calcium independent protein activation. The atypical PKCs lack a C2 
domain and are Ca2+ insensitive.
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The pseudosubstrate motif
The pseudosubstrate domain is a conserved motif present in the regulatory domain of all 
PKC isoforms but is differently located within the protein. Originally identiﬁed by Kemp and 
coworkers, the sequence resembles that of a PKC substrate except that an alanine 
occupies the phospho-acceptor position (House & Kemp, 1987). When PKC is inactivated, 
the pseudosubstrate domain covers the ATP binding pocket of the otherwise active 
catalytic domain. This theory was supported by the fact that an antibody  against the 
pseudosubstrate sequence is able to fully activate the enzyme in the absence of cofactors 
(MAKOWSKE & ROSEN, 1989) 
The PB1 domain
An exclusive feature of the atypical PKCs are the N-terminal PB1 (Phox and Bem1) 
domains. The PB1 domains consist of about 80 amino acid residues, mediate highly 
speciﬁc protein-protein interactions and are conserved in a variety of species ranging from 
plants to mammals. The PB1 domains are grouped into three types, type I, type II and 
typeI/II. Type I, also known as PC-motif (Phox and Cdc42) (Nakamura et al., 1998) is 28 
amino acids long with four highly conserved acidic residues with the sequence Asp-X-
(Asp/Glu)-Gly-Asp-X8-(Glu/Asp). This motif is also known as OPR (octicosapeptide repat) 
or AID (atypical PKC interaction domain) and is therefore generally  named OPCA (OPR, 
PC, AID).The type II variant of the PB1 domains is characterized by an invariant lysine 
residue on the ﬁrst beta strand. PB1 domains are highly speciﬁc for PB1-PB1 interaction 
and by now at least 13 PB1 containing proteins have been identiﬁed in humans, containing 
either type I, type II or both motifs. The protein-protein interactions are a result of 
heterodimeric assembly  between type I and type II PB1 domains in a front-to-back 
manner. In this also called canonical PB1 dimerization the acidic residues on the OPCA 
motif form salt bridges with basic residues of the type II domain. The aPKC PB1 domain is 
a typeI/II domain and has been shown to mediate interaction with several proteins, such 
as p62, par6 and Mek5 (Hirano, 2004a). In the case of the interaction between PKCɩ/ƛ and 
Par6ɑ, two residues of the Par6ɑ, Arg28 and Arg89 (on strand β2, respectively  β5) assist 
the salt bridge formation. In addition a conserved acidic residue, Glu76, forms another salt 
bridge with Arg27 on strand β2 of Par6ɑ. The speciﬁcity of the hetero-dimerization is 
increased by an interaction of the ɑ2 helix of PKCɩ/ƛ with the Par6ɑ PB1 domain (Hirano, 
2004b; Wilson, Gill, Perisic, Quinn, & Williams, 2003). Generally, type II domains are able 
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to interact with all types of PB1 domains and have the potential to mediate homo-
oligomerization. Even though this has not yet been reported for aPKCs, p62 another typeI/
II containing protein is also capable of homologous binding (Bjorkoy, 2005). p62, also 
known as sequestosome1 (SQSTM1) has also been shown to interact with both aPKCs 
(S. Ohno, 2001; Puls, Schmidt, Grawe, & Stabel, 1997). However, p62 is not a substrate 
and has no signiﬁcant effect on the kinase activity of the protein. Therefore it is likely  that 
p62 acts as a scaffold protein to restrict and direct the actions of aPKCs. Taking the nature 
of PB1-Pb1 interaction it is likely that over time more interactions will be identiﬁed and in 
the case of aPKCs more studies are necessary to fully  understand the function and 
regulation of the different PB1 interactions.
The Hinge region
The Hinge domain, also called variable region 3 (V3), is approx. 60 amino acid residues 
long and is located between the regulatory domain and the catalytic domain. This structure 
shows very  little homology among the PKCs and was originally  thought to have no 
particular function at all. Anyhow, some PKC isoforms including PKCδ, -ε, -θ and -ζ have 
been shown to be a target of proteolytic cleavage with a primary cleavage-site exclusively 
in the hinge region. PKCε possess in total 3 cleavages sites of which the primary  site for 
function is located in the hinge region. TNF-induced Caspase 7 mediated cleavage of 
PKCε results in an active kinase fragment with an anti-apoptotic function (Basu, 2002). 
PKCζ on the other hand contains two cleavage-sites, both within the hinge region. In 
contrast to PKCε, the cleavage of PKCζ is mediated by several caspases, including 
caspase-8, -3, -6, and-7 (L. Smith, 2000). The product of the cleavage, an active kinase 
fragment, is linked to the apoptosis pathway and as with PKCε, is linked to an anti-
apoptotic function (Berra et al., 1997; Frutos, Moscat, & Diaz-Meco, 1999). In nitric oxide-
induced apoptosis the catalytic activity  of the separated kinase domain is inhibited before 
the cleavage of the protein occurs. It has been shown that nitric oxide induces interaction 
of aPKCζ with the p38 kinase. This interaction leads to an inhibition of autophosphorylation 
at T560 and  inactivation of the kinase domain (J.-S. Kim, Park, Yoo, Yu, & Chun, 2005). 
This was discovered because earlier inhibition of caspase-3 in articular chondrocytes did 
not rescue the inhibition of aPKCζ, although cleavage of the protein was signiﬁcantly 
reduced (S.-J. Kim et al., 2002). Interestingly, treatment of chondrocytes with nitric oxide 
caused an enrichment of certain phospo-peptides identiﬁed through MS/MS analysis. The 
MS/MS spectra showed two phospho peptides which are located in the Hinge region of 
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aPKCζ, indicating that phosphorylation of serine residues in the aPKCζ Hinge region might 
play a role in p38 mediated inhibition of aPKCζ (J.-S. Kim et al., 2005). However, the 
cleavage of PKCs does not always result in fragment with anti-apoptotic properties. It has 
been shown, that the cleavage of PKCδ and PKCθ induces or promotes apoptosis in the 
corresponding tissue (R. Datta, 1997; Kato et al., 2009). In summary, an high number of 
publications described unique properties of the hinge region and given its location in the 
center of the protein and the vast heterogeneity of the sequence it is likely that more 
functions will be identiﬁed in the future. One theory is that PKCs with a cleavage site 
become most vulnerable not having co-activators. The inactive conformation could leave 
the Hinge region exposed and therefor more accessible to caspase-mediated cleavage. To 
completely understand the role of the Hinge region in PKC  more studies are necessary 
and most deﬁnitely require the full solution structure of the full-length proteins.
The kinase domain 
The C-terminal catalytic domain of PKCs consists of approx. 350 amino acid residues and 
is highly conserved in all three subfamilies of PKC. The overall structure of this domain 
shows high homology with members of the PKA, PKB/AKT families and PDK1. The tertiary 
structure of the domain consists of a small N-terminal lobe, a large C-terminal lobe and a 
hinge linker region. Considering the relative position of the lobes, the conformation of the 
catalytic domain can be classiﬁed as either ‘open’ or ‘closed’. Recruitment of ATP happens 
during the ‘open’ conformation, while transferring the y-phosphate onto its substrate 
happens in ‘closed’ conformation (Johnson, Akamine, Radzio-Andzelm, Madhusudan, & 
Taylor, 2001). The switch between those two states is tightly regulated and involves 
phosphorylation of a speciﬁc motif of the catalytic domain. The catalytic domain has 
several conserved motifs, present in all members of the AGC kinase family: 1. The ATP-
binding site is located at the interface of both lobes. ATP is usually bound by its 
nontransferable phosphate by  a motif that contains 3 glycine residues and acts as a kind 
of clamp. This motif is highly  conserved among 95% of all kinases (Hanks & Hunter, 1995). 
However, in aPKCs the phosphate-binding site differs from that of other family members. 
The N-terminal lobe of cPKCs and nPKCs contains the ATP binding loop with the 
conserved consensus sequence GXGXXG, whereas in aPKC the last glycine residue is 
substituted by an alanine. Thus, it adapts an open conformation and implies a different 
binding mechanism compared to other PKCs. 2. The activation loop (AL) stretches from 
residue 387 to 414. It is usually  in a phosphorylated state and interacts with two residues, 
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Lys392 and Arg368. This interaction is necessary for catalytic activity. 3. The hydrophobic 
motif (HM) of the C-terminus is conserved and interacts with the hydrophobic groove of the 
N-lobe. 
The C-terminal tail of the catalytic domain is less conserved among the AGC kinases and 
therefore shows a high sequence variation. However, in PKCi the C-terminal tail, also 
called V5 domain, contains a clearly deﬁned phosphorylation site (Thr555) of the turn motif 
(Messerschmidt et al., 2005). Both, the activation loop  and the V5 region play a crucial role 
in the structure of the catalytic pocket and are common targets for phosphorylation. 
Phosphorylation is thought to be crucial for activation of PKC, even though this theory  has 
been partly challenged by recent publications (Graybill, Wee, Atwood, & Prehoda, 2012). 
However, to achieve full kinase activity all three phosphorylation sites need to be modiﬁed. 
This maturation of the protein happens per se post-translational in cells and is mediated by 
other kinases such as PDK1 (Le Good, 1998), Src (Rybin, Guo, Gertsberg, Elouardighi, & 
Steinberg, 2007) and mTORC2 (Ikenoue, Inoki, Yang, Zhou, & Guan, 2008).
Many of the phosphorylation events activate the kinase and are also important for 
interactions with other proteins. PKCδ, PKCɩ/ƛ and PKCζ contain a Nuclear Export 
Sequence (NES; L-x1/2-L-x2-F-x-L/I) in the beginning of the catalytic domain. This motif has 
been shown to interact with CRM1/exportin1 to facilitate nuclear export of PKCɩ (Perander, 
2000). Interestingly, the corresponding NLS in PKCɩ requires phosphorylation by Src at 
T256 in PC12 cells to become exposed and is relevant for the localization of the protein 
(White, Seibenhener, & Wooten, 2002). Another well-established binding partner, Par3, 
binds through a 28 amino acid motif to the catalytic domain of aPKC, called the aPKC 
binding motif. Two serine residues within the motif act as substrates and phosphorylation 
of these residues leads to disassociation of the complex (Wang, Shang, Yu, & Zhang, 
2012). Kibra (kidney and brain protein), a WW domain containing protein and human 
ribunucleoprotein 1 (hnRNP A1) exclusively interact with activated aPKCs or with 
truncated proteins containing only  the catalytic domain. This indicates that the tertiary 
structure of the protein strongly regulates the interactions of the catalytic domain.
Noteworthy: The sequence connecting the two lobes contains a so-called “gatekeeper” 
residue that controls ATP binding and access to the binding pocket. This gatekeeper 
residue is usually  a large hydrophobic residue and is often mutated to create a kinase that 
is able to facilitate unnatural ATP analogs (Allen et al., 2007). This mutation is a highly 
speciﬁc tool for identiﬁcation of substrates in vivo. Conveniently, the mutated kinase is able 
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to facilitate normal ATP besides the unnatural analog. If applied to aPKCs this would be an 
excellent tool to identify common and speciﬁc substrates of both aPKCs in comparison.
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Activation of PKC
Traditionally PKCs were seen as generic enzymes that are anchored to the membrane 
during their activated state and that achieve target speciﬁcity  by close localization to their 
substrates. However, the notion that PKCs become activated mainly through translocation 
events has recently been challenged. It appears that the phosphorylation status of the 
serine/threonine residues of the enzymes affect stability, function, activity  and protein-
protein interactions. Cleavage of PKC  releases a free kinase domain that either can act as 
an inhibitory molecule or as an activator of the full-length protein. PKC  can also be 
activated by more traditional lipid cofactors, such as ceramide or arachidonic acid enabling 
PKC to signal throughout the cell, not limited to DAG containing membranes. These 
alternative regulation mechanisms were only  recently published and additional studies are 
necessary to fully understand these mechanisms.
As a rule of thumb inactive PKC is localized in the cytoplasma. Upon activation, PKC 
translocates to the membrane, where it phosphorylates target proteins. In order to activate 
PKC a series of phosphorylation events are necessary, which lead to a conformational 
change and allow the protein to interact with the cell membrane. Further release of the 
pseudosubstrate results in a fully  activated protein. Studies involving mutational analysis of 
predicted phosphorylation sites and mass spectrometry revealed three key 
phosphorylation sites for the activity  of the protein within the C-terminus of PKC. These 
sites are known as the activation loop (AL), the turn-motif (TM) and the hydrophobic-motif 
(HM). Interestingly, while all three sites are conserved in the cPKC and nPKC, the atypical 
PKC lack the hydrophobic motif and harbor a negatively  charged glutamic acid (Freeley, 
Kelleher, & Long, 2011). Whether this site mimics a constitutively phosphorylated state or 
not, remains unknown.
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A-loop phosphorylation
For most of the PKC isoforms, a phosphorylated A-loop is crucial for catalysis, since 
mutation of the residue to a non-phophorylatable residue abolishes activity. Furthermore, 
in some PKC the A-loop seems to contribute to the stabilization of the active conformation 
by forming ionic contacts with positively charged residues of the kinase domain (Grodsky 
et al., 2006; Messerschmidt et al., 2005). Some PKC possess a cleavage site in the 
HINGE region of the protein. When cleaved, an isolated but functional catalytic domain is 
released. As known so far, only PKCδ, PKCθ, PKCε, and PKCζ undergo caspase-
dependent cleavage in response to a range of apoptogenic stimuli. In this context the A-
loop is generally required for catalytic activity (L. Smith, 2002).
The main role in A-loop phosphorylation is played by the enzyme Phosphoinositide-
Dependent Protein Kinase-1 (PDK-1). PDK-1 has been known to phosphorylates the A-
loop of many protein kinase families besides PKC, such as PKB/Akt. PDK-1 has been 
shown to phosphorylate cPKC, nPKC and aPKCs in vitro and in cell lines when 
overexpressed (Le Good, 1998). Cells that lack PDK-1 have signiﬁcantly  reduced levels of 
PKC ɑ, ΒII, ɣ and ε (McManus, Balendran). In contrast, the PKC ζ isoform was reported to 
be stable in PDK-1 negative ES cells (McManus, Balendran). Very  little is known about the 
interaction modi of PDK-1 and PKCs. Initially  it was thought, that the PH domain of PDK-1 
is a key player in mediating that interaction, however, it has been shown, that in cells 
overexpressing a PH deﬁcient PKD-1 mutant instead of the wild-type protein, A-loop 
phosphorylation of PKCs appears to be normal, indicating another mechanism (McManus 
et al., 2004; Waugh, Sinclair, Finlay, Bayascas, & Cantrell, 2009). 
Besides the evidence that PDK-1 is the A-loop kinase of PKC in various cell types, there is 
proof of PKD-1 independent A-loop  phosphorylation. PKC δ A-loop phosphorylation was 
detected in ES cells and thymocytes lacking PDK-1(Balendran et al., 2000; McManus et 
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al., 2004).  In cardiomyocytes, PKC δ triggers autophosphorylation on the A-loop  after 
being phosphorylated by  Src kinases at the hinge domain (Rybin et al., 2007; Sumandea 
et al., 2008). Together these studies imply a PKD-1 independent A-loop phosphorylation or 
autophosphorylation of the protein. Other kinases than PDK-1 have been implicated to 
play a role in A-loop  phosphorylation of PKCs. Human biliverdin reductase (hBVR) may be 
involved in A-loop phosphorylation of PKCβII (Maines, Miralem, Lerner-Marmarosh, Shen, 
& Gibbs, 2007) and 5’-AMP-activated protein kinase (AMPK) has been shown to directly 
phosphorylate the A-loop of PKCζ during hypoxia (Gusarova et al., 2009).
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Phosphorylation of the turn-motif
The turn motif (TM) is highly conserved among all PKCs. The TM is located in the C4 
domain on the so-called C-terminal tail of the enzyme. The role of the TM is diverse and 
incompletely  understood. Phosphorylation of the TM enables interaction between the motif 
and residues in the enzyme to help stabilizing the enzyme (Grodsky et al., 2006; Hauge et 
al., 2007; Messerschmidt et al., 2005). In the two PKCβI and βII isoforms this 
phosphorylation is required for catalytic activity (Edwards, Faux, Scott, & Newton, 1999), 
while for PKCɑ, θ and ɩ it is dispensable (Bornancin & Parker, 1997; Hauge et al., 2007; 
Liu, Graham, Li, Fisher, & Shaw, 2002). In the case of PKCδ and ζ the results have been 
conﬂicting. After all it seems that the conformational and structural differences of the PKCs 
are in fact the cause for their different requirements for TM phosphorylation (Edwards et 
al., 1999). Anyhow, the differences reported for PKC δ and ζ indicate a more complex 
activation mechanism in which the phosphorylation requirement depends not only  on 
interactions but also on the expressing tissue and environment. In PKCα, mutation of the 
TM site has no effect on its catalytic function, but the mutant was more sensitive to thermal 
instability, oxidation, proteolysis and overall dephosphorylation (Bornancin & Parker, 
1997). In addition, the TM site seems to play a role in other aspects of PKCs. For example, 
the catalytic activity of PKCϴ is independent of the TM site. Since the TM mutant 
demonstrates an enhanced ability to activate the NF𝜅B pathway in T lymphocytes (Liu et 
al., 2002). Initially the TM site was described as autophosphorylation site, but recent data 
demonstrated that the mammalian target of Rapamycin (mTOR) is involved in the 
regulation TM phosphorylation. mTOR is a serine/threonine protein kinase and belongs to 
the phosphatydil-inositol 3-kinase-related kinase protein family. The protein forms multi-
protein complexes, mTORC1 and mTORC2, and is involved in the regulation of cell 
growth, -proliferation, -motility and -survival. mTORC2 is in contrast to mTORC1 
insensitive to rapid rapamycin treatment and has been implicated in TM phosphorylation of 
the PKC isoforms α, βI, βII, ɣ and ε (Facchinetti et al., 2008; Ikenoue et al., 2008). The 
effect of mTORC2 on these PKCs appears to be indirect and needs further 
investigation.Hydrophobic-motif phosphorylation
The hydrophobic-motif (HM) is a conserved motif present in cPKC  and nPKC, but is 
absent in aPKCs. In the case of aPKCɩ, the negatively charged glutamic acid residue 
positioned within the motif seems to perform similar functions (Messerschmidt et al., 
2005). It has been shown that similar to the TM phosphorylation, HM phosphorylation 
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regulates catalytic activity  of the enzyme as well as stability and function. In PKCɑ, 
phosphorylation of the HM protects the protein from phosphatasesand prevents its 
inactivation. Studies on its inﬂuence on the catalytic activity seem however highly 
dependent on the isoform. Mutation of the HM has no effect on PKCβII activity (Edwards & 
Newton, 1997), but induces a 5-fold reduction of PKC  ϴ activity (Liu et al., 2002), whereas 
in PKC δ it increases activity (Karmacharya, Jang, Lee, Lee, & Soh, 2010). The present 
studies highlight the varying roles of these phosphorylation sites on the functions of PKCs 
and it is difﬁcult to explain how one isoform is affected while another is not. Contradicting 
results may be explained by the use of different cell-lines. Depending on the cellular 
context the set of binding partners might vary and thereby change the behavior of the 
proteins. 
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The atypical PKCs
Atypical protein kinase C isoforms PKCiota and aPKCζ deﬁne a subclass of the PKC 
family and are functionally and structurally  distinct from other PKCs. In contrast to other 
PKCs the catalytic activity of atypical PKC is not dependent on calcium or 
phosphatidylserine. This is due to a unique composition of the N-terminal regulatory 
domain that lacks the corresponding binding motifs. Instead, aPKC activity  can be 
regulated by 3-phosphoinositides, phosphorylation by PDK1 and through protein-protein 
interactions with Par-6 (Graybill et al., 2012). As a result of a screening to identify PKC 
isoforms in the rat brain aPKCζ was the ﬁrst isoform to be identiﬁed, cloned and analyzed 
(Ono et al., 1989). Due to the insensitivity of the protein to Ca2+ and phorbol esters it 
became the ﬁrst member of the atypical PKC family. The mouse ortholog of aPKCζ shows 
a 99% amino acid homology and is located on chromosome 4 (Goodnight, Kazanietz, 
Blumberg, Mushinski, & Mischak, 1992).The second member of atypical PKCs was 
identiﬁed during an attempt to identify the aPKCζ isoform in a mouse P19 embryonal 
carcinoma cell line (Akimoto et al., 1994). The murine protein was named PKClambda, 
based on its 72%sequence homology to aPKCζ. Around the same time a group around 
Lisa Selbie isolated another atypical PKC from human insulin secreting cells. It later turned 
out to be the human homolog of PKClambda, leading to the consensus PKCiota/lambda 
(aPKCɩ/ƛ). Both genes consist of 18 exons and the corresponding proteins have a size of 
approx. 67 kDA, although the protein size on a SDS gel can vary  between 72 and 80 kDA. 
Expression analysis of both isoforms showed a much broader, almost universal expression 
of PKCiota (Selbie, Schmitz-Peiffer, Sheng, & Biden, 1993), while the expression of aPKCζ 
is restricted to a few organs including lung, kidney, testicles and the intestine (Goodnight et 
al., 1992). Initial studies failed to assign cellular functions to aPKCs, however, over the last 
20 years researchers were able to link these proteins to various cellular processes 
including the regulation of cell proliferation (Berra et al., 1993), DNA synthesis (Akimoto et 
al., 1998; Berra et al., 1995), induction of apoptosis and NFκB signaling (Sanz, 1999; 
2000), cartilage destruction (Litherland et al., 2010) and cell differentiation (Kampfer, 
2001). The high homology  of the proteins in combination with the fact that most 
commercially available biochemical tools could not reliably distinguish the two isoforms 
produced a number of ambiguous studies. More recently, however, tools and methods 
have signiﬁcantly improved and both isoforms have now been assigned to distinct, non-
overlapping roles. 
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The role of aPKC in polarization and maintenance of cellular polarity
All multicellular organisms, including simple metazoans and highly complex mammals 
share acommon feature: Polarity. Macroscopic (from the outside), polarity  often presents 
itself as a front and back or head and tail. However, on a cellular level it describes the 
asymmetric distribution of intracellular components and functional asymmetry  within the 
cell. The establishment and maintenance of ‘cell polarity’ is an essential feature of all 
eukaryotes. It appears that the same complexes are conserved in at least C. elagans, D. 
melanogaster and mammals. As expected such an important feature is tightly  regulated 
and involves many signaling pathways and molecules. The aPKCs are crucial components 
at the crossroad of polarization and their kinase activity is highly  regulated through 
interaction partners. This kinase activity  is required for polarization, as overexpression of 
kinase-dead aPKC mutants blocks the formation of important cell junctions and leads to 
mislocalization of polarity  proteins (Suzuki et al., 2001). The aPKC themselves interact 
only with few polarity proteins, such as Par-6, Par-3 and LGLs. In the following paragraph 
we will discuss the mechanisms behind polarization of epithelial cells, the key components 
of this process and how aPKC is involved in polarization, regulation and maintenance of 
cellular polarity.
By default cells are isotropic, meaning that the cell content is equally  distributed within the 
cell. In this state, cells can be referred to as ‘unpolar’. Certain stimuli, external and internal, 
are able to stimulate the cell to redistribute the cellular contents, thereby become ‘polar’. 
For example, during cell division the cytoskeleton reorganizes and the DNA aligns 
perfectly in the center, thereby the cell forms two equal daughter cells in a so called 
symmetric cell division. However, in multi-cellular organisms the challenge is not only to 
keep the cell-division symmetric, but also in plane with the surrounding tissue. Even the 
simplest multi-cellular organisms such as Spirogyra must tightly regulate the orientation of 
cell division to survive. Spirogyra is an algae growing as a single string of aligned cells with 
one basal cell responsible for attachment of the organism. Already in this context (1D) 
impaired orientation of cell division would affect growth and have severe consequences for 
Spyrogyra. In culture, adherent cells grow in a monolayer (2D) with cells next to each 
other. When the cells reach conﬂuency they stop  to proliferate and establish tight 
connections with each other. This process is called contact inhibition. Cancer cells often 
lack this control mechanism and therefore uncontrolled proliferation is one of the six 
hallmarks of cancer (Hanahan & Weinberg, 2011). In a monolayer, cells are no longer 
isotropic. At that stage the cell can be divided into three distinct functional domains. The 
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apical domain, which is the surface of the cell and in contact with the extracellular space 
and responsible for receiving signals and nutritions from ‘outside’. The basal domain, 
which is in contact with the surface and responsible for attachment and cell movement 
and, third, the lateral domain, which is in contact with neighboring cells, maintains  the cell-
cell communication and is important for the integrity of the cytoskeleton and the 
monolayer. However, depending on the cell line, the monolayer can be so compact that it 
is impermeable for molecules and thereby it may function as a barrier between ‘outside’ 
and ‘inside’. To achieve this level of interaction between cells they are connected by so-
called cell-junctions. There are four major types of cell-junctions. Tight Junctions (TJs) 
form the closest contact between cells and are localized in the apical region around the 
cell's circumference. Desmosomes (DS) serve localized adhesive function and connect the 
plasma membrane to intermediate ﬁlaments in the cytoplasm. Adherens junctions (AJs) 
play an important role in intracellular adhesion and the interaction of the actomyosin 
cytoskeleton with the plasma membrane, and Gap  junctions (GJs) that consist of 
intercellular channels in the plasma membrane of adjacent cells. Small molecules can 
diffuse across the channel and into the cytoplasm of the other cell. Their contribution to the 
tightness of the cell-cell contact is minimal. All four types of junctions are localized in the 
lateral surface of the cell and together they are grouped into the term apical junctional 
complexes (AJCs). Since TJ are the most important AJCs to establish polarity, the 
following paragraphs focus on TJs 
Tight junctions are the most apical components of the intercellular junctional complexes 
and a major player in the regulation of the degree of tightness of the cell layer. These 
multi-protein complexes mediate the strongest cell-cell contact to be found in nature and 
are almost unique to epithelial and endothelial cells. By the tight attachment of cell to their 
neighbors and the formation of a belt encircling the cell, this complex is preventing 
molecules from diffusing from the apical domain into the sheet between to cells, the lateral 
domain. This barrier function is a major mechanism in maintaining the apico-basal (AP) 
polarity  by restricting macromolecules to their distinct domains. Although the complete 
mechanism of TJ formation remains unknown, three protein families have been identiﬁed 
to be involved. The three main transmembrane protein families found in TJs are members 
of the occludin, claudins and junctional adhesion molecules (JAMs) families.
Occludin was the ﬁrst tight junction integral membrane protein to be discovered and was 
originally isolated from chick liver (Furuse et al., 1993). Depending on the tissue the 
expression levels of occludin vary dependent on the required “tightness” of the TJ. For 
example, occludins are highly  expressed in brain endothelium which forms a very  tight 
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barrier, but are expressed at much lower levels in endothelial cells of non-neuronal tissue 
that are characterized by much lower barrier properties (Hirase et al., 1997). Besides the 
role in regulating the quality of the barrier function, occludin is either not required for 
maintenance of the integrity of TJs or other proteins can compensate for the loss of 
occludin, since its absence has no effect on the structure of TJs (Saitou et al., 1998). 
Moreover, occludin interacts with a number of regulatory proteins at tight junction, 
including aPKCζ, c-Yes, PI3K (Nusrat et al., 2000) and ZO-1 (Furuse et al., 1994). The ZO 
family members (ZO-1, -2 and -3) interact with a wide variety  of cellular proteins through 
multiple interaction domains and play a central role in organizing TJs. Besides many  other 
interaction partners ZO-1 binds in vitro to F-actin and thus might serve as a linker for 
occludin to the cytoskeleton (Fanning, Jameson, Jesaitis, & Anderson, 1998) and to JAM 
(Ebnet, 2000). JAMs, another family of important structural proteins, are single pass 
transmembrane proteins found in epithelial and endothelial tight junctions. Overexpression 
of JAM reduces paracellular permeability in CHO (Chinese hamster ovary) cells in a 
calcium-dependent manner (Aurrand-Lions, Duncan, Ballestrem, & Imhof, 2001), showing 
that that it is an important component of tight junctions. JAM physically interacts with 
several tight junction proteins besides ZO-1, such as AF-6 and ASIP (Par3) (Ebnet, 
Schulz, Meyer Zu Brickwedde, Pendl, & Vestweber, 2000; Ebnet et al., 2001). The third 
large family of transmembrane proteins are claudins. Claudins have been shown to be 
important for TJ formation andwere discovered in occludin expressing chicken livers 
(Furuse, Fujita, Hiiragi, Fujimoto, & Tsukita, 1998), and later studies showed that claudins 
are expressed in many other tissues. Moreover, expression of claudin family members is 
speciﬁc for certain tissues. The properties of the barrier function mediated by TJs 
correlates with the claudin composition (Furuse, Sasaki, & Tsukita, 1999). Not surprisingly, 
claudins interact with ZO-1 through a conserved binding motif in the C-terminus of the 
protein (Itoh et al., 1999). In summary, all TJs are composed of members of one of the 
main transmembrane protein families, providing the basis for polarity by actively regulating 
the distribution of macromolecules along the cell membrane. 
In contrast to the AJCs, which is embedded into the apical and sub-apical membrane, the 
trimeric polarity  complex is located in the cytosol and thereby  able to translocate to 
different compartments in the cell. The three proteins that form the polarity complex, 
aPKC, Par6 and Par-3 are considered as the core compounds of cellular polarity  and have 
been shown to regulate multiple cellular processes via protein-protein interaction and 
modiﬁcation of substrates. When par-6 was initially  discovered in a screen for mutants with 
partitioning-defective phenotype in C. elegans it was immediately linked to cellular 
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asymmetry  and Par-3 (Watts et al., 1996). This early study showed that mutations in par-6 
result in disruption of asymmetry  in the early embryo causing disrupted spindle orientation 
at the second cell division (Watts et al., 1996). Furthermore Par-6 plays a role in Par-3 
localization. Under normal ﬁrst cell division of the C. elegans embryo, Par-3 is localized to 
the anterior periphery of the embryo. Mutations in Par-6 lead to mislocalization of Par-3 in 
the embryo (Watts et al., 1996). Par-3 itself was identiﬁed as an important player in 
establishing polarity through interaction with PKC-3, the homolog of the human aPKCs, in 
C. elegans. The expression pattern of PKC-3 has just been published earlier in the same 
year. (S. L. Wu, 1998). Knockdown of PKC-3 resulted in a Par-3 like phenotype, indicating 
a functional relationship. Subsequent immunoprecipitation analysis conﬁrmed the direct 
interaction of both protein in C. elegans (Tabuse et al., 1998). Only two month later the 
same group published data showing that the same interaction happens in mammalian 
cells (Izumi et al., 1998). It didn’t take long until a direct link between PKC-3, Par-6 and 
Par-3 was discovered, leading to the establishment of the trimeric polarity complex (Hung 
& Kemphues, 1999) also in human and mouse (Etienne-Manneville & Hall, 2003; Joberty, 
Petersen, Gao, & Macara, 2000). Today, the polarity complex is established as a crucial 
polarity  component and the mechanism by which the three proteins interact are well 
understood. The Par-6 and aPKCs proteins interact with each other through their PB1 
domains present in the N-terminal regions of the proteins (Hirano, 2004a). The Par-6/Par-3 
interaction is mediated through PDZ domains present in both proteins (Hung & Kemphues, 
1999). While Par-6 contains only one PDZ domain Par-3 has three (PDZ1-3). Finally, 
Par-3 is interacting with the catalytic domain of aPKC through an ‘aPKC  binding motif’. The 
mechanism behind complex formation and how the different proteins modify each other 
and possible substrates is not completely understood and still a focus for many 
researchers. There is however little doubt about the function of the complex. Work from 
several laboratories have demonstrated a role of the polarity complex in establishing AP 
polarity  and in regulating asymmetric cell division in C. elegans (Pellettieri & Seydoux, 
2002) as well as mammals (D. Lin et al., 2000). The present data suggest that the inactive 
Par-6/aPKC complex is stable and constitutively formed under normal conditions, while 
Par-3 is transiently interacting with the complex. In this complex the Par-6 protein is 
considered to be the regulator of aPKC activity, since studies have shown that 
overexpression of a truncated Par-6 protein, N-terminus alone, is able to increase aPKC 
kinase activity (Joberty  et al., 2000), but overexpression of the full-length Par-6 failed to do 
so (Yamanaka et al., 2001). The current model puts the repression of aPKC  by Par-6 in 
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the center, with transient interaction partner that regulates localization and target 
speciﬁcity. 
The ﬁrst evidence for a role of aPKC in TJ formation was published in 2001 by Suzuki and 
coworkers. The introduction of a dominant negative mutant of aPKC into MDCK II cells 
blocks the completion of the two-step  TJ formation and impairs cell surface polarity, 
causing inter-domain diffusion of a marker molecule (Suzuki et al., 2001). One year later 
the same group  showed that aPKC is recruited to the spot-like AJ complex where it co-
localizes with other ZO-1, Jam, occludin and claudin to promote the formation of TJs 
(Suzuki et al., 2002). In C. elegans the recruitment of the Par-6/aPKC complex is mediated 
by Par-3. In the one-cell embryo, Par-3 translocates to the cell periphery in the absence of 
PKC-3 (aPKC) or Par-6, while both absolutely require Par-3 (Hung & Kemphues, 1999; 
Tabuse et al., 1998; Watts et al., 1996). Similar observations have been made in MDCK 
cells where Par-3 is transiently localized at the spot-like AJ before the Par-6/aPKC 
complex translocates (Suzuki et al., 2002).This theory is supported by the most recent 
study showing that JAM, a Par-3 interaction partner, is phosphorylated at Ser285 in vitro 
and in epithelial cells (Iden et al., 2012). Non-phosphorylated JAM localizes to pAJ and 
most likely recruits Par-3. Once the trimeric polarity complex has formed at the pAJ Par6 
becomes activated by through binding of Rho family small GTPases (Joberty  et al., 2000; 
D. Lin et al., 2000), aPKC is activated and phosphorylates JAM. JAM phosphorylation 
subsequently  promotes the maturation of pAJ into TJ by recruiting other proteins such as 
ZO-1 to the site (Iden et al., 2012). In addition, there are numerous other proteins that 
might be involved in recruitment, interaction and/or regulation of aPKCs or that might be 
targets of phosphorylation. Two members of the FERM (protein4.1, ezrin, radixin, moesin)-
domain family of proteins, Willin and ezrin have been directly  linked to aPKC. Willin, 
together with Par-3, plays a role in the recruitment of aPKC and in the phosphorylation of 
the Rho-associated protein kinase (ROCK) by aPKC in epithelial apical morphogenesis 
(Ishiuchi & Takeichi, 2011). Ezrin seems to be a target of aPKCs and its phosphorylation 
leads to activation and localization to tight junction in mammalian cells (Wald et al., 2008). 
In summary, the Par-3/Par-6/aPKC complex is located at the apical domain of polarized 
cells through Par-3 mediated translocation, where it is involved in maturation of TJs by 
interacting with network of membrane bound proteins and thereby  orchestrates the 
formation of the AJCs. The regulation of the polarity complex is not fully understood, but it 
seems that the catalytic activity of aPKC  is essential for TJ maturation and is regulated by 
Par-6 binding.
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As mentioned earlier, the interaction between the Par-6/aPKC complex and Par-3 is 
transient and other interaction partners have been identified. Several studies  suggest that 
Lethal giant larvea (LGL) competes with Par-3 for Par-6/aPKC interaction and that the 
Par-6/aPKC/Lgl complex plays a role in earlier processes of polarity formation. LGL has 
first been identified as an interaction partner of Par-6/aPKC in Drosophila using 
immunoprecipitation experiments, which becomes phosphorylated by aPKC (Betschinger, 
Mechtler, & Knoblich, 2003). The same complex was identified in mammalian cells 
showing mammalian Lgl (mLgl) phosphorylation in fibroblasts after applying scratch 
wounds (Plant et al., 2003). Finally, mLgl1 and mLgl2 were identified to compete with 
Par-3 at an early stage of MDCK polarization during calcium switch and is segregated from 
the complex to the baso-lateral domain after phosphorylation by aPKC (YAMANAKA et al., 
2003). This observation is supported by the fact that overexpression of aPKCkn induces 
abnormal co-distribution of Par-6 and Lgl (YAMANAKA et al., 2003). Additional studies 
confirmed this model and postulated that mLgl functions as a mediator of cell adhesion 
stimuli to create a corresponding apical membrane domain and lumen during epithelial 
tissue morphogenesis by inhibiting the Par-3Par-6/aPKC-complex formation and Cdc42 
binding to Par-6 (YAMANAKA et al., 2006). 
Maintenance of cellular polarization through active exclusion
The mechanism described above occurs in a tightly regulated spacial context which is 
mostly  regulated by aPKC localization and activity. As part of the polarity  complex, aPKC is 
involved in maintaining cellular polarity  through active exclusion of important protein from 
distinct domains. The polarity complex is often localized in a complementary pattern to that 
of Par-1. This pattern seems to be facilitated through mutual phosphorylation of the two 
kinases, aPKC and Par-1. By phosphorylation they exclude each other from the 
complementary region of the cell. Par-1 phosphorylates directly Baz/Par-3 at several 
residues including S1085 (Benton & St Johnston, 2003). Phosphorylation of the S1085 
residue creates at Par-5 (which is a 14-3-3 protein) binding site and this binding effectively 
inhibits interaction with aPKC (Benton & St Johnston, 2003). The 14-3-3 binding to the 
Par-3 protein can be reversed by protein phosphatase 1ɑ (PP1ɑ) (Traweger et al., 2008), 
allowing the relocalization of Par-3 to the anterior cortex and reformation of the polarity 
complex. Conversely, Par-1 phosphorylation by aPKC inhibits both, the localization of the 
kinase at the membrane domain and the activity of the Par-1 kinase domain. Apparently, 
Par-1 gets phosphorylated at two residues and both of them have the same 
consequences. Direct phosphorylation through aPKC at T595 (Hurov, Watkins, & Piwnica-
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Worms, 2004) and aPKC dependent PKD mediated phosphorylation at S400 (Watkins et 
al., 2008). Furthermore, aPKCs are involved in the cellular distribution of many  more cell 
fate determinants such as Numb (C. A. Smith et al., 2007), Miranda (Atwood & Prehoda, 
2009) and the polarity protein LgL (Betschinger et al., 2003). In all cases phosphorylation 
by aPKC removes the target protein from the corresponding cellular cortex.
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Atypical PKCs in embryology
During development of the pre-implantation embryo two major mechanisms are involved in 
generating cell diversity: asymmetric cell division, leading to the formation of two daughter 
cells with different protein composition, and cellular interaction, leading to cells to adopt a 
distinct fate based on the environment. Thus, two distinguishable cell-lines ﬁrst appear at 
the 16-cell stage, recognizable by  position and phenotype (polarized and unpolar). The 
outer cells (polarized, trophoectoderm) are epithelial cells surrounding a cavity and a 
group of undifferentiated (unpolar) cells, the inner cell mass (ICM). This so-called ‘inside-
outside’-model is based on the theory that the position of the cell determines the fate 
(Tarkowski & Wróblewska, 1967). The apico-basal (AP) axis is ﬁrst formed at the 
compacted 8-cell stage (also E2.5). Each cell (blastomer) polarizes its cytoplasm along the 
AP-axis, which enables the cells to undergo asymmetric cell division leading to the two 
cell-lines at the 16-cell stage (also E3.0). These morphological events (asymmetrical 
contacts and polarity) are essential processes that contribute to the generation of 
trophectoderm (TE) and inner cell mass (ICM) through asymmetric divisions. The 
formation of these two cell types is a crucial process for the development of the mouse 
embryo since the ICM will mainly contribute to the formation of the embryo while the TE 
will participate to extra-embryonic structures.
Early studies investigating the establishment of polarity showed that in C. elegans 
embryos the anterior-posterior-axis occurs as early as during the ﬁrst cell cycle and is 
dependent on the functions of Par proteins (Kemphues, Priess, Morton, & Cheng, 1988) 
and PKC-3 (Tabuse et al., 1998), the ortholog of mammalian aPKCs. Without normal 
function of these proteins the asymmetric distribution of proteins is altered and especially 
PKC-3 is required for viability in C. elegans (S. L. Wu, 1998). The fact that PKC-3 does not 
localize to the periphery without PAR-3 (Tabuse et al., 1998) suggested that PAR-3 recruits 
PKC-3. Interestingly, in C. elegans fertilization induces polarized localization of PKC-3, 
Par-3 and Par-6 to the apical pole (Hung & Kemphues, 1999; Tabuse et al., 1998) with 
Par-1 localized to the basal pole (Boyd, Guo, Levitan, Stinchcomb, & Kemphues, 1996; S. 
Guo & Kemphues, 1995). The characterization of Par-3 and Par-6 proteins present in the 
early mouse embryo revealed that the proteins are expressed from the 2-cell stage 
onwards. Interestingly, asymmetric distribution of Par proteins occurs at the 8-cell 
compaction stage with mPar1 localized at the basal domain (Vinot et al., 2005). However, 
aPKCζ protein expression levels are very low until the 8-cell stage but increases at 16-cell 
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stage and onwards (Vinot et al., 2005). In contrast to the relatively  late onset of aPKCζ 
expression, aPKCɩ is already detectable at the 4-cell stage with increasing expression 
onwards (Dard, Le, Maro, & Louvet-Vallée, 2009; Eckert & Fleming, 2008). These 
differences in expression made aPKCɩ a more likely player in polarity formation, since 
aPKCζ is either absent or expressed at very low amounts. Expression analysis of both 
aPKC isoforms at later stages of mouse embryogenesis using in situ hybridization (ISH) 
showed ubiquitous expression of both isoform at E7.5 (Kovac, Oster, & Leitges, 2007). 
Further analysis showed consistently  lower expression of aPKCζ  compared to aPKCɩ in 
all tested stages (E7.5 - E14.5) and highly  speciﬁc expression patterns, especially  for 
aPKCζ at later time-points (Kovac et al., 2007). In summary, very little is known about 
isoform speciﬁc functions of the proteins in pre-implantation embryo and during 
embryogenesis. As mentioned before experimental approaches to adequately investigate 
this question were limited due to the lack of speciﬁc biochemical tools. The ﬁrst data about 
isoform speciﬁcity came from gene targeting approaches against aPKCζ. Leitges et al. 
showed that the disruption of aPKCζ protein expression has no effect on embryonic 
development but causes an impairment of the NFkB pathway in adult animals (Leitges et 
al., 2001). This study also shows that aPKCζ associates with, and directly phosphorylates 
p65 and that aPKCζ is required for the cytokine-induced p65 phosphorylation in mouse 
embryonic ﬁbroblasts (MEFs). Since aPKCɩ is present in the same tissues this data 
exclude possible redundancy between the two aPKCs and, for the ﬁrst time assigns a 
speciﬁc in vivo function to the aPKCζ protein. In contrast, disruption of aPKCɩ expression 
causes a severe phenotype. The aPKCɩΔ/Δ embryos display structural abnormalities as 
early as E6.5 and by E9.5 the embryos are shrunken with no recognizable structures 
(Soloff, Katayama, Lin, Feramisco, & Hedrick, 2004). Further analysis of the phenotype 
were performed in aPKCɩΔ/Δ cell.line and showed an alteration in actin stress ﬁbers in 
MEFs but no impairment of the NFkB pathway (Soloff et al., 2004), supporting the speciﬁc 
aPKCζ function. However, the gene targeting studies were based on knockdown studies in 
very  early stages of mouse embryogenesis that repeatedly failed to assign speciﬁc 
functions to an aPKC isoform. This was likely due to the lack of adequate biochemical 
tools and not due to a lack of scientiﬁc effort. Despite these problems the scientiﬁc ﬁeld 
continued to investigate the role of aPKCs in early embryogenesis. In the following years 
aPKCs were linked to important functions in polarity formation in the preimplantation 
embryo. As mentioned above, between the 16-cell and 32-cell (blastocyst) stage, the outer 
cells progressively differentiate into epithelial cells. During this phase cell junctions start to 
mature, characterized by a step-by-step  accumulation of tight junction proteins at the 
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border of the apical and the basolateral domains. During 8-cell stage compaction adhesive 
E-cadherin recruits ZO-1, rab13 and the Par-3/6/apKC-complex to the site of TJ formation. 
From the 8-cell stage to the blastocyst stage recruitment of JAM, Cdc42, cingulin and 
ZO-2 results in a functional TJ and a basolateral Zonula adherens (ZA) as reviewed in 
Eckert and Fleming (Eckert & Fleming, 2008). It also has been shown that both proteins 
show lineage-distinct staining patterns in blastocysts. While PKCiota is distributed to the 
TE membrane and cytoplasm, aPKCζ is predominantly localized at the apical membrane 
of TE, showing a similar staining than the ZO-1 protein (Eckert et al., 2004). While it is 
clear from these data that both proteins have distinct localization patterns, the role of the 
individual aPKC isoforms remains unclear. Despite the indications that aPKCζ might play 
the more important role in TJ formation, it is aPKCɩ that has been linked to this process in 
early mouse development and not aPKCζ. Mutant embryos either expressing a kinase 
dead dominant mutant or siRNA against endogenous aPKCɩ displayed mislocated ZO-1 
and cingulin, indicating a defect in TJ formation, while the setting up of polarity along the 
radial axis at 8-cell stage by E-cadherin showed no impairment (Dard et al., 2009).
The role of aPKC in very early embryogenesis
One of the biggest challenges in developmental biology is to understand how asymmetries 
are elaborated along the main body axis. Remarkably, the origin of this process can in 
many organisms be traced back to the one-cell stage. The one-cell stage or the egg 
contains cell axis determinants that localize to opposite ends of the cell, thereby  controlling 
the symmetry or asymmetry of the cell. Genetic screens in Drososphila and C-.elegans 
have identiﬁed several regulators of egg polarity. Soon after the discovery of a group of 
genes crucial for polarization of cells (par-genes) in C. elegans these genes were 
investigated in Drosophila. It turned out that these mechanisms were conserved with one 
exception: In C. elegans Par-3 and par-6 localize together with aPKC at the anterior 
domain, while par-1 and par-2 occupy the posterior domain. The remaining par-4 and 
par-5 are equally  distributed throughout the cytosol. In Drosophila, the par-2 protein is 
missing, while otherwise the machinery seems to be fully  conserved. Par6 was ﬁrst 
identiﬁed for its role in polarizing the C. elegans zygote (Watts et al., 1996). PAR-6 and 
PKC-3 become restricted to an anterior cortical domain of the zygote and regulate the 
localization of developmental determinants and proteins required for asymmetric cleavage 
(Pellettieri & Seydoux, 2002).  PKC3 was ﬁrst described to play a role in cell organization 
in C. elegans.  Oocytes lacking PKC3 failed to hatch (S. L. Wu, 1998). Examination by 
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interference microscopy revealed that arrested embryos contained highly disorganized 
cells. Thus, it appears that the atypical PKC3 of C. elegans is essential for the normal 
progression of early to mid-embryogenesis and the viability of the intact organism.
In both organisms D. melanogaster and C. elegans only one atypical PKC is expressed 
and several studies investigated the role of aPKC in both organisms over the last two 
centuries: The ﬁrst description of aPKC in D. melanogaster was published in 1989 as a 
detailed description including gene description, sequence analysis and protein expression 
(Schaeffer, Smith, Mardon, Quinn, & Zuker, 1989). Later studies showed Drosophila 
atypical Protein Kinase C associates with Baz/Par-3 and controls polarity of epithelia and 
neuroblasts (Wodarz, Ramrath, Grimm, & Knust, 2000). Surprisingly, Baz does not simply 
function as a scaffold to anchor DaPKC in the apical cytocortex, but is itself dependent on 
DaPKC for proper localization and stability. The dependency of Par-3 on aPKC for its 
localization is unique to D. melanogaster and not completely understood. In C. elegans the 
PKC3 protein was ﬁrst described by Wu et al. (S. L. Wu, 1998). As part of a bigger study, 
functional investigations showed that more than 90% (338 of 367) of embryos containing 
antisense against PKC3 mRNA failed to hatch. More detailed examination by interference 
microscopy revealed that arrested embryos contain 100–200 highly  disorganized cells. 
Thus, it appears that atypical PKC3 of C. elegans is essential for the normal progression of 
early to mid-embryogenesis and the viability of the intact organism.
In contrast to C. elegans and D. melanogaster, mammalian cells contain two aPKC 
isoforms, confronting the ﬁeld with the problem of possible overlapping function and 
speciﬁc role in embryogenesis. Several studies have investigated the PKC expression 
pattern in the unfertilized mammalian egg (UFE), early stages of egg activation  as well as 
embryogenesis (Dard et al., 2009; Eckert et al., 2004; Eckert & Fleming, 2008; Halet, 
2004; Kovac et al., 2007; Pauken, 2000; Pauken & Capco, 1999; Raz, Eliyahu, Yesodi, & 
Shalgi, 1998; Vinot et al., 2005). When fertilization-competent cells were detergent 
extracted, which means that all soluble unbound content is removed, aPKCζ remained 
tightly associated with the meiotic spindle and seemed to be bound to spindle ﬁbers 
(Baluch, Koeneman, Hatch, McGaughey, & Capco, 2004). The model that aPKCζ stays 
associated with the spindle apparatus during the complete cell division was conﬁrmed by 
ﬂuorescence resonance energy  transfer (FRET) using tubulin as an acceptor and aPKCζ 
as a donor (Baluch et al., 2004). After completion of the ﬁrst cell cycle aPKCζ localizes to 
the cytoplasm and the nucleus of two daughter cells. Interestingly, aPKCζ expression 
starts as early (or ‘as late as’ in the context of the previous data) as in the 2-cell stage and 
increases in the 4- and 8-cell stage (Pauken, 2000). In contrast to the expression data, 
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aPKCζ protein is already detected in the UFE, which might be maternal protein and not 
newly expressed protein. However, the localization in the 2- and 8-cell stage (before 
compaction) is mainly  cytoplasmic with nuclear localization, but exclusion from the 
nucleoli, while the localization pattern slightly changes during the 4-cell stage. In the 4-cell 
stage aPKCζ suddenly  translocates from the cytoplasm to the cell membrane facing the 
external milieu and relocates to the cytosol in uncompacted 8-cell embryos. During 
compaction aPKCζ relocalizes to the membrane and shows no nuclear localization 
(Pauken, 2000; Vinot et al., 2005).
Recent studies on aPKCɩ expression in the preimplantation mouse embryo revealed 
detectable, increasing protein expression from the 4-cell stage upwards with higher 
expression relative to aPKCζ (Dard et al., 2009; Kovac et al., 2007), with an important role 
in allocation of cell lineages (Dard et al., 2009). To further investigate the role of aPKCɩ 
during early embryogenesis fertilized eggs or embryos in the 2-cell stage were transfected 
with siRNA against aPKCɩ. Depletion of aPKCɩ has no effect on the development of the 
stage before 8-cell stage embryos and apico-basal polarity is correctly set up  at 
compaction. At the 16-cell stage embryo the absence of aPKCɩ shows an effect. In aPKCɩ 
depleted embryos ZO-1 and cingulin were mislocalized, causing impaired junction 
formation. Because of the impaired polarity the ratio between inside cells (forming ICM) 
and outside cells (tropho-ectoderm) is changed. The absence of aPKCɩ causes an 
increase in asymmetric cell division during the 8-16 cell stage resulting in decreased inner 
cells (Dard et al., 2009). Considering these studies, both atypical PKCs are co-expressed 
in the mouse embryo at least at the 4-cell stage and later. It has been shown that the 
aPKCζ protein is present at very high levels in the unfertilized egg without detectable 
mRNA present. Since the protein is likely from the mother, we cannot exclude the 
presence of maternal aPKCɩ protein.
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Present Investigations
Aims of the study
The atypical PKCs represent the third of the superfamily of serine/threonine kinases PKC. 
Atypical PKCs have been shown to be involved in a number of important cellular 
mechanisms such as proliferation, migration, differentiation and apoptosis. However, little 
is known regarding isoform speciﬁcity in mammals and PKCɩ and PKCζ are often 
considered to be functionally redundant. While biochemical studies have problems linking 
certain functions to the speciﬁc isoforms, genetic targeting approaches clearly show 
different phenotypes in aPKC knockout animals, indicating non-overlapping functions.
The main goal of this study  is to investigate isoform speciﬁcity. Considering published data 
and available unique tools in our lab we based the study on two approaches.
1. To identify possible isoform-speciﬁc functions we designed a number of aPKC GFP-
fusion proteins and expressed those in MDCK cells, an established model cell-line to 
study polarity. It is known that kinase speciﬁcity is often achieved by (either) interaction 
and/or localization. Based on that rationale we investigated the role of distinct domains 
within aPKC in mediating localization in MDCK cells to conclude possible isoform 
speciﬁcity. The proteins investigated include truncated proteins of both isoforms and 
mutant versions that speciﬁcally target known interaction partners to verify their possible 
role in aPKC regulation.
2. To further investigate possible redundancies between the two atypical PKC we 
performed a detailed analysis of aPKCɩΔ/Δ mice regarding the role of aPKCɩ during 
early stages of development and the possible reason for the observed lethal phenotype. 
As part of that study we also investigate the possible role of aPKCζ in the context of 
aPKCɩ deﬁciency.
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Synopsis of the papers
Paper I: Functional Comparison of protein domains within aPKCs involved in 
nucleocytoplasmic shuttling. The regulation of aPKC localization, translocation and 
interaction was investigated based on functional components and differences in the amino 
acid sequence. The comparative analysis of atypical PKCɩ/ƛ and PKCζ was performed in 
MDCK cells, an established model system for proteins involved in either establishing or 
maintaining cellular polarity. We expressed a series of GFP-fusion proteins including the 
full-length proteins, truncated proteins and functional mutants to investigate the role of the 
single domains in localization and nucleocytoplasmic shuttling. For the comparison of 
nuclear translocation of both aPKCs we were using the nuclear export inhibitor Leptomycin 
B showed. The analysis of the shuttling properties of both full-length proteins showed 
different kinetics of the two isoforms. Overexpression of truncated proteins revealed 
differences in subcellular localization between the two isoforms. Expression of the 
regulatory domain of aPKCɩ resulted in a protein with predominant nuclear localization. In 
contrast the regulatory domain of aPKCζ was almost exclusively  located at the membrane 
with little cytoplasmic signal. These results indicated a different regulation of localization 
between the two aPKC  members. A more detailed study of the regulatory domain identiﬁed 
the Hinge region as a possible carrier of a yet unidentiﬁed motif that mediates speciﬁc 
localization in MDCK cells. Analysis of the aPKCɩHINGE showed a dominant localization to 
the nucleus of the cell. The corresponding aPKCζ construct showed a cytoplasmic staining 
with an obvious absence of nuclear localization. Mutational analysis of the NLS of both 
PKCs revealed that PKCɩ can translocate to the nucleus independent of its NLS whereas 
PKCζ’s translocation is mainly regulated by its NLS. In the context of the full-length protein 
the PB1 domain partly regulates the translocation of aPKCɩ, but not aPKCζ. Together 
these data argue for a different regulation of aPKC isoforms regarding cellular localization 
and translocation.
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Paper II: Phenotypical analysis of atypical PKCs in vivo display a compensatory 
system at embryonic stage 7.5 p.c. (under review in PlosOne) The atypical protein 
kinases C (PKC) isoforms ι/λ and ζ play crucial roles in many cellular processes including 
development, cell proliferation, differentiation and cell survival. Possible redundancy 
between the two isoforms has always been an issue since most biochemical tools do not 
differentiate between the two proteins. Thus, many efforts  have been made during the last 
decades to characterize the functions of aPKCs using gene targeting approaches and 
depletion studies. However, little is known about the specific roles of each isoform during 
mouse development. We show that deletion of PKCι/λ, results in a reduced size of the 
amniotic cavity at E7.5 and impaired growth of the embryo at E8.5 with subsequent 
absorption of the embryo. Our data also indicate an impaired localization of ZO-1 and a 
disorganized structure of the epithelial tissue in the embryo. Importantly, using electron 
microscopy, embryoid body formation and immunofluorescence analysis, we found, that in 
the absence of PKCι/λ, tight junctions and apico-basal polarity were still established. 
Finally, our study indicates a non-redundant PKCι/λ function at E9.5, since expression of 
aPKCζ is able to rescue the E7.5 phenotype, but resulted in embryonic lethality at a later 
time-point (E9.5). Our data show for the first time that PKCι/λ is  crucial for mouse 
embryogenesis but is dispensable for the establishment of polarity and tight junction 
formation. We present a compensatory function of aPKCζ at E7.5, rescuing the phenotype. 
Furthermore, this study indicates at least one specific, yet unknown, PKCι/λ function that 
cannot be compensated by aPKCζ overexpression at E9.5.
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Discussion
Atypical PKCs represent a subgroup  of the PKC  family that shows a remarkable homology 
to each other. Irrespective of the distinguishable mode of activation compared to the rest 
of the family, very  little is known about possible differences between the two atypical 
PKCs. Several studies using gene targeting or RNA knockdown approaches have 
indicated the existence of isoform-speciﬁc functions. In recent years the view that speciﬁc 
interaction partners restrict the individual isoforms to certain cellular domains to create a 
speciﬁcity of action (Jaken & Parker, 2000). Several interaction partners have been 
identiﬁed to act on aPKCs, including lipid second messengers (e.g. PI-3,4,5-trisphosphate 
and ceramide) and members of the Par-family (Par3, -4 and -6). Some of the known 
binding proteins seem to interact with both isoforms, whereas others are speciﬁc for one 
isoform. For example, Zip/p62 has been shown to interact with both isoforms in PC12 cells 
(Samuels, Seibenhener, Neidigh, & Wooten, 2001) and links aPKCs (in this case) to the 
regulation of nerve growth factor (NGF)-induced differentiation and Par4 selectively 
interacts with both aPKCs during apoptosis (Diaz-Meco et al., 1996a). In contrast, lambda 
interacting protein (LIP) selectively  interacts with the zinc ﬁnger of aPKCɩ and is a very 
speciﬁc, potent activator of aPKCɩ but not aPKCζ. It has  been suggested that LIP activated 
aPKCɩ might play a role in the transactivation of a κB dependent promotors (Diaz-Meco, 
Municio, Sanchez, Lozano, & Moscat, 1996b). Isoform speciﬁcity is an important issue and 
a better understanding of the regulation of the speciﬁc isoforms is crucial for drug 
development and targeted studies. Thus, the aim of this thesis was to identify  functional 
differences among aPKCs and to study the role of speciﬁc protein domains in mediating 
isoform speciﬁc localization and/or interactions.
The HINGE domain and its role in sub-cellular localization of aPKCs.
As a starting point of our biochemical study (Paper I) we assumed that isoform speciﬁc 
function is linked to a speciﬁc localization in the cell and that localization is mediated by 
protein domains and their interaction partners. Moreover, we decided to focus on the 
regulatory domain, since this region contains conserved domains as well as highly variable 
regions. We hypothesized that conserved domains are either regulated differently  in the 
two isoforms and/or that localization is mediated by the variable regions through 
interactions with different proteins. We thought that removing the kinase domain would 
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simulate an open conformation of the regulatory domain and thereby promote protein 
interactions. 
We were indeed able to show that the isolated hinge regions of the aPKC isoforms have 
distinct cellular localization. Furthermore, we demonstrated that the hinge regions are 
essential for the localization of the regulatory domain. Switching the hinge regions of the 
aPKC isoforms changed the localization of the chimeric proteins and conﬁrmed a dominant 
effect of the hinge region on the localization of the regulatory domain and in the context of 
the full-length proteins. Our data shows that the hinge region of aPKCiota is involved 
mediating nuclear localization, while the aPKCzeta hinge region causes membrane and/or 
cytoplasmic localization. So far the only characterized motif in the hinge region is a 
caspase cleavage site that has previously been described in the hinge region of aPKCzeta 
(Frutos et al., 1999). In HeLa cells, longer exposure to UV light was shown to inactivate 
aPKCzeta that precedes it proteolytic degradation and produces a fragment of 
approximately  50 kDa (Frutos et al., 1999). In our setup, however, none of the aPKCzeta 
constructs showed signiﬁcant increase in caspase cleavage of the GFP-fusion protein and 
no accumulation of a 50 kDa fragment could be detected. To gain further understanding of 
the mechanism that inﬂuences localization and to possibly identify  new motifs that might 
be relevant for the speciﬁc cellular localization we develop a strategy based on random 
mutagenesis. The idea is to create a fusion protein library containing hinge domains 
mutants of both isoforms. The number of mutant has to be sufﬁcient to statistically hit all 
amino-acids in the sequence with at least one mutation. We are aware of studies that have 
shown that the GFP tag might be suboptimal for this kind of high throughput localization 
studies (Seibel, Eljouni, Nalaskowski, & Hampe, 2007) and we think that the intrinsic 
nuclear localization of the GFP protein might interfere with our read-out. We therefore 
consider an approach using a smaller tag such as Myc or FLAG. To avoid that diffusion of 
the protein interferes with our experimental setup  we also consider a much larger LacZ 
fusion protein. This approach is currently in process in our laboratory. 
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The nuclear shuttling of aPKCs is not exclusively regulated by the NLS
When we ﬁrst observed the nuclear localization of the N-terminal construct without the 
hinge region we assumed that this is due to the NLS motif present in the C1 domain of 
both isoforms, functionally described by others (Perander, 2000; Pu et al., 2006). Since the 
NLS has only been shown to be functional in the context of shorter fragments and not in 
the full-length protein (Perander, 2000) we decided to investigate the role of the NLS in 
more detail. Using MDCK cells, we were able to conﬁrm earlier work performed in Cos7 
and HeLa cells that showed increased shuttling of aPKCiota compared to aPKCzeta 
(Perander, 2000). However, when we mutated the NLS in both isoforms, the aPKCɩ mutant 
did not appear to be affected, whereas aPKCζ protein levels in the nucleus were 
signiﬁcantly decreased. Although reduced, the accumulation of aPKCζ in the nucleus of 
MDCK cells was signiﬁcant. Together our results strongly indicate the presence of 
alternative translocation mechanisms in both aPKCs.
 
In contrast to our data, in studies using PC12 cells both aPKCs have been reported to 
translocate into the nucleus after neural growth factor treatment (NGF) (Neri et al., 1999; 
M. W. Wooten, Zhou, Wooten, & Seibenhener, 1997; G. Zhou, 1997). In fact Wooten et al. 
convincingly showed phosphorylation of aPKCiota at Tyr256 by Src after NGF treatment. 
Sequence alignment of aPKCɩ and aPKCζ shows that the Tyr256 residue is conserved in 
both isoforms suggesting that it may play a role in the translocation of aPKCζ as well. It 
seems that phosphorylation of Tyr256 causes a conformational change leading to the 
exposure of the NLS and subsequent importin-β binding (White et al., 2002). It is likely that 
importin-β binds directly  to aPKCɩ, since arginine-rich NLS motifs do not need importin-ɑ 
(Palmeri & Malim, 1999). This is supported by other in vitro studies that have shown that 
human aPKCζ, which has the same NLS sequence then murine aPKCɩ, does not directly 
bind to importin-ɑ (Maiyar, Leong, & Firestone, 2003). Similar results were observed by 
Neri and colleagues, who showed a PI3K dependent translocation of aPKCζ into the 
nucleus of PC12 cells upon NGF stimulation. Unfortunately, none of these studies 
addressed whether these mechanisms are speciﬁc for aPKCɩ or aPKCζ as well.  Neri et al. 
suggested that the two phosphorylation products of PI3K, PtdIns(3,4)P2 and 
PtdIns(3,4,5)P3, are involved in the nuclear localization of the protein. Both products have 
been shown to activate aPKCζ in vitro (Nakanishi, Brewer, & Exton, 1993; Toker et al., 
1994). In their model aPKCζ shuttles between the cytosol and the nucleus and after NGF 
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stimulation PI3K translocates to the nucleus where nuclear PtdIns(3,4,5)P3 activates 
aPKCζ. Activated aPKCζ then remains in the nucleus. 
We used Leptomycin B (LMB) to show that both isoforms shuttle between the cytoplasm 
and the nucleus. LMB has been described to speciﬁcally  inhibit the export of protein with a 
leucine rich NES by inactivating CRM1 (Stade, Ford, Guthrie, & Weis, 1997). CRM1 
belongs to the superfamily of importin-β and together with four other family  members 
(CAS, exportin1, exportin and importin 13) it mediates nuclear export (Fornerod, Ohno, 
Yoshida, & Mattaj, 1997). Of these ﬁve proteins CRM1 regulates the vast majority of 
shuttling protein containing a leucine-rich NES, such as aPKCs, while the others are very 
speciﬁc for unique export substrates. Even though the sequence alignment of the two NES 
in aPKCs do not show a different amount of leucine residues we cannot exclude that the 
decreased accumulation of aPKCζ is partly a result of using LMB as an inhibitor and that 
other export proteins might be involved. Regarding the role of the NLS in aPKCiota we can 
only speculate that other yet unidentiﬁed NLS motifs are present or that importin 
independent mechanisms are involved in the nuclear translocation of this isoform. 
Despite extensive studies on the sequence of both aPKCs very little is known about novel 
NLS or other sequences related to nuclear import. However, importin independent 
mechanisms do exist like for example: 
1. β-catenin, which as a part of the Wnt/Wingless pathway, binds to the cytoplasmic tail of 
cadherin adhesion molecules and has been shown to translocate to the nucleus through 
importin-independent mechanisms. The protein binds directly to the nuclear pore 
machinery and translocates into the nucleus in a possibly  Ran-dependent manner 
(Fagotto, Glück, & Gumbiner, 1998). The β-catenin armadillo-repeats are present in a 
number of proteins including importin-β and present data suggest a role of this motif in 
nuclear translocation (Fagotto et al., 1998). Interestingly, an interaction between β-
catenin and aPKCs also has been shown in various tissues and is believed to be 
mediated by  the armadillo-repeat present in β-catenin and a yet unknown motif in 
aPKCs (Luna-Ulloa et al., 2011; Seifert et al., n.d.). In addition to the direct interaction of 
these proteins, aPKCζ kinase activity  is important for the nuclear localization of β-
catenin in cancer cell lines (Luna-Ulloa et al., 2011). Together these data show that β-
catenin shuttles importin-independent and CRM1-dependent between the nucleus and 
the cytosol. Not only the transcriptional activity of β-catenin is regulated by  aPKCζ, it 
also interacts directly with aPKCζ through its armadillo-repeat. We think that the link 
between β-catenin nuclear localization and aPKCζ activity might also be relevant for 
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other pathways and that β-catenin is a potential regulator of aPKC localization in an 
importin independent manner.
2. Alternatively, Pollard et al. described a 38 amino acid transport signal, termed M9, which 
confers bidirectional transport across the nuclear envelope (Pollard et al., 1996). For its 
nucleocytoplasmic shuttling, M9 serves as a NLS and nuclear export signal (NES) and 
its transport receptor is transportin (Trn)/karyopherin β2 (Calado, Kutay, Kühn, Wahle, & 
Carmo-Fonseca, 2000; Rebane, Aab, & Steitz, 2004). Attempts to deﬁne the sequence 
for Trn interaction produced a consensus Trn interaction sequence (Bogerd et al., 1999). 
This sequence is present in the kinase domain of both aPKCs and has the potential to 
interact with TRN. Whether the interaction between Trn and aPKC  happens in vivo or in 
vitro and whether this plays a role in translocation needs to be further investigated.
In this study we also investigated an involvement of a “hitchhiking” o “Piggyback”-
mechanism (Fagotto et al., 1998; Fang et al., 2007; Luna-Ulloa, Hernandez-Maqueda, 
Santoyo-Ramos, Castaneda-Patlan, & Robles-Flores, 2011; Pollard et al., 1996) as 
possible importin independent mechanism through which aPKCs might translocate into the 
nucleus. This principle is not completely new and the importin-β mediated translocation 
follows the same mechanism. Interestingly, importin-β competes with β-catenin for binding 
the nuclear envelope, suggesting a novel function for β-catenin (Fagotto et al., 1998). 
Earlier export models of β-catenin included APC  as a carrier protein (Fagotto et al., 1998; 
Henderson, 2000) but a more recent study showed that β-catenin can bind directly to 
CRM1 independently of APC (Ki, Oh, Chung, & Kim, 2008).    
Since the aPKC-PB1-domain is a protein-protein interaction domain (Hirano, 2004a; 
2004b) that theoretically interacts with at least 12 additional mammalian PB1-containing 
proteins (Lamark, 2003) we investigated the role of that domain during translocation. 
Interestingly, Par-6, a protein that has been shown to interact with aPKCs via the PB1 
domain is localized in the nucleus of MDCK cells. Therefor Par-6 represents a possible 
candidate to act as a partner during ‘hitchhiking’. Thus we mutated the PB1 domains in the 
full-length proteins to observe possible changes in the localization or translocation 
behaviour. We expected to see decreased nuclear accumulation of the mutant upon LMB 
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treatment. Instead, we observed an increased nuclear fraction of aPKCs in untreated cells, 
indicating an impaired shuttling. One possible interpretation of these data is that under 
normal conditions aPKCs are predominantly  localized in the cytosol of the cell through 
interaction with Par-6. A  fraction of that aPKC pool might translocate to other cell 
compartments through binding to other protein such as Par-3 and Cdc42. Another fraction 
of the same aPKC pool shuttles into the nucleus depending on importin-β and yet 
unknown binding partners.The disruption of the PB1 domain leads to the disruption of the 
Par6-aPKC interaction (Wilson et al., 2003) and might cause a shift in the distribution of 
the protein (Noda, 2003). As a result of the Par-6 release the aPKC  pseudo-substrate 
interacts with the kinase domain and causes a conformational change. Thus, more mutant 
protein is available for other interactions and this might lead to increased nuclear import. 
We think that Par-6 might act as an anchor and is not actively  involved in the nuclear 
translocation of aPKC  even though Par-6 has been described in the nucleus and it shows 
weak shuttling between the nucleus and the cytosol (Cline & Nelson, 2007). 
While this study  focus on the involvement and alteration of possible import mechanism of 
aPKCs into the nucleus we cannot fully  exclude that our observations are a result of an 
impaired export of the proteins. Some of the domains that we postulate to be involved in 
nuclear import have also been shown to play a role in the nuclear export of proteins. A 
recent publication has  shown that another PB1 containing protein, p62,  is important for 
the nuclear export of ALFY (autophagy-linked FYVE) in HeLA cells (Clausen et al., 2010) 
demonstrating that proteins can also “hitchhike” out of the nucleus. This suggests, as we 
have mentioned, that the increased amount of nuclear protein might as well be a result of 
decreased export rather than increased import. The p62 protein, also known as  zeta 
interacting protein (ZIP), has previously been identified as  a binding partner of aPKCs 
(Puls et al., 1997; Sanchez, De Carcer, Sandoval, Moscat, & Diaz-Meco, 1998) and has 
recently received more attention as a player in starvation induced autophagy (Lamark, 
Kirkin, Dikic, & Johansen, 2009; Pankiv et al., 2010) Bjørkøy et al. identified p62 as  a 
nuclear protein with shuttling properties similar to aPKC (Pankiv et al., 2010). Thus, we 
consider p62 as a likely candidate to mediate nuclear shuttling of aPKCs.
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Nuclear functions of aPKCs
Very little has been published regarding the nuclear functions of atypical PKCs and none 
of those publications differentiates between the two isoforms. We were and still are 
particularly interested in possible nuclear functions since our study is the ﬁrst to suggest 
multiple mechanisms of nuclear transport. This could mean that the cellular context plays a 
major role in the regulation of nuclear translocation and that the physiological conditions 
for nuclear translocation and activity  of both aPKCs are different. However, over the last 
decade three nuclear processes have been identiﬁed which potentially could be linked to 
aPKC function:
1. Both isoforms have been described as a binding partner of Par-3 and Par-6 (Henrique, 
2003; Joberty et al., 2000; Noda, 2003), forming a ternary complex, also known as 
polarity  complex. Recent work has revealed a nuclear localization of both Par proteins. 
In MDCK cells, Par-6 has been characterized as a constitutive dual-location protein 
present at the membrane and in the nucleus (Cline & Nelson, 2007). Furthermore the 
nuclear localization of Par-6 is partially dependent on a putative NLS present in the 
protein, but independent of aPKC, since deletion of the PB1 in Par-3 has no effect on 
the nuclear localization (Cline & Nelson, 2007). However, when we overexpressed the 
aPKC/???PB1 mutant in MDCK cells we noticed an increased nuclear localization of 
Par-6 (data not published), supporting a possible role of aPKC in regulation of Par-6 
localization. Par-3 has also been shown to be located in the nucleus and in contrast to 
Par-6 it has been associated with a distinct function. Par-3 was shown to interact with 
Ku70/Ku80 after ɣ-radiation (IR), a potent double strand break inducer in DNA often 
used in DNA repair studies. Subsequently, the DNA-dependent protein kinase (DNA-PK) 
associates with this complex (Fang et al., 2007). This study shows an unexpected link of 
Par-3 to DNA repair and that Par-3 is absolutely required for efﬁcient DNA repair and 
cell survival following DNA damage.The cellular localization of Par-3 has been shown to 
be independent of aPKC and Par-6 interaction. During the formation of tight junction, 
Par-3 is recruiting Par-6 and aPKC. Considering the robustness of the polarity complex 
in the cytosol it might as well exist in the nucleus with yet undiscovered functions. 
Furthermore, when we used known online tools to scan the protein sequence of both 
aPKCs for possible motifs we found a conserved phosphorylation motif for DNA-PK 
present in both proteins. The presence of a DNA-PK motif might represent a functional 
link between aPKCs and Par-3 in the nucleus that has not been reported before. More 
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detailed studies are necessary  and conclusions based on these data are highly 
speculative so far. However, we do think that aPKCs potentially  play a role in DNA 
damage repair including interaction with Par-3 and Par-6.
2. The role of aPKCζ in colonic epithelial proliferation. After aPKCζ has earlier been 
implicated in the control of cellular mitogenic signaling and survival (Diaz-Meco et al., 
1996a; Gómez et al., 1995; Powell et al., 1996). Recent studies in the murine colon 
showed a correlation of increased aPKCζ expression and crypt hyperproliferation 
(Umar, Sellin, & Morris, 2000). Furthermore, the study shows increased nuclear 
localization of aPKC in hyperproliferating crypt nuclei indicating a role in transmissible 
murine colonic hyperplysia (TMCH).
3. Lastly it has been shown in 293 cells and embryonic ﬁbroblasts that treatment with 
TNFɑ leads to the activation of aPKCs which subsequently  activates the NFκB signaling 
pathway thereby causing a translocation of NFκB to the nucleus. Activation and 
translocation of NFκB requires speciﬁc phosphorylation, for example at Ser311 at the 
RelA subunit, which is a target of aPKCζ (Duran, Diaz-Meco, & Moscat, 2003).Cells 
deﬁcient for aPKCζ showed a reduced RelA phosphorylation at Ser311 indicating that 
this process is speciﬁc for aPKCζ and aPKCɩ is not involved. Whether the 
phosphorylation of RelA by aPKCζ takes place in the cytosol or within the nucleus of the 
cell still remains unknown.
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The role of atypical PKCs in early mouse development
Many studies have been performed describing the role of aPKC during embryonic 
development including various species. Earlier studies on aPKCs were mainly  performed 
in C. elegans, Xenopus and D. melanogaster and showed an important role of aPKC in the 
establishment and maintenance of the apico-basal polarity  and epithelial structures. In 
contrast to mammals these organisms have only one aPKC isoform and therefore provide 
a straight forward model system with limited information about possible mechanisms 
controlled by speciﬁc isoforms in mammals. The ﬁrst evidence that there is functional 
exclusiveness of aPKC  isoforms came from gene targeting approaches for both aPKCs. In 
2004, Soloff et al. described an embryonic lethal phenotype when the aPKCɩ gene was 
knocked out by conventional gene targeting. Nevertheless that study did not investigate 
details such as the exact time and possible causes of the lethality. In comparison to the 
viable aPKCζ knock out animals this deﬁnes an important role of aPKCɩ during early 
mouse development. When we generated various aPKCɩ knockout alleles in our lab, mice 
deﬁcient for aPKCɩ showed a lethal phenotype as well. Further analysis of the mutants 
discovered ﬁrst morphological irregularities at E7.5. At this stage mutant embryos showed 
reduced size and an impaired formation of the amniotic cavity. 
Only  very little is known about the role of aPKCɩ in cavity formation and this is the ﬁrst time 
that the protein could be linked to the process of the amniotic cavity formation. Based on 
what is known about the role of aPKCɩ in polarization of cells we expected that the 
phenotype is a result of impaired polarity. We therefore compared our phenotype with 
described phenotypes of other polarity proteins. Surprisingly only a few knockout studies 
have been performed on proteins involved in polarization events that show comparable 
phenotypes. 
1. Studies on Zonula Occludens-1 (ZO-1) showed that ZO-1 deﬁciency causes a lethal 
phenotype between E10.5 and E11.5. Compared to the loss of aPKCɩ this phenotype 
occurs later and is most likely due to a defected yolk sac angiogenesis and apoptosis 
(Katsuno et al., 2008).
2. A phenotype that is strikingly similar to the aPKCɩ-deﬁciency is caused by the loss of 
afadin. Afadin deﬁcient embryos showed ﬁrst morphological impairment at E7.5 and 
degradation of the embryo at E9.5 (Wataru Ikeda, 1999). The loss of afadin causes 
impaired localization of ZO-1 and E-cadherin leading to disorganized cell-cell junctions 
of the embryonic ectoderm. Afadin has been shown to regulate aPKC activity through 
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Cdc42 (Atwood & Prehoda, 2009; Sato, 2005; Welchman, Mathies, & Ahringer, 2007) 
and therefore represents a link to the role of aPKCs.
3. Cdc42-deﬁcient mice show a much more dramatic phenotype then ZO-1 and Afadin. 
The lack of Cdc42 severely  impairs the development of the embryo resulting in a 
reduction in size at E5.5 and absorption of the embryo at E6.5.  As the author suggests 
the onset of the phenotype could even be earlier and that it may be delayed by  the 
maternal Cdc42 (F. Chen et al., 2000). 
Even though all three proteins have been described to play a role during the formation of 
tight junctions and adherens junctions (Komura et al., 2007; X. Wu et al., 2007) the various 
phenotypes all occur at different timepoints of the embryonic development and/or are 
different from what we see in the aPKCɩ deﬁcient animals. Since our attempt to ﬁnd a 
mechanistic explanations or hinds for the phenotype of the aPKCɩ deﬁciency by comparing 
existing knockout studies did not succeed, we choose alternative approaches.
Embryoid bodies as a model system for cavity formation
First we wanted to look at the process of cavity formation and the potential role of aPKCɩ 
since we observed a severe reduction of the amniotic cavity  in aPKCɩ deﬁcient embryos. A 
commonly  used system to investigate the molecular mechanism of cavity formation is the 
embroid bodie (EB) formation assay. This model system recapitulates early stages of 
embryonic development in vitro (Keller 1995). Our initial analysis using 
immunoﬂuorescence showed correct formation of the basal lamina and the apical domain. 
E-cadherin was found to be at the apical site facing the lumen in both genotypes, 
indicating the presence of cell junctions (Tunggal et al., 2005). We also used Par-3 as a 
marker for TJ-formation and established AP, as well as the adapter protein MUPP1, to 
check for the interaction of JACs with the cytoskeleton (Guillemot, Paschoud, Pulimeno, 
Foglia, & Citi, 2008). The localization of Par3 and MUPP1 were unaffected by the loss of 
aPKCɩ in analyzed EBs. The fact that Par3 localization remains unaffected in EB formation 
using aPKCɩ deﬁcient mammals ES cells conﬁrms earlier results from studies performed in 
C. elegans(Hung & Kemphues, 1999). Furthermore, our data show that the impaired cavity 
formation as a result of the loss of aPKCɩ is not caused by the loss of apico-basal polarity. 
Our study  also shows a remaining aPKC signal at the apical domain of aPKCɩ deﬁcient 
mutants. Western Blot analysis and RNA expression studies conﬁrmed the complete 
depletion of aPKCiota, thus the aPKC signal in deﬁcient embryos must be aPKCzeta. We 
think that it is likely that the remaining aPKCζ is compensating for the loss of aPKCɩ. To 
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verify  this theory we are in the process of making a double knockout of both aPKCs. 
However, supporting evidence for compensatory effects of aPKCζ come from earlier 
knockout/knockdown  studies on regulators of aPKC activity.
Cdc42, as a member of the small Rho-GTPase-family has been shown to interact with the 
Par6/aPKC-complex (D. Lin et al., 2000; Qi et al., 2011) and plays a role in cell polarity. In 
contrast to the aPKCɩ KO, EBs derived from Cdc42- deﬁcient ES cells not only fail to 
produce a single lumen, but also show a total loss of both aPKCs and Par-3 at the apical 
domain (X. Wu et al., 2007). This phenotype is much stronger than aPKCɩ KO alone and 
we think this is because Cdc42 interacts with both aPKC isoforms in a non-discriminating 
way. Thus, depletion of Cdc42 caused reduced activity of both aPKCs and resulted in a 
more dramatic phenotype. The overexpression of dn-aPKCζ in Cdc42 wild-type EB leads 
to an identical phenotype compared to the Cdc42 knockout (X. Wu et al., 2007), which 
supports our theory. Similar to the phenotype of the Cdc42-deﬁciency, the loss of afadin 
causes a loss lumen formation and impaired distribution of Par-3, Par-6 and aPKC in EBs 
(Komura et al., 2007). It is important to note that the formation of a single cavity is a two-
step process: ﬁrst, multiple small lumen form in the periphery of the EB with initiation 
ofAP at each site (Coucouvanis & Martin, 1995). In a second step the smaller lumen fuse 
and the inner cells undergo apoptosis to clear the central lumen. Our data suggest that the 
loss of aPKCɩ does not interfere with the ﬁrst step, since we see multiple lumen in the 
periphery of the EB, but disrupt the second step involving apoptosis. Activation of 
caspase-3 is an important step in apoptosis. Thus the reduced levels of activated 
caspase-3 in aPKCɩ deﬁcient EBs support the importance of aPKCɩ in the second part of 
cavity  formation. At this point we are not aware of any mechanism that might explain that 
observation. However, an earlier study  using aPKCζ pseudosubstrate to inhibit both 
aPKCs in MDCK cyst formation showed increased caspase-3 activation with a negative 
correlation with aPKC activity (M. Kim et al., 2007). These results imply that the loss of 
aPKCɩ might elaborate aPKCζ activity in EBs, which causes inhibition of apoptosis. 
Taken together, the loss of aPKCɩ causes impaired lumen formation and reduced 
apoptosis in embryoid bodies without inﬂuencing the AP formation. Whether this 
phenotype is strictly  an effect of the loss of aPKCɩ or is a result of reduced apoptosis by 
the remaining aPKCζ is unclear.
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 Further insights from alternative model systems for cavity formation
Data regarding the role of Par-6 and Par-3 in cavity formation comes from another model 
system using MDCK cells in a three-dimensional (3D) epithelial culture. In this model 
epithelial cells organize themselves into cyst structures that resemble their in vivo 
architecture and are an established model for lumen formation. 
1. Knockdown of Par-3 in this system results in a reduced lumen size, formation of multiple 
lumen and complete loss of aPKC at the apical domain (Hao et al., 2010; Horikoshi et 
al., 2009). Thus, the correct localization of Par-3 in aPKCɩ deﬁcient EBs might explain 
the remaining aPKC signal of aPKCζ at the apical domain in aPKCɩ deﬁcient EBs. 
2. Studies regarding Par-6 have shown that overexpression of the Par-6 N-terminus in 
MDCK cells results in impaired cyst formation with a smaller central lumen and 
redistribution of aPKC to the cytosol (M. Kim, Datta, Brakeman, Yu, & Mostov, 2007). 
Considering the majority  of publication, Par-6 binding to aPKC is thought to inhibit aPKC 
activity  in general (Yamanaka et al., 2001). In complex with Par-6, aPKC becomes 
activated through interaction with other proteins. However, a more recent study has 
demonstrated that Par-6 binding to aPKC replaces the pseudosubstrate from the kinase 
domain and activates aPKC (Graybill et al., 2012). It seems difﬁcult to combine both 
studies to a general mechanism and it is possible that each mechanism applies to one 
speciﬁc aPKC isoform. In fact, Yamanaka et al. presumably investigated aPKCɩ only, 
while the Graybill et al. study is based entirely on aPKCζ. If this model is true, 
overexpression of the Par-6 N-terminus would inhibit aPKCɩ and activate aPKCζ at the 
same time. Thus, it is likely  that the remaining aPKC signal at the apical pole in MDCK 
cysts is activated aPKCζ. Finally, similar to the EB model, overexpression of kinase-
dead aPKCɩ in MDCK cells results in the formation of multiple-lumen cyst, just like in the 
Par-3 knockdown studies. 
We therefore conclude that both aPKC isoforms are necessary for complete formation of a 
single central lumen in both models and that the deletion of aPKCɩ might be partly 
compensated by aPKCζ. To verify the results from aPKC inhibition studies it would be 
crucial to investigate cavity/lumen formation using a system deﬁcient for both aPKC 
isoforms on which we are currently working.
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aPKCɩ deﬁcient embryos show impaired TJ proteins
Others have reported that the absence, inhibition or depletion of aPKCs has an inﬂuence 
on TJ formation and lumen formation in various in vitro model systems (Desclozeaux et al., 
2008; Hao et al., 2010; Izumi et al., 1998). The fact that we see a size reduced amniotic 
cavity  in aPKCɩ deﬁcient embryos suggest an underlying mechanism that is similar to the 
systems using cell-based approaches. Thus we further looked at the localization of marker 
proteins for polarity and cell-cell junctions in mutants embryos. First we investigated the 
localization of E-cadherin and occludin using immunoﬂuorescence (IF). The correct 
localization of E-cadherin showed that the apical domain was established even though the 
signal was slightly diffuse. The localization of occludin at the intersection of two cells in a 
spot-like manner is an important marker for TJ formation and was detectable in both 
genotypes. Similar to the E-cadherin the Occludin signal was more diffuse compared to 
the wildtype.. Next we looked at the localization of ZO-1, a marker for TJs in aPKCɩ 
deﬁcient embryos. We found a massive reduction of the ZO-1 protein at the apical domain 
of mutant embryos which might be due to reduced expression levels. It has been shown 
that inhibition of aPKCs or expression of a dominant-negative  (dn) version of aPKC 
results in loss of ZO-1 at the TJ and causes reduced tightness of the TJs (Gopalakrishnan 
et al., 2007). The main different between these studies and the study on aPKCɩ deﬁciency 
in embryos is that the knockout approach is speciﬁc for one isofrom, while the expression 
of a dn protein affects both isoforms. Most inhibitors, such as myristolated 
pseudosubstrate (PS) act on both isoforms, therefore all effects upon PS treatment are a 
result of a pan-aPKC inhibition. Atypical PKCs play a crucial role in TJ formation, but the 
existing body of evidence does not proof that the loss of aPKCs directly causes ZO-1 
relocation which directly causes TJ disassembly. Besides, if aPKCɩ and ZO-1 would share 
a common exclusive pathway the phenotypes of the KO mice would be expected to be 
similar, unless there is a functional redundant substitute. When we compared the two 
phenotypes we saw that ZO-1 deﬁcient mice die around E9.5, thus later than the aPKCɩ 
deﬁcient embryos (Katsuno et al., 2008). Likely candidates to compensate the loss of ZO-1 
are naturally ZO-2 and ZO-3. The deletion of ZO-2 causes a phenotype with ﬁrst signs of 
growth retardation at E6.5. At E8.5 the embryos display  impaired gastrulation resulting in 
complete apoptosis (Xu et al., 2008). In contrast, ZO-3 deﬁcient mice show no apparent 
phenotype (Xu et al., 2008). However, in ZO-1-/- Eph4 cells it has been shown that ZO-2 
gets recruited to the junctional areas during polarization and substitutes ZO-1 (Umeda, 
2004). In spite ZO-2 localization at the junctional site ZO-1 deﬁcient cells still show 
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retarded recruitment of occludin. This indicates a unique function of ZO-1 in regulating the 
tightness of the TJs.
In the case of occludin we have to rely data from other model systems. In MDCK cells and 
chick intestinal epithelial cells occludin phosphorylation highly correlates with TJ formation 
(Sakakibara, Furuse, Saitou, Ando-Akatsuka, & Tsukita, 1997; Wong, 1997). Even though 
there are no studies showing deﬁnitive data that aPKCs might be the kinase that regulates 
occludin phosphorylation and localization it had been shown in MDCK cells that 
overexpression of kinase-dead aPKCɩ causes delocalization of various TJ proteins 
including ZO-1, Par-3, occludin and E-cadherin. A study on the role of aPKC activity in TJ 
formation showed that treatment with myristolated pseudosubstrate results in decreased 
levels of phoshorylated occludin and ZO-1 in MDCK cells. In addition, aPKCs have been 
reported to directly interact with or phosphorylate a number of proteins that colocalize at 
the TJ including JAM-1 (Iden et al., 2012), Par3 (Gopalakrishnan, Hallett, Atkinson, & 
Marrs, 2007), Par-6 (Heather E Cunliffe, 2012) and ZO-1 (Fanning, Ma, & Anderson, 
2002). Thus, occludin appears to be a likely substrate of aPKCs. 
Both, the EB data and the immunoﬂourescence data from the mutant embryos indicates 
that the loss of aPKCɩ inﬂuences the formation of cell-cell junctions. Thus, we used 
electron microscopy to further support our data from the IF analysis and we found no 
apparent differences in mutants compared to wild-type animals regarding AJCs. According 
to our work, neither TJ formation nor AJ and desmosomes were impaired in embryos 
lacking aPKCɩ. 
The fact that we still have correct localization in the absence of aPKCɩ indicates a similar 
role of aPKCζ regarding occludin regulation.
Considering the present data the following model would be possible: Deletion of aPKCɩ 
interferes with the recruitment of ZO-1 and thereby with the establishment of TJs. 
However, ZO-2 is able to substitute ZO-1 at the apical domain and allows the formation of 
TJ. The incorporation of ZO-2 inﬂuences the recruitment of occludin and causes slight 
structural impairments. As a result of a feedback loop, the formation of TJs causes a 
decline in ZO-1 expression by a yet unknown mechanism (Anderson et al., 1989). In later 
stages of embryogenesis the functionally impaired TJ result in growth retardation and 
ﬁnally  reabsorption of the embryo. This model is not entirely conclusive since we still 
detect ZO-1 expression in wild-type embryos where proper TJ are established and 
therefore also should suppress ZO-1 expression. The ZO-1 signal might be unaffected, 
because this mechanism only effects the cells forming the apical domain and therefore 
55
55
reﬂects a small pool of the whole embryo. Regarding the role of aPKCζ in ZO-1 
phosphorylation and possible redundancy  we assume that expression levels of the protein 
are too low to compensate the loss of the aPKCɩ function. This is backed-up  by our own 
data from mutant embryos that shows no up-regulation of aPKCζ expression in aPKCɩ 
deﬁcient embryos. 
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Expression of aPKCζ partially rescues the aPKCɩ phenotype
The issue of redundancy among aPKCs has probably been discussed since scientists 
have looked at the ﬁrst sequence alignment of the two isoforms. With a staggering 
72%(Clustal2W) homology those two proteins are very similar to each other. Even more 
interesting is that most of the differences are found within two regions of the proteins: the 
very  N-terminal part (approximately 14aa) and the hinge region (approximately 60aa) are 
highly variable. Sequence alignment of these two regions shows a 7% homology 
(Clustal2W) between the isoforms. In contrast, alignment of the functional domains results 
in 80% homology. Only little work has been published showing a direct functional 
comparison of the two aPKCs and both isoforms have been treated as equals in most 
studies. However, when Kovac et al. compared expression levels in the early stages of 
embryogenesis and speciﬁc tissues in adult mice they were showing ubiquitous expression 
of aPKCɩ and in comparison a more restricted and lower aPKCζ expression (Kovac, Oster, 
& Leitges, 2007; Oster, Eichele, & Leitges, 2004). Analysis of aPKCɩ and aPKCζ in 
zebraﬁsh revealed multiple and redundant functions during vertebrate retinogenesis (Cui, 
Otten, Rohr, Abdelilah-Seyfried, & Link, 2007). The majority of the early data is either 
based on unspeciﬁc inhibition studies, overexpression of one isoform without considering 
the other or on the use of ‘speciﬁc antibodies’. Thus, most biochemical studies regarding 
aPKCs are studies on aPKC functions with limited information about isoform-speciﬁcity. In 
recent years an increasing amount of data has been published using deletion models of 
aPKC isoforms either from conventional knockouts or, in the case of aPKCɩ, conditional 
knockout material. Many of these publications address the role of aPKC isoforms in 
various cancer types including among others lung (Regala et al., 2009), breast (Heather E 
Cunliffe, 2012) and colon cancer (N. R. Murray, Weems, Braun, Leitges, & Fields, 2009) 
However, we know from earlier studies that aPKCζ expression is lower in most tissues 
compared to aPKCɩ (Kovac et al., 2007; Oster et al., 2004). Thus, one can argue that 
thephenotype of the aPKCɩ deﬁcient mice is stronger than of the aPKCζ-deﬁcient mice 
because aPKCζ is not present in sufﬁcient protein levels. Consequently, the aPKCζ 
phenotype is milder because of the high expression of aPKCɩ that compensates the loss. 
To further address this possibility we decided to design a knock-in approach based on the 
aPKCɩ KO mice. If both isoforms are functionally redundant then overexpression of aPKCζ 
without aPKCɩ present should rescue the phenotype. Therefore, the knock-in approach 
was designed to assure comparable expression levels of the introduced aPKCζ compared 
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to the native aPKCɩ. This was achieved by using the same regulatory elements that 
regulate the endogenous aPKCɩ expression. Similar to the aPKCɩ deﬁciency, no 
homozygous rescue animals were born, indicating a lethal phenotype. When we analyzed 
embryos we noticed that:
1. Embryos at E7.5 we were not able to distinguish between wild-type embryos and 
homozygous carrier of the rescue allele ( all embryos appeared to be normal). Our 
study indicates that whatever causes the lethality  at stage E7.5 in aPKCɩ deﬁcient 
embryos can be rescued by aPKCζ expression. 
2. Embryos at E8.5 appeared to be normal. We detected embryos with reduced size at 
E9.5 which were proven to be homozygous for the rescue allele exclusively. This 
clearly  shows that the phenotype of the aPKCɩ deﬁcient embryo at E7.5 can be 
rescued by  additional aPKCζ, indicating a redundancy between both proteins at this 
stage of development. 
After E7.5 and before E11.5 the deﬁciency of aPKCɩ is causing a problem that cannot be 
compensated by aPKCζ and subsequently  leads to absorption of the embryos. Our studies 
did not include further experiments on the rescue animals but further studies on the 
phenotype will be performed in the future.
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Summary and future perspectives
In this thesis we present evidence for distinct functions and speciﬁc regulatory 
mechanisms of the atypical PKC isoforms. Despite the order of publication, the idea of 
paperI was based on preliminary  data from paperII. Since the phenotypes of the aPKC 
knock-out are so dramatically different we hypothesized that speciﬁc function of the aPKCs 
might be achieved by speciﬁc localization and/or regulation of the proteins. Our effort 
resulted in the ﬁrst publication “Functional comparison of protein domains within aPKCs 
involved in nucleocytoplasmic shuttling”. This paper clearly  shows that the current 
perception of atypical PKCs as two proteins with redundant functions needs to be 
reconsidered and that both isoforms not only have overlapping roles but also might have 
unique functions not only in cancer but also in other cellular processes. For the ﬁrst time 
we were able show the hinge region as a functional domain within aPKCs with distinct 
properties in each isoform. Subsequentlywe performed the analysis of the aPKCiota 
deﬁcient embryos which partly was based on data from paper I in order to characterize the 
underlying mechanism of the observed phenotype.
As a result, paperII “Phenotypical analysis of atypical PKCs in vivo functions display a 
compensatory system at embryonic stage 7.5 p.c.” provides more than a description of a 
phenotype. In PaperII we show that the phenotype is not due to impaired apico-basal 
polarization or failure in development of the germlines. It seems that the lethal phenotype 
of aPKCiota deﬁciency at 7.5 p.c. is mostly due to the insufﬁcient amounts of aPKCzeta 
present at this stage. This theory is backed up by overexpression of aPKCzeta, which is 
able to rescue the early  lethality  but leads to a lethal phenotype at 10.5 p.c. At the same 
time we could see an increased expression of aPKCzeta in aPKCiota deﬁcient EBs. To 
further investigate whether aPKCzeta is indeed upregulated in aPKCiota deﬁcient embryos 
we are in the process to produce embryos deﬁcient for both aPKS. These animals will 
allow us to verify the remaining signal and to show whether it really is aPKCzeta or a 
unspeciﬁc background.  Even if aPKCzeta is overexpressed in aPKCiota deﬁcient embryos 
we still do not understand why the rescue animals that expression additional aPKCzeta die 
around E.9.5. Future work on the role of aPKCzeta in embryogenesis will include the role 
of caspase cleavage of the protein in the observed rescue phenotype and which speciﬁc 
function of aPKCiota is not compensated by aPKC zeta expression. The latest will include 
morphological analysis of the rescue animals 
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Summary
The atypical protein kinases C (PKC) isoforms i and f play
crucial roles in regulation of signaling pathways related to
proliferation, differentiation and cell survival. Over the years
several interaction partners and phosphorylation targets have
been identified. However, little is known about the regulation
of atypical aPKC isoforms. To address this question, we
performed a comparative analysis of atypical aPKCi/l and f
in MDCK cells. By using green fluorescence protein (GFP)
fusion proteins containing the full-length or truncated
proteins, we were able to recognize differences in
subcellular localization and nucleocytoplasmic shuttling of
both isoforms. We show, that an earlier described nuclear
localization sequence (NLS), plays a role in the regulation of
atypical aPKCf but not in aPKCi, despite the fact that it is
present in both isoforms. Leptomycin B treatment induces
accumulation of GFP-fusion protein of both isoforms in the
nucleus. Regardless, the loss of the NLS only decreases
shuttling of aPKCf, while aPKCi remains unaffected. In
addition, we identified the hinge region as a potential
regulator of localization of atypical PKCs. With a set of
chimeric proteins we show that the hinge region of aPKCi
mediates nuclear localization. In contrast, the hinge region of
aPKCf causes exclusion from the nucleus, indicating two
different mechanisms leading to isoform specific regulation.
Taken together, we show for the first time, that the atypical
isoforms aPKCi and f underly different mechanisms
regarding their regulation of subcellular localization and
translocation into the nucleus in MDCK cells.
 2012. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial Share Alike
License (http://creativecommons.org/licenses/by-nc-sa/3.0).
Key words: GFP-fusion protein, HINGE domain, NLS, Atypical
Protein kinase C, Nuclear translocation, Nucleocytoplasmic shuttling
Introduction
Signal transduction is an essential process that enables the cell to
interpret incoming signals and interact with the surrounding
environment. Many different signaling pathways and a wide
variety of mechanisms are utilized to accomplish this translation.
Kinase activation is a very common mechanism that alone can
amplify the incoming signal through the phosphorylation of
specific substrates. Kinase substrates are often themselves
kinases.
Protein Kinase C (PKC) represents a serine/threonine kinase
gene family that has often been described as having a major role
in signal transduction events. Nine PKC members have been
described in mammals which are divided into three subgroups
based on their biochemical properties and sequence homology:
Classical PKCs (a, b and c), novel PKCs (d, e, h and g) and
atypical PKCs (f and i/l). Classical and novel PKCs have been
found to bind and be activated by tumor-promoting phorbol
esters (TPA) which has connected at least some of their
physiological in vivo functions to the promotion of cancer.
Atypical PKCs were the last to be identified and characterized.
Remarkably, early findings showed that both aPKC isoforms are
unresponsive to TPA and are also activated independently of
calcium and diacylglycerin under normal cell conditions. Thus
aPKCs represent a PKC subgroup that is clearly separated from
the rest by its mode of activation. Both atypical PKC isoforms
have been found to be regulated through their cysteine-rich C1
domain by Par-4 activation (Dı´az-Meco et al., 1996) and through
their Phox/Bem1 (PB1) domain by interaction with p62 and
PAR-6 (Puls et al., 1997; Joberty et al., 2000; Sa´nchez et al.,
1998). Another striking point within the aPKC subgroup is the
high content of homologous amino acids between them (72%
overall) (Akimoto et al., 1994) which limits the availability of
isoform-specific tools. Thus it remains difficult to biochemically
analyze and distinguish between the two aPKC isoforms. In
addition, many overexpression studies have so far failed to assign
functional differences to PKCf and PKCi/l (Diaz-Meco and
Moscat, 2001; Uberall et al., 1999).
Nevertheless recent attempts utilizing the gene targeting
approach in mice have revealed that highly specific in vivo
functions exist for both aPKCs. For example, the phenotypical
analysis of the PKCf deficient mouse line lead to the
identification of impairment of the NFkB signalling pathway
(Leitges et al., 2001) as well as changes in IL-4 and IL-6
signaling (Martin et al., 2002; Galvez et al., 2009). A
conventional knock-out of PKCi/l revealed a fundamental role
for this kinase during embryonic development (Bandyopadhyay
et al., 2004; Soloff et al., 2004; unpublished data). Tissue specific
knockouts of this isoform have also shown the importance of
PKC i/l in the adult organism (Farese et al., 2007; Huber et al.,
2009; Murray et al., 2009; Yang et al., 2009).
Whereas the embryonic lethal phenotype of PKCi/l could be
partly explained by the lack of PKCf expression at the defined
Research Article 1
B
io
lo
g
y
O
p
e
n
time of development (Kovac et al., 2007) all other described
phenotypes of both aPKC knockouts take place with the
existence of the alternate aPKC isoform. Thus these in vivo
findings clearly imply that both aPKCs have an isoform-specific,
non-redundant function in the cell, even when co-expressed. How
these specificities are regulated remains largely unclear. Since
specific localization of PKCs within a cell is believed to be one
way of controlling specificity (Rosse et al., 2010) we decided to
screen for domains within both aPKCs which are able to direct
localization and are different between the two isoforms.
Results
1. Generation of truncated aPKC/GFP fusion proteins.
We have used truncated aPKC proteins fused with a GFP tag to
follow and identify domains that confer aPKC isoform specific
translocation ability. Except for the full length constructs of both
isoforms, we have generated mutant constructs that focus on
changes in the N-terminal regulatory region of the proteins and
have a truncated C-terminal, thus they are missing the kinase
domain. Although we cannot say that translocation sequences do
not exist in the C-terminal kinase region, we expected to see
more changes in translocation potential upon alteration of the N-
terminal regulatory region. Thus we initially generated the
following for both isoforms: the GFP labeled full length
construct; an (aPKCDcatalytic) construct missing the whole
kinase domain including a nuclear export sequence (NES); an
N-terminal version (aPKC AA1-176(177*)) including the PB1
(Phox and Bem1) and a C1 (cystein-rich) domain but excluding
the hinge region. We further generated a construct consisting of
the hinge region alone (aPKCHINGE) (Fig. 1A). All fusion
proteins have been tested for expression and stability of the
protein in MDCK cells via western blot (supplementary material
Fig. S1).
2. Isoform-specific domains cause different
subcellular localization.
To test whether the truncation mutants are able to identify
domains within aPKCs which convey isoform-specific
localization we overexpressed each construct in MDCK cells.
Both full length constructs showed a widely distributed diffuse
GFP signal over the whole cell without prominent membrane
localization. There was a slightly increased PKCi nuclear
localization when compared to aPKCf full length (Fig. 2A,B).
Deletion of the C-terminal kinase domain changed the
distribution. The aPKCiDcatalytic fusion protein localized
exclusively in the nucleus with a regional concentration of the
GFP signal within the nucleolus (Fig. 2C). In sharp contrast the
corresponding truncated PKCfDcatalytic construct showed an
almost exclusive and very strong membrane signal (Fig. 2D)
which resembled that associated with the role of aPKC in
polarity.
We proceeded by testing N-terminal truncations missing the
hinge region (aPKCAA1-176(177)) and found there was a reversion
back to a similar localization pattern between the two isoforms
(Fig. 2E,F). However, in contrast to the full length proteins, both
truncated versions located to the nucleus with a distinct punctate
pattern. This pattern was different to that seen with the
aPKCiDcatalytic form.
Based on these results further investigation focused on the
hinge region alone was merited. Analysis of the aPKCiHINGE
construct showed a dominant localization to the nucleus as well
as a diffuse weak staining in the cytoplasm (Fig. 2G). The
corresponding PKCfHINGE construct showed cytoplasmic
staining with some aggregates surrounding the nucleus, no
membrane staining, and most significantly, an exclusion from the
nucleus (Fig. 2H).
Taken together these results identified first that the hinge
region of both aPKCs harbors information important for
subcellular localization and second that the N-terminal causes
localization to the nucleus and does not need the hinge region for
this localization to occur.
3. Functional investigation of aPKC nuclear localization
sequence (NLS).
Given the fact that nuclear localization of aPKC represents a new
area of research in aPKC in vivo function, we decided to
investigate the underlying mechanism. A functional nuclear
localization sequence (NLS) located within the C1 domain had
been defined in both aPKCs (Perander et al., 2001). To evaluate
whether this motif drives the PKCiAA1-177 fragment into the
nucleus within our experimental context we mutated the amino
acid sequence AKRNFRR to AKRNFEE in order to generate a
nonfunctional NLS. Upon transfection with this construct in
MDCK cells we were not able to detect any difference to that
found with the parental construct (data not shown). These
findings suggested that the N-terminal PKCiAA1-177 fragment
translocates into the nucleus in an NLS independent manner
through a different mechanism and we assumed that this was also
true for the N-terminal PKCfAA1-176 fragment.
We next asked whether the NLS could have an impact on the
kinetics of nuclear translocation of both aPKCs. Differences in
the nuclear translocation kinetics among aPKCs had been earlier
discussed by others (Perander et al., 2001). Based on the finding
that N-terminal constructs localize to the nucleus we next worked
with full length constructs for both aPKCs in order to analyze the
Fig. 1. Schematic presentation of GFP-fusion proteins. Domain
organization of atypical PKC and the constructs generated to test the
localization of truncated atypical PKC proteins. All proteins were expressed as
a GFP fusion protein with a C-terminal tag.
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translocation kinetics upon Leptomycin B (LMB) treatment.
Treatment with LMB effectively blocks all nuclear export related
to CRM1/Exportin and represents an established method to study
nucleo-cytoplasmic shuttling (Lischka et al., 2001; Kudo et al.,
1998).
When comparing mouse aPKC cDNA sequences we
observed that aPKCf contains a G to R exchange at position
141(AKRFNRG; supplementary material Fig. S3). This sequence
variation in the NLS had been described to affect the binding of
importin a/b and subsequently affect the nuclear translocation
Fig. 2. Differences in sub-cellular localization of truncated aPKC protein. MDCK cells were transfected with different aPKCi (A,C,E,G) or aPKCf fusion
proteins (B,D,F,H). The insert shows magnification of the marked area (square) in the overview. Visualization of the nucleus was achieved by DAPI staining.
Membrane staining was performed using Alexa FluorH 647 conjugated wheat-germ agglutinin (WGA). All pictures were taken with the ZEISS LSM 520 microscope.
The areas representing the cytosolic fraction or nuclear fraction are indicated with bars at the top of each histogram. The histogram analysis was performed with the
‘profile tool’ in the LSM MetaH software. The analyzed area is indicated by the yellow straight line in the overview. Scale bar: 50 mm (overview), 10 mm (insert). All
experiments were performed in triplicates.
Nucleocytoplasmic shuttling PKCs 3
B
io
lo
g
y
O
p
e
n
kinetics since the AKRNFRR motif containing three arginine’s
(as found in PKCi) enables a direct binding of importin b instead
of a sequential binding of importin a followed by importin b
(Palmeri and Malim, 1999). Thus we first analyzed the
translocation behavior of both full length aPKC-GFP fusion
constructs by measuring the GFP signal ratio between the cytosol
and the nucleus. Both aPKCs accumulated in the nucleus upon
LMB treatment but it was clear that PKCi accumulated faster and
attained a higher level after 6 hours of treatment (Fig. 3).
We next introduced a construct with an R to G mutation at
position 142 in PKCi which mimics a PKCf NLS. We found that
the kinetics of nuclear accumulation upon LMB treatment did not
change at all with this construct, which was opposite to our
expectations. We then generated a R141/142E mutation in the
PKCi/GFP full length construct thereby destroying the NLS
motif. The subsequent analysis of this mutant (aPKCi R141/
142E) again revealed no significant change in the nuclear
translocation behavior of PKCi thus the NLS present in aPKCi
appears to be nonfunctional in the context we tested here.
We then concentrated on PKCf, first generating a mutant of
the full length construct which mimics the PKCi situation
(aPKCf G141R). As indicated in Fig. 3, this conversion lead to a
faster increase and higher amount of the nuclear signal after
2 hours with no significant change after 6 hours, thus resembling
the aPKCi wildtype situation. Next we analyzed the aPKCf
R140E/G141E mutant representing a NLS deficient aPKCf
variant. In this case we were able to detect a significant
decrease of the nuclear fraction after 2 and 6 hours LMB
treatment implying that the NLS in PKCf is functionally
involved in the nuclear transport of this aPKC. Nevertheless it
was also clear that even in the NLS deficient situation a smaller
fraction is translocated to the nucleus suggesting that beside the
NLS driven transport other nuclear transport mechanism(s) exist
which aid in the localization of PKCf to the nucleus (Fig. 3).
Taken together the mutational analysis of the NLS of both
aPKCs revealed that PKCi can translocate to the nucleus
independent of its NLS whereas PKCf’s nuclear translocation
is mainly regulated by its NLS. In addition we observed that the
sequence variant we identified in mouse for PKCf slows the
translocation kinetics and also that PKCf retains a nuclear
translocation capacity that is independent of the NLS.
4. Mutations within the PB1 domain alter the subcellular
localization of both aPKCs.
Having established that the generation of a NLS deficient N-
terminal PKCiAA1-177 fragment does not abolish its nuclear
localization we decided to investigate the possibility of other
nuclear translocation domains existing within this fragment.
Besides the C1 domain which includes the discussed NLS,
another protein-protein interacting domain has been described in
the N-terminus of both aPKCs; the Phox/Bem1 (PB1) domain.
Several PB1 aPKC interacting proteins have been identified e.g.
Par6 and p62 (Joberty et al., 2000; Hirano et al., 2004). Of
particular interest in this context is a recent report describing the
translocation of Par6 to the nucleus via an internal NLS (Cline
and Nelson, 2007). Thus we hypothesized that aPKCs may be
translocated to the nucleus through a ‘‘hitchhiking’’ mechanism
by their binding to PB1 containing proteins, like Par6. To verify
this hypothesis we first introduced a D63A mutation in the
PKCiAA1-177 fragment. This D-A mutation has been shown by
Hirano to disrupt interaction between the aPKC PB1 domain and
the PB1 domain of Par6 and p62 (Hirano et al., 2004; Hirano et
al., 2005). However, the abolishment of a functional PB1 domain
did not prevent a nuclear translocation of this construct
(Fig. 4A,B). In addition, the corresponding D62A mutation in
the PKCfAA1-176 fragment reflected the same outcome
(Fig. 4C,D). Thus we assumed that in both atypical PKC N-
terminal fragments either a cryptic NLS or another sequence
motif existed that was responsible for the observed nuclear
localization.
We then focused attention on the analysis of the full length
protein fusions to investigate the consequence of a PB1 mutation
in aPKC nuclear localization in this context. Thus we introduced
the D63A or D62A mutations respectively in each full length
aPKC construct which we subsequently analyzed in an LMB
experiment.
In order to verify the functionality of the introduced mutation
we first checked whether the PB1 mutation caused a loss of
membrane association due to the protein’s inability to form the
polarity complex with Par6/aPKC/Par3 (Lin et al., 2000; Wodarz
Fig. 3. Nucleocytoplasmic shuttling is dependent on the NLS in the case of
aPKC f but not aPKC i. MDCK cells either expressing full-length aPKC
wild-type protein of aPKCi (left panel) or aPKCf (right panel) or the indicated
mutation within the NLS of both isoforms. The cells were left untreated in
normal medium for 18 hours after transfection with Lipofectamin. Afterwards,
the cells were treated with 4 ng/ml Leptomycin B in normal growth medium for
either 2 or 6 hours and fixed afterwards with 4% paraformaldehyde. Analysis
was done by using the Zeiss LSM 510 confocal microscope. Calculation of
ratios between nuclear signal and cytoplasmic signal were performed as
described in the methods section. n540, *P,0.05. All experiments were
performed in triplicates.
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et al., 2000; Joberty et al., 2000). In fact, we observed a clear
decrease of GFP membrane signal in both constructs, indicating
the introduced mutation was functionally significant
(supplementary material Fig. S2). Upon further analysis of the
subcellular localization of these constructs we observed that both
aPKC isoforms harboring the D to A mutation showed a
significant increase in the pool of nuclear located fusion
protein in the non-LMB treated samples (Fig. 4E,F, control
values).
With regard to PKCf, LMB treatment caused a similar kinetic
rate of nuclear accumulation for both wild type and mutated
constructs whereby the D62A mutant translocation started at a
significantly higher level, but both reached maximum
accumulation levels after 4 hours of LMB treatment (Fig. 4F).
In contrast, PKCi gave a different picture of nuclear
accumulation. Whereas the wild type construct increased its
amount in the nucleus constantly over the 6 hour time line, the
D63A mutation of PKCi increased its nuclear level only slightly
(but significantly) within the first 2 hours. We were unable to
detect any further significant increase of the mutant construct in
the nucleus beyond this time-point (Fig. 4E).
Taken together we have shown that the PB1 domain within
both aPKCs is not involved in the nuclear translocation of the N-
terminal constructs used here indicating the existence of an
alternate nuclear translocation mechanism for these two fusion
proteins. However, this analysis also revealed that in the context
of the full length protein, the PB1 domain does influence the
localization of aPKCs in an isoform specific manner: whereas
PKCf appears to translocate into the nucleus independent of its
PB1 domain, PKCi translocation seemed unable to proceed
beyond a certain level of nuclear content (reached at 2 hours after
addition of LMB) implying that at least a fraction of the
transported GFP fusion protein depends on a functional PB1
domain.
5. Atypical PKCs hinge region mediates different localization of
aPKCi and aPKCf.
Our initial screen revealed that the hinge region of both aPKCs
appeared to be involved in the unique sub-cellular localization of
each isoform (Fig. 2). To further elucidate these findings we
generated mutants with exchanged hinge regions that either
harbored the aPKCi specific hinge sequence within the aPKCf
specific background or vice versa (Fig. 1B). Upon transfection of
the N-terminal chimeric aPKCiN-fHINGE/GFP fusion protein into
MDCK cells it became apparent that the aPKCf specific hinge
sequence is able to keep the aPKCi protein outside of the nucleus
(Fig. 5A,C). Interestingly this chimeric fusion protein did not
reflect the same pattern as the aPKCfDcatalytic with regard to
membrane staining (compare Fig. 5B and Fig. 5C), thus an
interplay between the remaining f-N-terminus and its hinge
region must exist which has the capacity to drive the aPKCf
construct to the membrane.
The corresponding experiment with a aPKCfN-iHINGE/GFP
fusion protein showed an exact phenocopy of the parental i-hinge
construct i.e. an exclusive nuclear localization with an
enrichment of the GFP signal within the nucleoli (Fig. 5A,B,D).
These findings clearly identified that the hinge region of
atypical PKCs can be distinguished as harboring specific sub-
cellular localization information.
We then proceeded to ask the same question in the context of
the full length protein. We used either wildtype or chimeric
fusion proteins which contained the corresponding hinge region
of the alternate aPKC isoform (Fig. 1B). We first analyzed the
subcellular localization of these constructs by measuring the
nuclear to cytosol ratio of the GFP signal. As indicated in Fig. 5E
Fig. 4. The PB1 domain of atypical PKCs influences localization of both
atypical isoforms. MDCK cells were either transfected with a construct
expressing the regulatory domain of aPKCi (A) or aPKCf (C) wildtype, or
corresponding mutant proteins (B,D). Cells were tranfected with
Lipofectamin and left untreated for 18 hours before preparation for imaging
analysis. Visualization of the nucleus was achieved by DAPI staining. Analysis
was done by using the Zeiss LSM 510 confocal microscope. Scale bar: 10 mm.
(E,F)MDCK cells either expressing full-length aPKC wild-type protein or full-
length protein containing a PB1 mutation of aPKCi (E) or aPKCf (F). Eighteen
hours after transfection cells were treated with 4 ng/ml leptomycin B in normal
growth medium for 2, 4 and 6 hours before preparation for imaging analysis.
Calculation of ratios between nuclear signal and cytoplasmic signal were
performed as described in the methods section. n540, *P,0.05. All
experiments were performed in triplicates.
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(control lane) an aPKCf protein harboring a i-hinge region
showed a significant increase in the nuclear fraction of the GFP
signal whereas the chimeric aPKCi protein did not appear to be
affected by the f-hinge region with regard to its nuclear
localization (Fig. 5F, control lane). After 6 hours of LMB
treatment the chimeric aPKCfiHINGE construct showed a higher
accumulation of the GFP signal in the nucleus (at a similar level
to that of the aPKCi wildtype construct) (Fig. 5E). In contrast,
the chimeric aPKCifHINGE protein showed a significant decrease
of its nuclear signal after 6 hours of LMB treatment thus
mimicking the levels reached by the aPKCf wild type construct
(Fig. 5F).
In summary, both approaches identify the hinge region of both
aPKCs as a domain that contains isoform specific sub-cellular
localization information.
Discussion
Atypical PKCs represent a subgroup of the PKC family
distinguished by their mode of activation and their remarkably
high homology content to each other (Steinberg, 2008). Most
published work on aPKCs has not distinguished between the two
isoforms due to the lack of specificity of available tools such as
reliably specific antibodies and peptide inhibitors. In addition,
due to the high homology of the amino acid sequence, there is a
great potential for redundancy between these two isoforms.
Nevertheless studies using either RNA knockdown (Durgan et
al., 2011) or gene targeting approaches in mice (Leitges et al.,
2001; Farese et al., 2007) clearly indicate the existence of
isoform-specific functions. Phenotypical analysis has revealed
quite opposite in vivo functions even in cells where both isoforms
coexist, for example in the intestinal epithelial cell, (Oster and
Leitges, 2006; Murray et al., 2009). Thus the question of how
these different functions are regulated given the high degree of
homology becomes poignant.
The intention of this study was to identify how specific
domains within both isoforms transfer specificity to the
individual protein. As described for other PKCs (Parker and
Murray-Rust, 2004) we assumed that one method to achieve
specificity is through protein localization within the cell. Thus in
an unbiased approach we tested aPKC/GFP fusion constructs for
their location after their transient transfection in MDCK cells.
In accordance with others (Horikoshi et al., 2009), we found
both full length constructs mainly located in the cytoplasm but
we also observed that while the aPKCf construct was excluded
from the nucleus the aPKCi construct showed weak nuclear
staining implying a tendency for its nuclear localization
compared to aPKCf .
A clear difference between the two isoforms became obvious
when analyzing the N-terminal constructs missing the catalytic
kinase domain (aPKCfDcatalytic and aPKCiDcatalytic). It is worth
stating here that this truncation eliminates a nuclear export
sequence (NES) from both constructs (aPKCf AA 247–255,
aPKCi AA 239–247) and leaves the truncated protein in a
somewhat open conformation. Whereas the aPKCf specific
construct showed prominent membrane staining, aPKCi was
found exclusively in the nucleus. These observations per se
Fig. 5. Atypical PKC hinge region
mediates different localization of
aPKCi and aPKCf. MDCK cells were
transfected with constructs expressing
either the regulatory domain of aPKCi
or aPKCf (A,B) or chimeric proteins
consisting of the regulatory domain of
aPKCi with a aPKCf hinge region, or
vice versa (C,D). The insert shows
magnification of the marked area
(square) in the overview. Visualization
of the nucleus was achieved by DAPI
staining. Membrane staining was
performed using Alexa FluorH 647
conjugated wheat-germ agglutinin
(WGA). All pictures were taken with the
ZEISS LSM 510 microscope. The areas
representing the cytosolic fraction or
nuclear fraction are indicated with bars
at the top of each histogram. The
histogram analysis was performed with
the ‘profile tool’ in the LSM MetaH
software. The analyzed area is indicated
by the yellow straight line in the
overview. Scale bar: 50 mm (overview),
10 mm (insert). All experiments were
performed in triplicates.
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indicate a clear difference between both aPKC isoforms. The
robust membrane localization of aPKCf could be explained by its
previously reported association with the signaling cascade of the
ternary polarity par3/aPKC/par6 complex which is localized at
the cell membrane (Suzuki et al., 2001), while the accumulation
of the aPKCi construct might be a consequence of the missing
NES. The explanation for this obvious difference in localization
remains elusive.
Further investigation identified the hinge region of both
isoforms to be essential in this localization process. We found
that in both isoforms the deletion of the hinge domain caused a
nuclear localization that was different in appearance to that
observed in aPKCiDcatalytic construct expression where the hinge
region is intact. We also found that expression of hinge/GFP
fusion proteins showed an isoform-specific difference.
Whereas the aPKCiHINGE predominantly localized in the
nucleus (showing a homogenous distribution within) the
aPKCfHINGE was excluded. Thus, given the fact that the hinge
region within aPKCs contains the most diverse nucleotide
sequence it is interesting to observe that both isoforms contain
information related to isoform-specific, distinct, subcellular
localization in this region. This was finally confirmed by the
expression of chimeric proteins that were generated containing
the hinge fragment of one isoform sub-cloned to the
corresponding N-terminus (or full length) of the alternate aPKC
isoform (Fig. 5). In both cases i-hinge drives the protein into the
nucleus whereas f-hinge either keeps it outside (N-terminal
construct) or significantly reduces (in the context of the full
length protein) the nuclear pool upon LMB treatment.
Until now, the only verified functional motif within the
atypical hinge sequence had been a caspase cleavage site which
exists only in aPKCf and is involved in the regulation of the
protein’s enzymatic activity rather then its localization (Frutos et
al., 1999). Any other functional derivation based on the crude
amino acid sequence is highly speculative without experimental
verification. Current approaches in our laboratory employed
mutagenesis to establish hinge region mutants with abolished
localization behavior, thereby enabling the identification of the
underlying sequence motifs (and mechanisms) that cause these
observed differences between hinge regions in different aPKC
isoforms.
The N-terminal construct (depleted of the hinge region) of both
aPKCs was found exclusively in the nucleus which could be
explained by the NLS motif located in the C1 domain,
functionally described by others (Perander et al., 2001; Pu et
al., 2006). Nevertheless we investigated the NLS in more detail
and showed that mutations destroying the functionality of the
NLS did not completely abolish the nuclear translocation of
either the N-terminal or the full length GFP fusion proteins in
either aPKC. This was a surprising result since the NLS had been
shown to cause localization to the nucleus in the context of both a
smaller fragment and a full length construct containing a kinase
defective mutation in a different cellular context (Perander et al.,
2001). We found that neither an N-terminal nor a full length
aPKCi/GFP construct containing an R141/142 mutation appeared
to be affected in its nuclear translocation behavior. However, a
full-length aPKCf/GFP construct harboring an R140/141
mutation showed a significant reduction in the amount of
nuclear accumulation after 2 and 6 hours LMB treatment.
Although reduced, the accumulation was significant, thus
indicating the possible existence of alternate methods of
translocation.
During our analysis we identified a sequence variant in the
NLS sequence which appears to be mouse specific and converts
the PKCf specific NLS to AKRFNRG (Uniprot.org entry
Q02956). This variation could explain the slower nuclear
translocation of PKCf observed upon LMB treatment compared
with PKCi based on the described mechanism of the importin a/b
system. Also the G141R mutation of PKCf which converts the f-
NLS into a i-NLS, supports this notion since the construct
mimicked the PKCi nuclear translocation kinetics exactly (higher
maximum, reached after 2 hours LMB treatment). However, this
is not a valid argument for the observed differences regarding the
nuclear translocation kinetics between both aPKC isoforms made
previously by others (Perander et al., 2001) since the aPKC
cDNAs from other species that do not contain this sequence
variation were used. Thus, our observation may be either a cell
type or species specific phenomena or a combination of both. In
any case our data show a clear difference between both aPKCs
and their NLS dependent nuclear translocation in MDCK cells
upon LMB treatment when using mouse specific constructs.
PKCi translocates to the nucleus independently of its NLS
whereas PKCf mainly depends on a functional NLS.
One reason for the NLS independent translocation of PKCi
might be hidden in its hinge region which we have shown to be
able to direct nuclear translocation. Other mechanisms must also
exist since N-terminal constructs of both aPKC isoforms (missing
each hinge region and containing NLS mutations) retain the
capacity to translocate to the nucleus.
We have further analyzed the PB1 domain which remained
intact in our N-terminal constructs and which has been implicated
as a mediator of protein-protein interactions between PB1
containing proteins (Hirano et al., 2004; Hirano et al., 2005).
To our knowledge, the PB1 interacting proteins include at least
13 mammalian proteins (Lamark et al., 2003).
The background notion for this attempt was that it was possible
that interacting partners of aPKCs were able to translocate to the
nucleus and could serve as a shuttle vehicle for aPKCs. However,
when introducing a D-A mutation which had been described to
abolish PB1 specific interactions (Hirano et al., 2004) we were
not able to detect any effect on the N-terminal constructs with
regard on the nuclear/cytoplasm ratio. Upon the introduction of
the same mutation into full length proteins we were readily able
to detect an increased nuclear fraction in non-treated cells. We
interpreted this result as an indication that there is reduced export
rather than increased import.
One likely candidate for the export shuttle might be p62. This
protein was originally identified as a binding partner for aPKC
(Puls et al., 1997; Sa´nchez et al., 1998) and has received some
attention recently based on its involvement in starvation induced
autophagy (Pankiv et al., 2010; Wooten et al., 2008; Lamark et
al., 2009). More important for us was the identification of p62 in
the nuclear compartment (Bjørkøy et al., 2005) and the finding
that the shuttling of p62 between cytoplasm and nucleus appears
to be a very dynamic process (Pankiv et al., 2010) similar to that
we have observed for aPKC. In addition, most recently it has
been shown that p62 is involved in the nuclear export of ALFY
(autophagy-linked FYVE) proteins through protein-protein
interaction (Clausen et al., 2010). Thus, it could well be that
p62 is also involved in the nuclear export of aPKC. Nevertheless,
we do not exclude other PB1 containing proteins, like Par6, also
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recently described as a nuclear protein (Cline and Nelson, 2007),
being involved in the nuclear translocation of aPKC.
With regard to nuclear import, the PB1 mutation did not
influence PKCf (similar kinetics and amounts of nuclear
accumulation were seen) but it did reduce the total amount of
PKCi in the nucleus upon LMB treatment. Thus a certain fraction
of PKCi translocation to the nucleus depends on an as yet
undefined PB1 domain protein-protein interaction.
Our study revealed clear differences between the two aPKC
isoforms which have not been analyzed in such a comparative
structure to function study before. The hinge region, representing
the most heterologous amino acid stretch between the two
aPKCs, contains isoform-specific, sub-cellular localization
information. In particular, with regard to the nuclear
localization of aPKCs the functionality of the NLS, the PB1
domain and in the case of PKCi the hinge region, are shown to
influence the nuclear import to a different degree when both
isoforms are compared directly.
We are not the first to show that aPKC is present in the nucleus
but our data suggests that there are multiple modes of nuclear
transport that differ between aPKC isoforms. This could mean
that the physiological conditions in which each aPKC
translocates to the nucleus are distinguishable. What exactly
drives PKCf and PKCi into the nucleus is not clear. Our attempts
to locate aPKC/GFP proteins to a more precise sub-nuclear
domain or to the nucleus during specific cell cycle periods have
thus far been unsuccessful (data not shown).
Another option is the activation of aPKC in the context of
NFkB signaling leading to a translocation of NFkB to the
nucleus. Besides this translocation, specific phosphorylations are
required to regulate NFkB specific gene expression. Ser 311 on
the RelA subunit has been identified as a PKCf target (Duran et
al., 2003) but where this phosphorylation takes place remains
unknown. Thus it could well be that PKCf must be translocated
into the nucleus to phosphorylate RelA on Ser 311.
Both aPKC isoforms have been described as forming
complexes with Par6 and Par3 (Noda et al., 2003; Henrique
and Schweisguth, 2003; Joberty et al., 2000) to build a ternary
complex (also called polarity complex (Suzuki and Ohno, 2006).
Recent work has also identified nuclear accumulation of Par6 in
MDCK cells after LMB treatment indicating nucleocytoplasmic
shuttling similar to that we observed for aPKC (Cline and Nelson,
2007). Cline could not identify a specific nuclear function for
Par6, but a participation in gene transcription, RNA splicing and
mRNA transport was excluded.
Par3 has also been found to be located in the nucleus (Fang et
al., 2007). In this case an association with Ku70/Ku80 proteins
was reported and functional analysis revealed that Par3 regulates
DNA-PK activity through this interaction which is needed in the
repair of double-strand breaks. Neither Par6 nor Par3 has been
evaluated for aPKC interaction/complex capability. Thus aPKC
could be involved in individual nuclear functions with Par6 and/
or Par3 but in addition it is also conceivable that the well
established polarity complex (Par6/aPKC/Par3) exists in the
nucleus independently and fulfills as yet uncharacterized
functions.
It is necessary at this point to mention that the N-terminal
constructs (PKCiAA1-177 and PKCfAA1-176) we have used in our
study have an average molecular weight of around 55 kDa (and
even smaller with regard to the individual hinge constructs). Thus
as a consequence we are not able to exclude that some of our
immunfluoresence data are discolored by the fact that smaller
proteins can enter the nucleus by passive diffusion (Nigg, 1997).
Regardless of this fact we are convinced that our major findings
are not influenced by this fact since all relevant mutation have
been introduced and analysed in the full length proteins as well.
In addition also the hinge domains have been tested in the context
of a bigger fusion protein.
In conclusion, evidence for the implication of aPKCs in
nuclear function(s) are accumulating, some may be redundant
and some may be assigned to a single aPKC isoform. The
functions may be dependent on specific stimuli since we have
found that defined domains within the aPKC protein have various
influences on the nuclear translocation behavior of the protein.
Future challenges include the identification of the physiological
conditions in which individual aPKC isoforms translocate to the
nucleus which may then suggest links to specific nuclear
function.
Materials and Methods
Cell cultures
Madin Darby Canine Kidney (MDCK) cells were grown in Gibco
DMEM+GlutaMAX2-I (Invitrogen) with 15% Gibco fetal calf serum
(Invitrogen), Gibco non essential amino acids (Invitrogen), Penicillin (50 units/
ml) and streptomycin (100 mg/ml) (Invitrogen). For the nuclear export
experiments, Leptomycin B (Sigma-Aldrich) was added to the medium to a final
concentration of 4 ng/ml.
Plasmid constructions and site-directed mutagenesis
The murine cDNA was amplified from mouse brain RNA after reverse
transcription by PCR using HotStarTaq Master Mix from QIAGEN (203,443).
Following Primers were used: i/lPKCwt for: CAC CAT GCC GAC CCA GAG
GGA CAG CAG C; i/lPKCwt rev: GAC ACA CTC TTC TGC AGA CAT CAA
GAG GGG; fPKCwt for: CAC CAT GCC CAG CAG GAC GGA CCC CAA GAT
G; fPKCwt rev: CAC GGA CTC CAC AGC AGA CAG CAG AA; i/lPKCDC
rev: ACT GGA CGA CGC TTT ACC ACT CTC CCT GG; fPKCDC: CCC CTG
AGA GAT TTT GAT CCC ATC CAC; i/lPKC AA1-186rev: GAC CAG CTT
GTG GCA CTT CTT ATG; fPKC AA1-178rev: GAC GAG GAC GTG GCA
GCG TTT ATG GAC; i/lPKC AA27-247 for CAC CAT GTC CCA CAC GGT
CGC GTG; fPKC AA18-246: CAC CATGCG CGT CCG TCT GAA GGC GCA
CTA CGG; i/lPKC Hinge for: CAC CATGAC AAT TGA GTG TGG GCG GCA
CT; fPKC Hinge: CAC CATGGC TGA CCT GCA GGA GGC ATA TGG AT. All
PCR products were sub-cloned into pENTR-D-TOPO by using the Gateway
cloning system (Invitrogen) according to the manufacturer’s instructions. All
plasmids were verified by restriction enzymes and sequencing to confirm the
correct coding sequence. All expression plasmids were constructed using the LR
clonase Kit (Invitrogen) according to the manufacturer’s instructions. The pDEST
expression vector with a c-terminal GFP-tag was provided by Kjetil Tasken (The
Biotechnology Centre of Oslo, Norway). For sequencing of the constructs we used
following primer EGFP-N rev: CTGAACTTGTGGCCGTTTAC EGFP-N for:
TCCGCCCCATTGACGCAA. For the site directed mutagenesis we used the
Quickchange Site Directed Mutagenesis Kit (NO. 200518, Stratagene). The
primer-design was done with the Quick Change Primer Design tool on the
companies homepage. Following primers were used for the mutagenesis: i/
lPKCR141/142E for: GCC AAA CGT TTC AAT GAG GAG GCC CAC TGT
GCC ATC; i/lPKCR141/142E rev: GAT GGC ACA GTG GGC GCG CCT ATT
GAA ACG TTT GGC; i/lPKCR142G for: GCC AAA CGT TTC AAT AGG GGC
GCC CAC TGT GC; i/lPKCR142G rev: GCA CAG TGG GCG CCC CTA TTG
AAA CGT TTG GC;
fPKCR140/141E for: AAG CCA AGC GCT TTA ACG AGG AAG CGT ACT
GCG GCC AG; fPKCR140/141E rev: CTG GCC GCA GTA CGC TTC CTC GTT
AAA GCG CTT GGC TT; fPKCG141R for: AGC GCT TTA ACA GGA GAG
CGT ACT GCG GC; fPKCG141R rev: GCC GCA GTA CGC TCT CCT GTT
AAA GCG CT; i/lPKCD63A for: CAC CAT GAA ATG GAT AGC TGA GGA
AGG AGA CCC AT; i/lPKCD63A rev: ATG GGT CTC CTT CCT CAG CTA
TCC ATT TCA TGG TG; fPKCD62A for: CCT CAA GTG GGT GGC CAG TGA
AGG TGA CC; fPKCD62A rev: GGT CAC CTT CAC TGG CCA CCC ACT
TGA GG.
To generate aPKCfN-iHINGE and aPKCiN-fHinge constructs we designed
primers to add an additional BfaI restriction site to the N-terminus of the
corresponding Hinge-region and the C-terminus of the N-terminal region without
changing the amino acid sequence. The following primers were used: i/lPKCN-
Bfarev: GAC TAG GAC GTG GCA CTT CTT ATG; i/lPKCHINGE-Bfafor:
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GTC CTA GTC ACA ATT GAG TGT GGG CGG CAC T; fPKCN-Bfarev: GAC
TAG GAC GTG GCA GCG TTT ATG GAC; fPKCHINGE-Bfafor: GTC CTA
GTC CCG CTG ACC TGC AGG AGG CAT ATG GAT.
Both PCR products were sub-cloned into the pCRII-Topo plasmid according to
the manufactures protocol (Invitrogen). The fragments were then excised using
BamHI/EcoRV for the Hinge fragments and HindIII/XbaI for the N-terminal
fragments. Afterwards all fragments were digested with BfaI and ligation was
performed using the T4 DNA ligase from NEB according to the manufacturers
protocol. The ligation product was amplified using a specific primer set (see
above) and sub-cloned into the pENTR vector according to the manufacturers
protocol.
For the chimeric full length constructs (aPKCi-zeta HINGE, aPKCf-iHINGE) a
similar approach was chosen. An additional EcoRI site was added to the PCR
products of the kinase domain and aPKCfN-iHINGE and aPKCiN-fHinge
constructs using specially designed primers: i/lkinaseEcoRIfor: GAA TTC CTA
GGT CTG CAG GAT TTC G; i/lPKCDCEcoRIrev: GAA TTC ACT GGA CGA
CGC TTT ACC ACT CTC CCT GG; fkinase EcoRIfor: GAA TTC CTG GGG
CTG CAA GAC TTC G; fPKCDCEcoRIrev: GAA TTC CCC CTG AGA GAT
TTT GAT CCC ATC CAC.
The PCR products were then subcloned into pCRII-Topo plasmid. The resulting
plasmid was digested with EcoRI for 16 h at 37 C˚ to create EcoRI fragments. Both
fragments were ligated with T4 DNA ligase (NEB) according to the
manufacturer’s protocol. The ligation product was amplified by PCR using
primers for the wild-type full-length sequence and the PCR product was further
sub-cloned into the pENTR vector. All constructs were verified by Restriction
pattern and sequencing.
Subcellular localization analyzes and immunocytochemistry
For the sub-cellular localization studies of the different GFP fusion proteins,
MDCK cells were seeded in a 4-well dish with a 14 mm microscope cover glass
(Marienfeld), coated with 0.2% Gelantine at a density of 7.36106 per well 18 h
before transfection. The cells were then transfected with 0.8 mg of expression
vector using Lipofectamine. The cells were fixed with 4% paraformaldehyde for
15 min and permeabilized in 0.01% Triton X-100 for 10 min at room temperature,
24 hours after transfection. We used the Vectashield mounting medium with DAPI
(Vector) to mount the cells on a microscope slide (VWR). The GFP fusion proteins
were visualized by confocal microscopy using the Zeiss LSM 510 Meta invert
microscope equipped with a Zeiss LSM laser module and a AxioCam HMr digital
camera.
Image analysis
The color digital images of the fluorescing cells were processed by the Adobe
Photoshop CS5 (Adobe Systems Inc., USA) and analyzed by the ImageJ 1.43r
(National Institute of Health, USA, http://rsb.info.nih.gov/ij) software. The ‘Mean
Gray Value’ was quantitatively assessed in the selected regions of interest (ROI
‘‘Oval Selection’’) from the images using ‘‘Analyze’’ plugin (‘‘Measure’’ option).
The obtained data were in the arbitrary units of the 8-bit gray scale (0–256 units).
Ratios were presented as means with standard deviations.
Data analysis
The histogram analysis of the fluorescence signal was performed with the profile
tool provided by the LSM Image Examiner from Zeiss. The software enables the
user to analyze the pixel strength of a defined area and all channels. We used the
linear tool to analyze the localization of the GFP-fusion protein within the cell. To
visualize and analyze the dimension of a cell and the position of the nucleus we
used Alexa FluorH 647 (Invitrogen) labeled Wheat Germ Agglutinin (WGA). In
the histogram each peak represents a cell membrane. The two outer peaks
represent the outer cell membrane and the inner peaks the nuclear envelope. The
position and dimensions of the nucleus were visualized and analyzed by using 49,6-
diamidino-2-phenylindole (DAPI). Channel coding: red 5 WGA, blue 5 DAPI,
green 5 GFP.
Western Blot analysis
MDCK cells were transfected according to the Lipofectamine 2000 transfection
reagent from Invitrogen dependent of the size of the used cell culture dish.
24 hours after transfection the cells were trypsinized with 16 Trypsin (Invitrogen)
for 10 min at room temperature, the reaction was stopped by supplementing
DMEM containing 15% FCS. The pellet was collected and incubated in 80 ml of
protein extraction buffer (50 mM Tris/HCl, pH 7.5–8.0; 2 mM EDTA, pH 7.0;
10 mM EGTA, pH 7.0; 0.1% TritonX-100, 3% b-mercaptoethanol) supplemented
with Proteinase Inhibitor Cocktail (Sigma, NO. P-2714), incubated on ice for
20 min. After supplementation of 25 ml of protein sample loading buffer the
samples were boiled for 5 min. Subsequently. the samples were run on a 10%
SDS-polyacrylamide gel and blotted onto BioRad nitrocellulose membranes. The
membranes were blocked in 5% nonfat dry milk in TBST for 1 h at room
temperature. Incubation with the primary antibody happened overnight in TBST at
4 C˚. The following antibodies were used: anti-GFP (Santa Cruz Antibodies NO.
sc-8334) (1:500).
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Phenotypical analysis of atypical PKCs in vivo function 
display a compensatory system at embryonic stage 7.5 p.c.
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Abstract
Background: The atypical protein kinases C (PKC) isoforms ι/λ and ζ play  crucial roles in 
many cellular processes including development, cell proliferation, differentiation and cell 
survival. Possible redundancy  between the two isoforms has always been an issue since 
most biochemical tools do not differentiate between the two proteins. Thus, many efforts 
have been made during the last decades to characterize the functions of aPKCs using 
gene targeting approaches and depletion studies. However, little is known about the 
specific roles of each isoform in mouse development.
Methodology/Principal Findings: To evaluate the importance of PKCι/λ in mouse 
development we designed PKCι/λ deletion mutants using the gene targeting approach. We 
show that the deletion of PKCι/λ, results in a reduced size of the amniotic cavity at E7.5 
and impaired growth of the embryo at E8.5 with subsequent absorption of the embryo. 
Our data also indicate an impaired localization of ZO-1 and disorganized structure of the 
epithelial tissue in the embryo. Importantly, using electron microscopy, embryoid body 
formation and immunofluorescence analysis, we found, that in the absence of PKCι/λ, 
tight junctions and apico-basal polarity were still established. Finally, our study points to 
a non-redundant PKCι/λ function at E9.5, since expression of aPKCζ is able to rescue the 
E7.5 phenotype, but resulted in embryonic lethality at a later time-point (E9.5). 
Conclusion: Our data show that PKCι/λ is crucial for mouse embryogenesis but is 
dispensable for the establishment of polarity  and tight junction formation. We present a 
compensatory function of aPKCζ at E7.5, rescuing the phenotype. Furthermore, this 
study indicates at least one specific, yet unknown, PKCι/λ function that cannot be 
compensated by aPKCζ overexpression at E9.5.
Introduction
The protein kinase C (PKC) family of serine-threonine kinases consists of 9 different 
genes giving rise to at least 12 isoforms, subdivided into 3 subfamilies. The subdivision is 
based on sequence homologies and dependencies on cofactors during their activation 
process. Thus the classical PKCs (cPKC: α, β and γ) are supposed to be dependent on 
Ca2+ ions and diacylglycerol for their activation whereas the novel PKCs (nPKC: δ, ε, η 
and θ) based on the lack of a binding domain are Ca2+ ion independent but still need 
diacylglycerol for their activation. In sharp contrast, the subfamily  of the atypical PKCs 
(aPKC: ζ and ι/λ) are independent of Ca2+ ions and diacylglycerol for their activation, 
thereby, representing quite a distinguishable subgroup among the PKC family. This even 
becomes more pronounced by the fact that aPKCs are unresponsive to Tumor Promoting 
Agent 12-O-Tetradecanoylphorbol-13-Acetate (TPA) treatment, an early described 
feature for PKC family  members (see review Steinberg, 2008). Nevertheless, all PKC 
family members (including aPKCs) have been described to participate in a multitude of 
signaling pathways involved in cell growth, differentiation and apoptosis.
In 1989 Nishizuka and coworkers isolated the aPKCζ isoform out of a rat cDNA library 
{Ono:1989tp}. Four years later a second aPKC isoform (PKCɩ) was isolated and 
characterized {Selbie:1993ud} followed by  the identification of the mouse ortholog 
PKClambda {Akimoto:1994we}. As true for all other PKCs, the aPKC proteins can be 
divided into a regulatory N-terminal and a catalytic C-terminal part, separated by a hinge 
region. The exception is PKMζ which represents only the C-terminal kinase domain 
generated by  an internal promotor whose activity has been assigned to neurons 
{Hernandez:2003cq}. In contrast to other PKCs the N-terminal domain contains a Phox/
Bem1 (PB1) motif mediating interaction with p62 {Puls:1997vi, Sanchez:1998vv}and 
other signaling molecules like Mek5 {Hirano:2004gg} and Par-6 {Noda:2003fc} all of 
which are supposed to mediate aPKC signaling. In addition both aPKC also contain a 
cystein-rich zinc-finger like domain within the regulatory  N-terminal domain defined as 
C1. Whereas all other PKCs possess a tandem repeat, aPKCs possess only  one C1 
domain. Interestingly, this domain accounts for the binding of diacylglycerol and TPA in 
classical and novel PKCs. The aPKC C1 domain has been reported to bind directly to 
phosphatidylinositol (3, 4, 5)-triphosphat thereby inducing conformational changes in the 
protein leading to activation similar to diacylglycerol binding to other PKCs {Nakanishi:
1993tz}. But also other interacting partners, inhibitory as well as activating, have been 
described {DiazMeco:1996tw, Suzuki:2003il}. The aPKC C-terminal part represent the 
catalytic kinase domain sharing 86% homology to each other but only  45-55% to other 
PKCs. Overall both aPKCs show a 72% homology on amino acid level {Akimoto:
1994we}. Based on this high degree of homology and the limited availability of isoform-
specific tools the in vivo analysis of isoform-specific aPKC functions remained 
insufficient in mammals. Nonetheless, it has been shown that aPKCs are conserved in 
numbers of organisms, including C. elegans {Tabuse:2002tt} and D. melanogaster 
{Schaeffer:1989up} in which only one isoform was detected.
We have previously shown that both aPKCs are expressed during mouse embryonic 
development {Kovac:2007ev} as well as in distinct domains in the adult mouse brain 
{Oster:2004ik}. As a conclusion of these studies PKCι/λ was defined as being 
ubiquitously expressed whereas aPKCζ expression was pronounced in lung, kidney  and 
brain. The spectrum of physiological processes linked to aPKCs function is huge and 
covers cell proliferation {Berra:1995ub}, cell polarity {Lin:2000iw}, carcinogenesis 
{Regala:2005gm}, neurogenesis {Baye:2007ht} and many more. Attempts to investigate 
individual in vivo functions also made use of the gene targeting approach. We and other 
have generated aPKC deficient mouse lines which were subjected to various phenotypical 
investigations. Interestingly, a conventional aPKCζ knockout did not  display an 
embryonic phenotype in contrast to expectations raised by previous publications on a role 
for PKCζ during mouse preimplantation development {Pauken:2000ey}. Early  studies 
using the conventional aPKCζ knockout revealed a functional link to NFkB signaling 
{Leitges:2001tb, Martin:2002wq}. Subsequent studies also identified aPKCζ to act as 
tumor suppressor due to its regulatory  function on the Il-6 promotor {Galvez:2008je}. In 
sharp contrast a convential aPKCɩ knockout displayed an embryonic lethal phenotype 
{Soloff:2004vx}(personal communication with Shigeo Ohno and own data presented 
within this publication), clearly distinguishing both aPKC isoforms for the first time. 
Later studies using the conditional gene targeting approach showed inter alia specific in 
vivo functions for aPKCɩ but not for aPKCζ in muscle and podocytes {Farese:2007ix, 
Huber:2009jy}. 
Atypical PKCs have been described to form complexes with the partition defective 
proteins Par6 and Par3 {Joberty:2000uz}. Par genes have been cloned and characterized 
in 1995 {Guo:1995tp} and were shown to be crucial for asymmetric cell division in C. 
elegans and other organisms {EtienneManneville:2003tl, Watts:1996uo}. The association 
of aPKCs to this ternary complex, also called polarity complex {Suzuki:2006ke} 
integrates aPKC signaling into all aspects of polarity without any isoform specificity. 
Here, we subjected several established mutant mouse lines of the PKCɩ gene to a 
thorough developmental investigation. We present a detailed description of the embryonic 
lethal phenotype caused by the PKCɩ deficiency  and provide more insights into the 
redundancy within the aPKC subfamily. 
Results
Generation of 3 different Prkci alleles in mice. To investigate PKCɩ in vivo function, we 
decided to generate various mutant alleles following standard gene targeting approaches 
in mouse embryonic stem cells (ESs). First  we generated a conventional Prkci knock-out 
allele by inserting a neo cassette into the second exon of the gene causing a disruption of 
gene transcription (PKCɩNeo, details see supplementary figure 1). Since homozygozity of 
this allele caused embryonic lethality  (see later), we decided to generated an additional 
conditional allele for the Prkci. Again, the second exon of the gene was targeted by 
inserting loxP sites at the appropriate positions. This floxed allele (PKCɩflox) has been 
described and its functionality  has previously been shown {Farese:2007ix, Yang:2009uh, 
Murray:2009hf, Huber:2009jy}. We subsequently crossed PKCɩflox/flox mice with a 
transgenic mouse line {FSchwenk:1995wd} expressing the Cre recombinase in the germ 
line and in a ubiquitous fashion starting at embryonic day  (E) 13.5 (details see 
supplementary  figure 1) and obtained a second null allele for Prkci named PKCɩ△. Third, 
we generated a rescue allele (PKCɩζRes) in which a PKCζ cDNA was integrated into the 
Prkci locus such that it  became expressed under Prkci genomic and transcriptional 
regulatory elements (details see supplementary figure 1). 
PKCι/λ depletion during mouse development resulted in embryonic lethality. To 
investigate whether homozygozity of Prkci null alleles (PKCɩNeo and PKCɩ△) are 
compatible with embryonic development, we analyzed more than 100 offspring from 
matings of heterozygous carries for each line at 3 weeks after birth. For both individual 
lines we did not observe any homozygous offspring whereas heterozygous and wild-type 
mice were detected in the expected ratio. This implied an embryonic lethal phenotype for 
both mutant alleles in agreement with earlier data by  Hedrick and coworkers {Soloff:
2004vx}. We next  examined litters from heterozygous crosses at different  developmental 
stages to identify  the time point when first morphological abnormalities manifested in 
homozygous embryos. At embryonic day (E) 6.5, no morphological differences between 
litter-mates were apparent. At day E7.5, morphological inspection recognized a group of 
embryos which appeared “compressed” along the proximal-distal axis of the egg cylinder 
and harbored a small amniotic cavity  (Figure 1A). Histological analysis showed that the 
epiblast  was present but was thickened compared to non-affected litter-mates. 
Genotyping of individual embryos confirmed that this phenotype was restricted to 
homozygous embryos. 
At E8.5, mutant embryos were severely growth retarded. An anterior-posterior polarity  of 
the body axis was not readily apparent since head folds and a linear heart tube 
distinguishing the anterior end of the embryo and the allantois representing the most 
posterior aspect were reduced or lacking (Figure 1B). In contrast to control embryos that 
harbored 4-6 somites at this stage, somites were not discernible by histological analysis in 
the mutants. By E10.5, mutant embryos were reabsorbed by  the mother. Since phenotypic 
changes were indistinguishable between the two targeted alleles, we decided to 
exclusively use the PKCɩ△ line for further analysis.
PKCι/λ embryos are normally patterned along the anterior-posterior body axis but 
exhibit defects in mesodermal differentiation. Since morphological and histological 
analysis indicated a deficit in axial elongation and germ layer formation, we used a panel 
of marker genes to test for formation and differentiation of the germ layers and 
establishment of an anterior-posterior body axis in E8.5 embryos. 
In wildtype embryos, Otx2 expression marks the forebrain {Monaghan:1995uu}, Pax2 
the midbrain {Rowitch:1995we} and Fgf8 the midbrain/hindbrain boundariy  {Crossley:
1995tu}. In PKCɩ-deficient embryos all three genes were expressed in the “anterior” 
embryonic region but the domains were compressed indicating that  the (neuro-) ectoderm 
is patterned along the anterior-posterior axis but the expansion of the different primordial 
brain segments is comprised. Fgf8 is additionally  expressed in the primitive streak at the 
posterior end of the embryo overlapping with Brachury (T) that additionally marks the 
notochord, a thin line of cells extending from the forebrain/midbrain border to the 
primitive streak underneath the neural tube {Crossley:1995tu, Wilkinson:1990ih}. 
Expression of both genes was established in the mutant  but the primitive streak appeared 
much reduced and the notochord was disrupted. This shows that PKCɩ mutant embryos 
are polarized along the anterior-posterior body axis but  that differentiation of the axial 
mesoderm is impaired. Tcf15 (also known as paraxis) marks the praaxial msoderm 
{Burgess:1995wu} which was organized into 4-8 distinct somite pairs at this stage in teh 
wild-type. In PKCɩ-deficient embryos a domain of Tcf15 expression was found in the 
middle region of the embryos but individual somites were not formed. Expression of 
Bmp4 in the lateral plate mesoderm, the extraembryonic mesoderm and the 
extraembryonic ectoderm was found in mutant embryos as in the wild-type. Tbx20 was 
expressed in the allantois, a derivative of the extraembryonic mesoderm, and in the linear 
heart tube, which derives from the cardiac subregion of the anterior lateral plate 
mesoderm in the wild-type {Kraus:2001vs}. Again, both expression domains were 
established at opposite poles of the mutant embryos but neither domain was appropriately 
developed into a and an allantois, respectively. Finally, Gja, that is expressed in the 
cardiac endoderm and dorsal aorta in wild-type embryos {Delorme:1997uu} was 
restricted to cell clusters at the anterior and posterior pole of the mutant embryos but 
clearly  lacked an organization into vessel like structures. Together, this analysis suggests 
that PKCι/λ-deficient embryos exhibit a normal anterior-posterior polarization of their 
main body axis. Mesoderm formation is initiated but comes to a premature halt, 
mesoderm differentiation into axial, paraxial, lateral and extraembryonic subtypes occurs 
but subsequent formation of tissues and organs completely fails. As a consequence PKCι/
λ-deficient embryos die due to lack of a cardiavascular system.
Embryonic body formation is impaired by PKCɩ deficiency: Embryonic stem cells, when 
cultured as aggregates, form spherical structures which are defined as embryonic bodies 
(EBs). These structures are thought to recapitulate early  steps of the pre-implantation 
development including endoderm formation, basement membrane assembly, epiblast 
polarization and subsequent cavity formation {Coucouvanis:1995wi}. When cultured in 
suspension for 5 days, EBs form epithelial cysts consisting of an outer endoderm and an 
inner columnar epiblast epithelium (CEE), separated by a basement membrane. As PKCι/
λ mutants displayed an abnormal amniotic cavity at E7.5 we decided to use the 
embryonic body formation assay to analyze cavity formation in more detail.
When wild-type and PKCɩ deficient embryonic stem cells {Bandyopadhyay:2003dy}
were subjected to this assay, we detected obvious differences among the two genotypes. 
Wild-type EBs displayed the expected appearance in a phase contrast representation, 
aPKCɩΔ/Δ EBs showed a disorganized structure (Figures 3 B). Most  of the wild-type EBs 
formed a single large cavity enclosed by CEE after 5 days, whereas the mutant EBs did 
not cavitate at all or formed multiple small cavities adjacent to the polarized CEE, 
although the endoderm differentiated normally. When cultured for additional 2 days, most 
mutant EBs formed small cavities but failed to complete cavitation (Figure 3 A, B and C). 
Since caspase-dependent apoptosis has been described as a key mechanism involved in 
the early steps of cavity  formation {Coucouvanis:1995wi} we immunostained 5-day  EBs 
for cleaved (activated) caspase-3. Wild-type EBs displayed massive central apoptosis as 
evidenced by cleaved caspase-3 staining (Figure 3 D). By contrast, only  scattered 
apoptotic cells were detected in PKCι/λ deficient EBs. DAPI staining of condensed and 
fragmented nuclei, another hallmark of apoptosis, also showed reduced apoptosis at the 
center of mutant EBs (Figure 3 D). To further analyze the apoptosis during EB cavitation, 
we cultured EBs of both genotypes for 2 to 5 days and performed immunoblotting for 
cleaved caspase-3. Indeed, PKCι/λ deficient EBs expressed less apoptotic activity at all 
time points tested than the corresponding wild-type extracts (Figure 3 E). These results 
demonstrate that PKCι/λ deficient EBs fail to form a single cavity possibly due to 
reduced central apoptosis. 
Gene targeting experiments have shown that laminin-mediated basement membrane 
formation is essential for primitive ectoderm epithelialization and cavitation in EBs {Li:
2002hn, Murray:2000we}. The laminin α-1 chain is a key component of the embryonic 
basement membrane expressed early  on during development {Cooper:1983wb}. In the 
wild-type EB the laminin α-1 staining formed a continuous thin layer between endoderm 
and epiblast cells (Figure 3A). We did not observe obvious changes in basement 
membrane assembly in mutant EBs. These findings were confirmed by using perlecan as 
an alternative marker for the BM (Figure 3 F and G). However, ectopic basement 
membrane formation was detected at the center of ~20% mutant EBs (Figure 3F). This 
may be caused by failure in endodermal cell migration to the EB surface. Nonetheless, 
these results suggest that the cavitation defect in PKCι/λ deficient EBs is unlikely caused 
to ectopic basement membrane assembly. 
Atypical PKCs have been functionally linked to the establishment and maintenance of 
epithelial polarity and tight junction formation due to their association with Par3 and Par6 
(forming the so-called polarity complex). To determine if epiblast  polarity  is disrupted in 
the absence of PKCι/λ, we immunostained EBs for the apical marker MUPP1, Par3, the 
adherens junction protein E-cadherin and the Golgi marker GM130. The apical actin belt 
was visualized using rhodamine-phalloidin. As shown in Figure 3A, F-actin staining was 
detected as a continuous layer at the most inner cell membrane surrounding the single 
cavity in wild-type EBs. In mutant EBs, no such staining was detectable. The apical 
markers MUPP1 and Par3 were expressed at the same location (Figure 3F). The Golgi 
marker GM130 was positioned away from the basement membrane and localized on the 
apical side. Similarly, E-cadherin was enriched at the apex of the epiblast where they 
formed adherens junctions. These results provide evidence that polarity of the epiblast 
was intact.
Since the embryo and the EB express both PKCι/λ and PKCζ, we were wondering if the 
remaining aPKCζ could possibly compensate for some PKCι/λ function. Therefore, we 
immunostained aPKC using a pan aPKC antibody in wild-type and mutant EBs. In both 
genotypes similar signals at  the apex of the epiblast were detected (Figure 3G). Whether 
the signal in the wild-type reflects a combination of both aPKC isoforms is unclear but 
for sure the observed signal in the mutants represents PKCζ. In addition we also carried 
out a western blot analysis for aPKCs using protein extracts from EBs after 4 and 5 days 
of differentiation. The aPKC signal (ergo PKCζ in the PKCι/λ deficient background) 
appeared slightly  up-regulated at 4 days in PKCι/λ deficient extracts whereas after 5 days 
it became down-regulated when compared with wild-type EBs (Figure 3H). Taken 
together these results suggest  that PKCζ may compensate for the loss of PKCι/λ to confer 
an apical-basal polarity to epithelial cells in the epiblast.
Immunohistochemical and electron microscopical investigation revealed subtle changes 
in the overall organization of PKCι deficient embryos: Since PKCι/λ deficient EBs lacked 
apoptosis, we wished to evaluate the contribution of this process in the mutant embryos 
as well. However, we failed to detect increased apoptosis by cleaved (activated) 
caspase-3 staining nor did we detect changes in cell proliferation using a phospho-
specific histone 3 antibody between E7.5 embryos of either genotype (supplementary 
Figure S2).
We next analyzed whether the embryonic ectoderm of E7.5 mutant embryos harbored 
epithelial cells with normal apical-basal polarity and junctional complexes. Again we 
used an antibody specific for E-cadherin as a marker for adherens junctions (AJ). As 
shown in the overview and the higher magnification (Figure 4A and C) both genotypes 
displayed a clear signal at the apical side of the embryonic ectoderm. This indicated that 
polarity in the epithelial cell layer was established. However, in mutant embryos the 
signal did not form a sharp thin line but was interrupted at the apical side (figure 4A and 
C). We then further applied Occludin and ZO-1 specific antibodies as marker proteins for 
tight junctions (TJ). In both cases the wild-type showed a punctuated pattern at the apical 
pole as expected (Figure 4C, white arrows). In PKCι/λ mutants we detected signals for 
Occludin at the apical pole of the epithelial cell layer, but weaker (Figure 4C, open 
arrows). In contrast we were not able to detect  any signal for ZO-1 at the apical side in 
mutants. Instead we observed a weak cytoplasmic background signal. A semi-quantitative 
RT-PCR analysis of E7.5 embryos did not amplify a significant ZO-1 specific transcript. 
Western blot analysis did not detect ZO-1 protein in at E8.5 PKCι/λ mutants either 
(supplementary  figure 3). Thus we concluded that TJ exists in mutant  embryos but  that 
the composition of tight junction protein complexes is altered.
Based on our observation in EBs, we analyzed the aPKC content and localization in wild-
type and mutant embryos. As shown in figure 4B a commonly used antibody against 
aPKCs (Santa Cruz # sc121 C-20) stained primarily the apical pole of the embryonic 
ectoderm cell layer with a minor fraction also detected in the cytoplasm in the wild-type. 
In the mutant embryo the signal (representing PKCζ) is maintained at  the apical side. 
When applying a PKCι/λ specific antibody {Helfrich:2006de} the signal in the wild-type 
appeared broader, indicating that PKCι/λ is more widely distributed within the cells than 
indicated by the pan aPKC antibody, but still showing an accumulation at the apical 
membrane. The PKCι/λ mutant embryo did not show staining proving the specificity of 
the antibody. Hence, both aPKCs showed overlapping localization at the apical pole of 
embryonic ectodermal cells at E7.5 suggesting possible compensatory mechanisms.
To further elucidate the structural organization of the cell-cell contacts, we analyzed wild-
type and mutant embryonic tissue by using electron microscopy. Both genotypes showed 
a clear electron dense area at  juxtaposed membranes located at the apical side defined as 
tight junctions (TJ) (Figure 5A). Adherens junctions (AJ) and desmosomes (DS) were 
detected without identifying any difference among the genotypes (see figure. 5A). 
However, when focusing on the overall appearance, we observed a general tendency of 
mutants to possess a looser contact  zone between individual cells. This was indicated by 
more open gaps within the extracellular space when compared with wild-type (exemplary 
shown in figure 5B). At  the same time we observed in sections of mutants that F-actin 
normally localized in tight bundles in close proximity to the membrane appeared less 
tight organized. In addition, the distance between the bundles and the outer membrane 
seemed to be larger (Figure 5C). In summary the electron microscopic analysis provides 
further evidences for changes in the integrity of cell-cell contacts in the absence of PKCι/
λ.
PKCζ is able to rescue the early PKCι/λ in vivo function: PKCι/λ and PKCζ are 
structurally  highly related, suggesting shared functions and redundancy. We tested this 
assumption by  establishing a PKCɩζRes/+ mouse line which expresses a chimeric PKCζ 
protein under PKCι/λ conditions using its endogenous promotor and 5 ´and 3´ 
untranslated regulatory RNA sequences (see above and supplementary figure 1).
At E7.5, we did not detect any morphological changes within 111 embryos obtained from 
heterozygous intercrosses of this line. In addition, we were able to identify 21 
homozygous embryos (18.9%) for the rescue allele (PKCɩζRes/ζRes) when we genotyped 
these embryos by PCR (Figure 6, table). A Western Blot analysis of individual embryos 
revealed that wild-type and PKCɩ△/+ embryos showed a reasonable aPKC signal (using a 
pan aPKC antibody) whereas in the aPKCɩΔ/Δ no such signal was identified. 
Interestingly  in PKCɩζRes/ζRes embryos an aPKC specific band was detectable including a 
50kDa fragment which is supposed to be a proteolytic product of PKCζ, proving the 
isoform specificity  of the expressed protein (Figure 6C). We concluded that PKCζ 
expressed under endogenous PKCι/λ condition is able to rescue the early  PKCι/λ 
phenotype. In contrast, we failed to identify any PKCɩζRes/ζRes animals in 150 offspring 
derived from heterozygous crosses at  P21 indicating that PKCζ is not able to compensate 
for PKCι/λ ´s function during later stages of development (see table in figure 6). To 
define the lethality of  PKCɩζRes/ζRes embryos, we screened several embryonic stages for 
morphologically divergent embryos. At E9.5, PKCɩζRes/ζRes embryos were severely 
retarded in growth (Figure 6A). Western blot analysis revealed that PKCζ but not PKCι/λ 
was expressed in the rescue embryos whereas PKCζ was not expressed in the wild-type 
(Figure 6D). Thus, PKCζ is able to compensate for PKCι/λ in vivo function at E7.5 but 
not at later stages.
Discussion 
The aim of this study was to shed more light on early  embryonic in vivo functions of PKCι/λ in 
mouse. Earlier genetic studies in C. elegans, Xenopus and Drosophila melanogaster 
indicated a pivotal role of aPKC in the establishment and maintenance of polarity of 
oocytes and epithelial cells {Izumi:1998tb, Tabuse:1998vr, Cha:2011di, Dominguez:
1992vl}. These findings were mainly  connected to the functional and physical association 
of aPKC to par3 and par6, which together form the polarity complex {Suzuki:2006ke}. 
This ternary  complex is conserved among species suggesting a related phenotype upon 
depletion of PKCι/λ in mouse embryos. In fact a report by Soloff et. al, 2004 described an 
embryonic lethal phenotype when the PKCι/λ gene was knocked out by conventional 
gene targeting without a detailed developmental analysis. Both of our generated knock 
out mouse lines for PKCι/λ showed an embryonic lethal phenotype with first 
morphological manifestations around E7.5. Mutant embryos appeared compressed and 
are characterized by a severely reduced amniotic cavity. Nevertheless a histological 
examination revealed still the existence of epithelial cells which was rather unexpected 
since all studies from other species identified alterations in epithelial cell layers. So far 
publications describing gene knockouts in mice of polarity related proteins do not exactly 
match phenotypically  with the PKCι/λ knockout. For example a conventional knock out 
of cdc42, an established activator of aPKCs in the context of the par3/aPKC/par6 
complex, revealed a much earlier phenotype. Embryos deficient for cdc42 showed first 
signs of alterations at E5.5 and were degraded at E6.5 {Chen:2000gp}. Rac1, another 
small GTPase, which had been implicated many times as signal mediator of aPKC 
signaling also revealed an earlier phenotype in the knockout. In this case the main cause 
of lethality was linked to failures in the actin cytoskeletal reorganization combined with 
reduced motility and increased programmed cell death {Sugihara:1998ii}. A complete 
knock out of par3 caused mid-gestational embryonic lethality (around E9.5) which was 
correlated to a defective cardiac development {Hirose:2006ih}. Unfortunately published 
data on a par6 knockout in mice are currently not available to our knowledge. One of the 
most similar knock outs published so far, when taking morphological criteria into 
account, is represented by the afadin knockout. Similar to the PKCι/λ knockout 
morphological changes occurred at E7.5 and resembled what we saw in the PKCι/λ 
deficiency (compressed embryo and small amniotic cavity) {WataruIkeda:1999ws}. 
Nevertheless the described disorganized cell-cell junctions did not exactly  match our 
observation. Interestingly afadin has been described as adapter protein connecting nectin 
to actin filaments {Komura:2007km} and to colocalize with par3/aPKC at adherens 
junctions in the neuroepithelium of the developing mouse central nervous system [55]. 
Thus a similar function earlier during development is conceivable but further experiments 
are needed to underpin this hypothesis. 
Our marker analysis revealed that PKCι/λ-deficient embryos start to gastrulate and 
establish distinct anterior-posterior and dorso-ventral body axes at around E7.5-E7.75. 
However, axial elongation and mesoderm formation arrests around this stage and 
elaboration of all mesodermal tissues and organs fails. Absence of a functional 
cardiovascular system is the cause of the subsequent death. Given the fact that all 
embryonic tissue are affected our data suggest that PKCι/λ is not regionally but cellularly 
required. 
Applying the embryonic body formation assay  we showed that mutant EBs failed to 
establish a single cavity instead they formed multiple small cavities. Nevertheless a 
proper formation of the basal lamina and the apical domain by various marker proteins 
could be detected (see figure 3). Particular the correct localization of par3 and Mupp1 
implied an established apical pole which to some content did not surprise since studies 
performed in C. elegans showed that loss of PKC-3 did not affect par3 localization either 
[56]. Interestingly EBs deficient for cdc42 not only fail to form a single lumen cavity but 
also showed a complete loss of aPKC and par3 localization at the apical domain [57]. 
One reason for this difference might be that cdc42 is not able to distinguish between the 
two aPKC isoforms and we showed that PKCζ is still present in PKCι/λ deficient EBs. 
Thus we assume that depletion of cdc42 resulted in a robust  reduction of both aPKC 
activities causing a more severe phenotype. This finds support by  the fact that 
overexpression of a dominant negative aPKCζ version in wild-type EBs mimics the 
cdc42 phenotype [57]. The formation of a single cavity has been described as a two-step 
process: first, multiple small lumen are formed in the periphery of the EB and within a 
second step smaller lumen are fused and remaining inner cells undergo apoptosis to clear 
the central lumen [42]. Our data suggest  that the loss of PKCι/λ did not interfere with the 
first step but disrupted the second. Whether PKCι/λ acts on the fusion of the small 
cavities or the subsequently induced apoptosis or both is not solved yet but from our data 
it´s clear that PKCι/λ deficiency caused a decrease of activated caspase-3 and less 
apoptotic cells in EBs.
The immunohistochemical analysis of E7.5 embryo sections revealed by  the E-cadherin 
staining that the general polarity of the embryonic ectoderm is preserved in mutants. But 
it became apparent that the fine structure of the apical side is changed (indicated by  its 
fuzzy  appearance) when compared to the wild-type at higher magnification (Figure 4 C). 
As a possible explanation we found ZO-1, a tight junction protein, to be down-regulated 
and dislocated in epithelial cells deficient for PKCι/λ. ZO-1 is believed to function as a 
junctional organizer by direct binding to tight junctional proteins (like occludin and 
claudins) and the actin cytoskeleton. Thus it  could well be that the absence of ZO-1 in 
tight junction complexes could lead to a lack of proper connections of tight junctions to 
the actin cytoskeleton, causing a less well organized actin belt at the apical side which 
leads to the initially  observed fuzzy appearance. This hypothesis finds support by the EM 
analysis, which clearly  showed that F-actin filaments are less compact organized and the 
distance between the outer membrane and the F-actin filaments appears to be increased in 
mutants. Nevertheless a conventional ZO-1 knockout displayed a later phenotype mainly 
associated with defect in angiogenesis and increased apoptosis [58]. One plausible 
explanation for this might be the existence of compensatory mechanisms in the ZO-1 
knock out, which do not exist in the PKCι/λ deficiency. As for example the remaining 
ZO-2/3 proteins might function redundant when ZO-1 was deleted whereas a knockout of 
a crucial downstream kinase cannot be compensated for in this system. 
When analyzing aPKCs cellular localization (Figure 4B) we mainly detected aPKC at the 
apical side, representing the expected pattern for aPKC in epithelial cell layer [59-61]. To 
our surprise a nearly unchanged pattern was detected in mutants as well, indicating that 
either aPKCs share overlapping expression domains or PKCζ becomes up-regulated in 
mutants. We favor the first since neither a semi-quantitative PCR nor a Western Blot 
analysis of E7.5 PKCɩ△/+ and E8.5 aPKCɩΔ/Δ was able to identify an up-regulation of 
PKCζ (supplementary  Figure 3). Thus, we assume that PKCζ can potentially take part at 
the predicted in vivo function of aPKCs with regard on the establishment and 
maintenance of polarity due to its cellular localization, thereby might compensate for 
PKCι/λ deficiency. In addition the increased cellular localization pattern of PKCι/λ, 
identified by a specific antibody, implied that PKCι might fulfill other in vivo functions 
than the ones predicted by its association to the par3 and par6 proteins. 
When PKCζ was expressed under the same spatial and temporal conditions like PKCι/λ 
(PKCɩζRes/ζRes allele) we were not able to detect embryos at E7.5 displaying the 
morphological changes described earlier. We concluded that PKCζ is able to compensate 
for PKCι/λ in vivo function at E7.5 when expressed at  higher levels than in the wild-type. 
Thus the originally defined PKCι/λ specific in vivo function at E7.5 represents an aPKC 
signalling pathway which became PKCι/λ specific through a very tight transcriptional 
control. Interestingly the PKCɩζRes allele is not able to compensate for PKCι/λ functions at 
E9.5 since embryos homozygous for this allele showed a clear growth retardation 
resulting in lethality one to two days later. This points to the fact that later during 
development PKCι/λ in vivo function exists which are not redundant among the aPKC 
subfamily and could therefore be described as isoform-specific. 
In summary we showed that the depletion of PKCι/λ caused embryonic lethality with the 
earliest time-point of visible morphological changes at E7.5. To our surprise we still 
detected a strong staining for aPKC at the apical membrane in PKCι/λ deficient embryos 
indicating that a reasonable amount of PKCζ still localize to this area. This per se might 
be a reason why the basal to apical cell architecture in PKCι/λ deficient embryos was still 
conserved. In addition it also identified a possible PKCζ function in this context by its 
very precise localization which by far was not  expected based on expression data earlier 
published. As a consequence of PKCι deficiency we identified a severe down-regulation 
of ZO-1 which could explain the subtle alteration in the cellular structure. Nevertheless 
the cellular mechanism of PKCι/λ in vivo function at E7.5 remained unsolved. 
Interestingly  PKCζ was able to rescue the PKCι/λ deficient phenotype when expressed at 
the same levels like PKCι/λ. This identifies the aPKCs as a very redundant kinase 
subfamily in which transcriptional as well as spatial cues regulate its isoform specificity.
Materials and Methods
Generation of mutant Prkci alleles: To clone the mouse Prkci locus a 129/Ola genomic 
cosmid library (obtained from the Resourcenzentrum, Berlin, Germany) was screened 
using a full length mouse cDNA as a probe. Several cosmid clones were identified and 
further purified. One of those containing the genomic 5´prime part of the gene was 
selected for further cloning. To generate several targeting constructs for the PKCι/λ gene 
a 10.9 kb genomic EcoRI fragment, including the 2nd exon, was subcloned into a 
bluescript backbone. The convential targeting vector was generated by inserting an 
independent neo-cassette (derived from pMC1neoPolyA from Stratagene) into a Sal I 
restriction site, which was introduced into the 2nd exon by site directed mutagenesis. The 
conditional targeting vector was generated by introducing a single loxP site into the 
EcoRV restriction site 3.3 kb located upstream of the 2nd exon and insertion of a loxP-
flanked neo-cassette into a BglII restriction site 1.5 kb downstream of the 2nd exon. The 
PKCι/λ rescue targeting vector was generated by introducing an appropriate PKCζ 
cDNA fragment into the SalI restriction site introduced by mutation within the 2nd exon 
which corresponds to the 29th codon. The PKCζ cDNA fragment contained the complete 
3´untranslated PKCι/λ UTR and a loxP-flanked neo-cassette along with the coding 
sequence. All three targeting vectors were linearized before electroporation in ES cells of 
the E14.1 background (129/Ola). For each electroporation 2 x 96 G418-resistant ES cell 
clones were screened for homologous recombination in the PKCι/λ gene locus by 
Southern blot analysis. For each construct at least 2 ES cell clones were identified proved 
to be correctly targeted. These were further used for injections into NMRI blastocysts. 
Chimeric males were obtained for each construct and subsequently mated to NMRI 
females to test for germ-line transmission. Each targeted mutation gave rise to F1 
heterozygous males which were then further used for establishing the corresponding 
mouse lines for phenotypic analysis.
Mice and genonotyping: Mice carrying a null allele of Prkci and the PKCɩζRes allele were 
maintained on an outbred (NMRI) background. For timed pregnancies, vaginal plugs 
were checked in the morning after mating; noon was taken as embryonic day (E) 0.5. 
Pregnant females were sacrificed by cervical dislocation; embryos were harvested in 
phosphate-buffered saline, decapitated, fixed in 4% paraformaldehyde overnight, and 
stored in 100% methanol at -20°C before further use. Genomic DNA prepared from yolk 
sacs or tail biopsies was used for genotyping by polymerase chain reaction (PCR). 
Ethics statement: All animal work conducted for this study was approved by … and 
performed according to Norwegian and German legislation.
Hematoxylin and eosin staining of embryonic sections: For histological analysis, wild-
type or aPKC mutant embryos were fixed in 4% paraformaldehyde and embedded in 
paraffin wax. Sections of 4 µm were processed for cytohistochemistry after de-
paraffinization. After rehydration the section were incubated in 1x Gill’s Hematoxylin 
(haematoxylin 6.0g, aluminum sulphate 42.0g, ethylene glycol 269ml, citric acid 1.4g, 
sodium iodate 0.6g, distilled water 680ml) for 5 minutes. After washing the samples were 
incubated in acid alcohol (1% HCl in 70% EtOH) and washed again. After incubation in 
ammonia water the samples were rinsed and incubated in eosin Y (Sigma-Aldrich, 
HT110132-1L) for 1 minute. Before mounting with a xylene-based mounting medium 
cells were dehydrated. Embryos were documented using Zeiss Lumar V.12 with 
AxioCam HRc camera.
Whole mount RNA in situ analysis: Whole-mount in situ hybridization on E8.5 embryos 
was performed following a standard procedure with digoxigenin-labeled antisense 
riboprobes [62]
Embryoid body culture and processing: The ES cell line used for this study were wild-
type E14 and aPKCɩΔ/Δ ES cells [43]. Wild-type and aPKCɩΔ/Δ ES cells were cultured 
on mitomycin C-treated STO cells. EB formation was initiated from ES cell aggregates in 
suspension culture as described previously  (Li 2006). For immunofluorescence, EBs were 
collected into 15-ml conical tubes, allowed to sediment by gravity, washed once in 
phosphate-buffered saline (PBS), and fixed with 3% paraformaldehyde. EBs were then 
embedded in OCT compound, sectioned on a Leica cryostat and immunostained for 
antigens of interest (Li 2006). F-actin was stained with rhodamine-phalloidin (Molecular 
Probes). Nuclei were counterstained with DAPI. Slides were examined with a Nikon 
inverted fluorescence microscope (Eclipse TE 2000) and digital images were acquired 
with a cooled CCD camera (Hamamatsu) controlled by  IP Lab 4.0 software (Scanalytics). 
For immunoblotting, EBs were washed 3 times in PBS and lysed in SDS lysis buffer (50 
mM Tris, pH 7.4, 150 mM  NaCl, 1% SDS) containing protease and phosphatase inhibitor 
cocktails. Protein concentrations were determined using BCA reagents (Pierce). Proteins 
of equal loads were resolved by SDS-PAGE and then transferred onto PVDF membranes, 
which were blocked with 5% nonfat dry milk. After incubation with primary antibodies, 
specific signals were detected with HRP-conjugated secondary antibodies and ECL 
reagents. Antibodies used: PKCζ rabbit polyclonal antibody (Cat# 07-264) and GAPDH 
mouse monoclonal antibody  were purchased from Millipore. Perlecan rat monoclonal 
antibody was purchased from Santa Cruz Biotechnology, Inc. Cleaved caspase-3 rabbit 
polyclonal antibody  was bought from Cell Signaling Technology. Actin polyclonal 
antibody was bought from Sigma.
Immunohistochemistry and imaging analysis: For Immunohistological analysis, wild-type 
and aPKC mutant embryos were fixed in 4% paraformaldehyde and embedded in paraffin 
wax following standard protocols. Sections of 4 µm were processed for 
immunohistochemistry. Antigen retrieval was performed after de-waxing to enhance 
staining. Sections were then incubated with 5% fetal calf serum for 1 hour, and then 
washed three times with sterile PBS (pH 7.5) prior to overnight incubation with the 
appropriate primary antibodies at optimal dilutions (aPKCζ, SantaCruz, 1:200; aPKCɩ, 
1:5000; aPKCζ, 1:7500 [47]; claudin, Zymed, 1:500; Occludin, Zymed, 1:500; ZO-1, 
Zymed, 1:100; cleaved caspase-3, Cell Signaling, 1:500, phistone 3, Cell Signaling, 
1:500, E-cadherin, Santa Cruz, 1:500). The secondary  antibody, AlexaFluor 647 
conjugated anti-rabbit antibody was bought from InvitrogenⓇ, was used in a 1:1000 
dilution and overnight incubation. The section were then mounted in Prolong Gold with 
DAPI reagent from InvitrogenⓇ (#P36930). Images were taken with the Zeiss LSM 510 
Meta invert microscope equipped with a Zeiss LSM laser module and a AxioCam HMR 
digital camera.
Electron microscopy: The embryos were fixed in 2% glutaraldehyde in 0.1 M sodium 
cacodylate buffer. After washing, specimens were rinsed twice for 10 min in 0.1 M 
sodium cacodylate buffer and postfixed with 2% osmiumtetroxide (OsO4) containing 
1.5% potassium ferric cyanide ((K3Fe(CN)6)) for 1 h. Following extensive rinsing with 
water, dehydration with an alcohol series was performed. Specimens were placed in 
100% alcohol and Epon 1:1 overnight and then embedded in pure Epon. Ultrathin 
sections were cut with a Leica microtome for TEM microscopy and placed on carbon 
coated copper grids. Images were taken with a Philips CM  100 transmission electron 
microscope (TEM) at various magnifications.
Western blot analysis of embryos: Embryos were collected isolated at either E7.5 or E9.5 
from the mother animal. All extraembryonic tissue was removed before lysing the whole 
embryo in protein extraction buffer for 20 min. on ice (50mM  Tris/HCl, pH 7.5-8.0; 2 
mM EDTA, pH7.0; 10 mM  EGTA, pH 7.0; 0.1% TritonX-100, 3% β-mercaptoethanol) 
supplemented with Proteinase Inhibitor Cocktail (Sigma, #P-2714). A 31 gauge syringe 
was used to disrupt  the tissue. The samples were centrifuged at 8.000rpm for 8 min and 
the supernatant was transferred into a new tube before supplementing protein sample 
loading buffer and boiling for 5 min. The samples analyzed on a 10% SDS-
polyacrylamide gel and blotted onto BioRad nitrocellulose membranes. The membranes 
were blocked in 5% nonfat dry  milk in TBST for 1 h at room temperature. Incubation 
with the primary  antibody overnight in TBST at 4℃. The following antibodies were 
used: anti-PKCζ (Santa Cruz, C-20), anti aPKCɩ 1:10.000, anti-aPKCζ 1:5000.
Semi-quantitative RT-PCR analysis: Embryos were isolated at appropriate stage and 
directly  lysed in TRIZOL reagent from InvitrogenⓇ . The RNA isolation was performed 
according to the TRIZOL manual. The reverse transcription to obtain cDNA was 
performed using the iSCRIPT- cDNA synthesis kit  from Bio-RAD. For the expression 
analysis the HotStar Taq PLus DNA Polymerase from Qiagen in combination with 
following primers was used: ZO-1 (forward-primer AGCTGTTTCCTCCATTGCTG, 
reverse-primer: GAGATGTTTATGCGGACGGT), aPKCζ (forward-primer: 
G C C T C C C T T C C A G C C C C A G A , r e v e r s e - p r i m e r : 
C A C G G A C T C C T C A G C A G A C A G C A ) a n d a P K C ɩ ( f o r w a r d - p r i m e r : 
AGGAACGATTGGGTTGTCAC, reverse-primer: GGCAAGCAGAATCAGACACA). 
All primers were designed with an optimal annealing temperature at 60℃ and a amplicon 
size of around 300bp.
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Figure Legends
Figure 1: Histological overview of E7.5 and E8.5 embryos. (A) Sagittal sections of wild-
type and aPKCɩΔ/Δ embryos at E7.5 (right). Image of the corresponding embryo (left) 
(B) Sagittal sections of wild-type and aPKCɩΔ/Δ embryos at E8.5 (right). Image of the 
corresponding embryo (left). Abbreviations: ac, amniotic cavity; all, allantois; am, 
amnion; ec, ectoplacental cavity; fnf, forebrain neural-fold; hb, hindbrain; mb, midbrain; 
h, heart;  ps, primitive streak; S=somites; tl; tiny lumina.
Figure 2: Whole-mount in situ hybridization analysis of markers for germ line formation 
and establishment of an anterior-posterior body axis in E8.5 embryos. 
Figure 3: Immunofluorescence analysis of embryoid bodies (EBs) from either wild-type 
(WT) or aPKCɩΔ/Δ. (A) EBs from WT and aPKCɩΔ/Δ ES cells were stained with 
Rhodamin-Phalloidin (red, F-actin) and an antibody against Laminin-ɑ1 (green, Lm ɑ1). 
(B) Phase-contrast picture of 5 days old WT and aPKCɩΔ/Δ EBs. (C) Statistical analysis 
of lumen formation of 5 days and 7days old EBs from WT and aPKCɩΔ/Δ ES cells. (D) 
EBs from WT and aPKCɩΔ/Δ ES cells were stained with antibodies against cleaved 
caspase-3 (green, cleaved cas-3) and perlecan (red). (E) WB analysis of activated 
caspase-3 at different time-points in WT and aPKCɩΔ/Δ EBs. (F) Immunofluorescence 
analysis of EBs from either WT or aPKCɩΔ/Δ ES cells including localization of E-
cadherin, MUPP1, Par3 and GM130 (green), perlecan and laminin ɑ1 (red) (G) EBs from 
WT and aPKCɩΔ/Δ ES cells were stained with antibodies against perlecan (green) and 
aPKCzeta (red, PKCζ). (H) WB analysis of PKCζ in 4days and 5days old WT and 
aPKCɩΔ/Δ EBs. Nucleus staining was performed with DAPI. Scale is as indicated.
Figure 4: Immunofluorescence analysis of marker proteins in aPKCɩΔ/Δ embryos: 
Analysis were performed using the indicated antibodies. (A) Overview of a section 
showing a complete embryo with immunostaining against  E-cadherin (E-cad). (B) 
Immunofluorescence analysis of aPKC localization at the apical pole of wt and PKCɩ- 
deficient embryos in high magnification. (C) Immunofluorescence analysis of proteins 
involved in cellular polarity  (E-cad, E-cadherin; Occl., Occludine; ZO-1, Zonula 
Occludens-1). Localization of Occl. is indicated by  open arrows and the localization of 
ZO-1 by solid arrows. The scale bars indicate 20µm.
Figure 5: Electron microscopic analysis of aPKCɩ-deficient embryos: Embryos were 
isolated at E7.5. (A) Apical junctional complex (AJC) formation in wild-type (aPKCɩ-wt) 
and aPKCɩ-deficient (aPKCɩΔ/Δ) embryos was compared. Functional complexes are 
indicated: tight junction (TJ), adherens junctions (AJ) and desmosomes (DS). The 
amniotoc cavity  is indicated by an asterix. (B) Arrows indicate intracellular space in the 
apicobasal membrane in aPKCɩ-wt and aPKCɩΔ/Δ embryos. The orientation of the 
images is comparable to the images in A. (C) Arrows indicate the F-actin bundles parallel 
to the cell-membrane in aPKCɩ-wt and aPKCɩΔ/Δ embryos. EM  analysis was performed 
as described in Materials and methods. Representative micrographs are presented. Bar is 
equivalent to 200 micrometer (200 μm).
Figure 6: Overexpression of aPKCζ rescues PKCɩ KO phenotype: (A) Comparison of the 
appearance of embryos, that are either wt, heterozygous for the rescue allele (PKCƖζRes/+) 
or homozygous for the rescue (PKCƖζRes/ζRes) allele embryos at embryonic stage E9.5. (B) 
Table containing the total numbers of analyzed embryos at stage E7.5 and E9.5 and the 
corresponding percentage of the genotypes. (C) Western blot analysis of E7.5 embryos 
using an antibody against pan-aPKC (D) Western blot analysis of E9.5 embryos using 
indicated antibodies.
Supplementary  figure 1: Targeting of the PKCι/λ locus in mice. A) Schematic 
representation of the chosen targeting strategy. A restriction map indicating relevant 
restriction sites of the wild-type locus is shown. The black box represents the second 
exon of the PKCι/λ gene which was further used for all targeted modifications. The 2 
white boxes below indicate the 5´HindIII-EcoRI RFLP probe and the 3´KpnI-EcoRI 
RFLP probe used for later southern blot analysis. Generated targeting constructs are listed 
below; convential - harbors an inserted neo cassette into the 2nd exon, conditional - 
contains a single LoxP site 5´ and a floxed neo cassette 3´ of the 2nd exon and lastly 
rescue - represents an inserted PKCζ cDNA into the coding sequence of the 2nd exon 
followed by a floxed neo cassette. Resulting targeted alleles after homologous 
recombination and subsequent Cre expression are indicated. B, BamHI; Bg, BglII; E, 
EcoRI; EV, EcoRV; H, HindIII; K, KpnI. B) Southern blot  analysis of embryonic stem 
cell clones after G418 selection (PKCι/λ Neo allele; PKCι/λ floxed allele) and 
heterozygous offspring from intercrosses of the PKCι/λ Δ allele and PKCι/λ ζRes allele. 
From left to right; BamHI RFLP using the 5´probe identifies 2 clones of the convential 
targeting by a 6.5kb band whereas the 8.0 kb band represents the wild-type band, HindIII 
RFLP using the 5´probe identifies 1 targeted ES clone for the floxed allele (2.0kb band); 
the PKCι/λ Δ allele was characterized by EcoRI using the 3´probe resulting in a 11.0kb 
wild-type and a 3.2kb mutant band and by BglII in association with the 5´probe resulting 
in a 8.4kb wild-type and 10.4kb mutant band, the PKCι/λ ζRes allele was characterized 
by EcoRI using the 3´probe resulting in a 11.0kb wild-type and a 5.1kb mutant band and 
by BglII in association with the 5´probe resulting in a 8.4kb wild-type and 14.4kb mutant 
band. C) PCR genotyping of DNA samples generated from progeny of heterozygous 
intercrosses of the indicated alleles. For PKCι/λ Δ and PKCι/λ ζRes embryos at E7.5 were 
used as starting material for the DNA extraction. Corresponding genotypes are indicated 
above the individual agarose gels. 
Supplementary  figure 2: Proliferation and apoptosis in PKCι/λ mutant embryos: E7.5 
embryos were embedded in paraffin and then sectioned into a 5µm thick slices. 
Immunofluorescence analysis were performed using the indicated antibodies. Markers for 
either apoptosis (cleaved caspase-3, 1:500) or proliferation (phospho-histone-3, 1:500) 
were used for immunofluorescence analysis of aPKCɩΔ/Δ embryos or wild-type (WT). 
All analysis were done by using the Zeiss LSM 510 confocal microscope. Scale bar: 100 
µm
Supplementary  figure 3. Protein expression and protein levels analysis in wild-type and 
aPKCiota-deficient embryos (A) Expression analysis of indicated proteins in wild-type 
(WT) and aPKCɩΔ/Δ embryos at stage E7.5. (B) WB analysis of WT and aPKCɩΔ/Δ 
embryos at stage E7.5 and E8.0 using antibodies as indicated. Results of the aPKC blot 
are shown with different exposure times: 2 min (lower lane) and 5 min (upper lane).
Contributions of individuals:
SS - western blotting, rescue work, RT-PCR and IF
UB - involved in most of the experimental work
SL - EB work
NR - EM work
AK - RNA in situ and writing manuscript
ML - Design, supervision and writing manuscript
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